SCHEDULE 14A
(Rule 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934 (Amendment No. )
Filed by the Registrant |X|
Filed by a Party other than the Registrant |_|
Check the appropriate box:
|_| Preliminary Proxy Statement
|_| Confidential for Use of Commission Only (as permitted by Rule 14a-6(e)(2)
|X| Definitive Proxy Statement
|_| Definitive Additional Materials
|_| Soliciting Material Pursuant to Rule 14a-11(c) or Rule 14a-12
RCG COMPANIES INCORPORATED
(Name of Registrant as Specified in Its Charter)
--------------------------------------------------------------------------------
(Name of Person(s) Filing Proxy Statement, if Other than the Registrant)
Payment of filing fee (Check the appropriate box):
|X| No fee required.
|_| Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
(1) Title of each class of securities to which transaction applies:
--------------------------------------------------------------------------------
(2) Aggregate number of securities to which transaction applies:
--------------------------------------------------------------------------------
(3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee
is calculated and state how it was determined):
--------------------------------------------------------------------------------
(4) Proposed maximum aggregate value of transaction:
(5) Total fee paid:
--------------------------------------------------------------------------------
|_| Fee paid previously with preliminary materials.
|_| Check box if any part of the fee is offset as provided by Exchange
Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was
paid previously. Identify the previous filing by registration statement number,
or the Form or Schedule and the date of its filing.
(1) Amount Previously Paid:
--------------------------------------------------------------------------------
(2) Form, Schedule or Registration Statement No.:
--------------------------------------------------------------------------------
(3) Filing Party:
--------------------------------------------------------------------------------
(4) Date Filed:
RCG COMPANIES INCORPORATED
6836 Morrison Blvd., Suite 200
Charlotte, NC 28211
June 1, 2005
Dear Fellow Stockholders:
On behalf of the Board of Directors of RCG Companies Incorporated, we
invite you to join us at the Annual Meeting (the "Meeting") of Stockholders,
which will be held at the Westin at 3391 Peachtree Road NE, located in Atlanta,
Georgia on June 24, 2005 at 9:30 a.m. EST.
At the Meeting, you will be asked to (i) elect eight directors of the
Company; (ii) ratify the appointment of BDO Seidman, LLP, as our independent
registered public accounting firm for the Company for the fiscal year ending
June 30, 2005; (iii) to approve, to the extent required for compliance with the
American Stock Exchange rules, the issuance of additional shares of the
Company's common stock in connection with the Company's February 2005
acquisition of Farequest Holdings, Inc., as needed for full (a) conversion of
the Company's Series B 6% Redeemable Participating Preferred Stock into Common
Stock; (b) payment of the Company's $6,037,872 Promissory Note with 3,018,936
shares of Common Stock for the principal amount, plus payment of interest of 4%
per year in shares of Common Stock as needed, and (c) issuance of shares of
common stock as needed in full satisfaction of the Contingent Shares payable to
the Farequest Holdings, Inc. former shareholders; (iv) to approve, to the extent
required for compliance with the American Stock Exchange rules, issuance of
additional shares of the Company's common stock as needed for the full
conversion of the Company's Series A 6% Convertible Preferred Stock and exercise
of Warrants and Additional Investment Rights sold in a private placement
offering completed by the Company in September 2004 and Warrants sold in private
placement offerings completed by the Company in October 2003 and February 2005
and adjusted in April 2005; (v) to approve, to the extent required for
compliance with the American Stock Exchange rules, issuance of additional shares
of the Company's common stock as needed for full conversion of the Company's
Series C Convertible Preferred Stock and exercise of the Company's Warrants sold
in a private placement in April 2005; (vi) to approve an amendment to the
Company's Certificate of Incorporation effecting a 1 for 10 reverse split of the
Company's common stock and reduction of the Company's authorized common stock to
50,000,000; (vii) to approve, to the extent required for compliance with the
American Stock Exchange rules, the issuance of additional shares of the
Company's common stock as needed for full conversion of the Company's aggregate
$12,500,000 Secured Promissory Notes issued for the acquisition of OneTravel,
Inc.; and (viii) act upon such other business as may properly come before the
Meeting or any adjournment(s) or postponement(s) thereof.
We hope that you will be able to attend the Meeting, and we urge you to
read the enclosed Proxy Statement before you decide to vote. Whether or not you
plan to attend, we encourage you to complete, sign, date and return the enclosed
proxy or vote over the internet or by telephone in accordance with the
instructions on the proxy card as promptly as possible in order that your shares
are represented at the Meeting. We look forward to seeing you at the Meeting.
Sincerely,
------------------------------------------
William A. Goldstein
Chairman of the Board
RCG COMPANIES INCORPORATED
6836 Morrison Blvd., Suite 200
Charlotte, NC 28211
June 1, 2005
NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
To Be Held On June 24, 2005
To the Stockholders of RCG Companies Incorporated:
Notice is hereby given that the Annual Meeting of Stockholders
(together with any adjournments or postponements thereof, the "Meeting") of RCG
Companies Incorporated, a Delaware corporation (the "Company"), will be held at
the Westin, located at 3391 Peachtree Road NE, Atlanta, Georgia, on June 24,
2005 at 9:30 a.m., local time, for the purpose of considering and voting upon
the following matters:
(1) To elect a board of eight directors, each to serve a one-year
term;
(2) To ratify the appointment of BDO Seidman, LLP as our
independent registered public accounting firm for the Company
for the fiscal year ending June 30, 2005;
(3) To approve, to the extent required for compliance with the
American Stock Exchange rules, the issuance of additional
shares of the Company's common stock in connection with the
Company's February 2005 acquisition of Farequest Holdings,
Inc., as needed for full (i) conversion of the Company's
Series B 6% Redeemable Participating Preferred Stock into
Common Stock; (ii) payment of the Company's $6,037,872
Promissory Note with 3,018,936 shares of Common Stock for the
principal amount plus payment of interest of 4% per year in
shares of Common Stock as needed, and (iii) issuance of shares
of common stock as needed in full satisfaction of the
Contingent Shares payable to the Farequest Holdings, Inc.
former shareholders;
(4) To approve, to the extent required for compliance with the
American Stock Exchange rules, issuance of additional shares
of the Company's common stock as needed for the full
conversion of the Company's Series A 6% Convertible Preferred
Stock and exercise of Warrants and Additional Investment
Rights sold in a private placement offering completed by the
Company in September 2004 and Warrants sold in private
placement offerings completed by the Company in October 2003
and February 2005 and adjusted in April 2005;
(5) To approve, to the extent required for compliance with the
American Stock Exchange rules, issuance of additional shares
of the Company's common stock as needed for full conversion of
the Company's Series C Convertible Preferred Stock and
exercise of the Company's Warrants sold in a private placement
in April 2005;
(6) To approve an amendment to the Company's Certificate of
Incorporation effecting a 1 for 10 reverse split of the
Company's common stock and reduction of the Company's
authorized common stock to 50,000,000 shares;
(7) To approve, to the extent required for compliance with the
American Stock Exchange rules, the issuance of additional
shares of the Company's Common Stock as needed for full
conversion of the Company's aggregate $12,500,000 Secured
Promissory Notes issued for the acquisition of OneTravel,
Inc.; and
(8) To transact such other business as may properly come before
the Meeting.
If our stockholders do not approve all of the proposals 4, 5 and 6,
then none of them will be implemented even if one or two of them are separately
approved. These items are more fully described in the accompanying Proxy
Statement, which is hereby made a part of this Notice of the Meeting of
Stockholders.
The Board has fixed the close of business on April 27, 2005 as the
record date for the determination of Stockholders entitled to notice of, and to
vote at, the Meeting.
Copies of the Company's Annual Report on Form 10-K/A for the fiscal
year ended June 30, 2004 and the Company's Quarterly Report on Form 10-Q for the
fiscal quarter ended March 31, 2005, are enclosed. These Reports are not a part
of the proxy soliciting material enclosed with this Notice.
BY ORDER OF THE BOARD,
-----------------------------------------
WILLIAM A. GOLDSTEIN
Chairman of the Board of Directors
Charlotte, NC
June 1, 2005
All Stockholders are cordially invited to attend the meeting in person.
Whether or not you expect to attend the meeting, please complete, date, sign and
return the enclosed proxy or vote over the internet or by telephone in
accordance with the instructions on the proxy card as promptly as possible in
order to ensure your representation at the meeting. A return envelope (which is
postage-prepaid if mailed in the United States) is enclosed for that purpose.
Even if you have given your proxy, you may still vote in person if you attend
the meeting. Please note, however, that if your shares are held of record by a
broker, bank or other nominee and you wish to vote at the meeting, you must
bring to the meeting a letter from the broker, bank or other nominee confirming
your beneficial ownership of the shares. Additionally, in order to vote at the
meeting, you must obtain from the record holder a proxy issued in your name.
PROXY STATEMENT/ANNUAL MEETING OF STOCKHOLDERS OF
RCG COMPANIES INCORPORATED
June 1, 2005
INFORMATION CONCERNING SOLICITATION AND VOTING
General
This Proxy Statement (the "Proxy Statement") and the accompanying form
of proxy are being furnished to the Stockholders (the "Stockholders") of RCG
Companies Incorporated (the "Company") in connection with the solicitation of
proxies by the Board of the Company (the "Board") from holders of its
outstanding common stock (the "Common Stock"), for use at the Annual Meeting of
Stockholders of the Company (together with any adjournments or postponements
thereof, the "Meeting") to be held at the Westin, located at 3391 Peachtree Road
NE, Atlanta, Georgia, on June 24, 2005 at 9:30 a.m., local time. This Proxy
Statement, the accompanying form of proxy, and the Annual Report to Stockholders
are expected to be mailed to Stockholders of the Company on or about June 1,
2005.
Solicitation
The expense of this solicitation will be borne by the Company. In
addition to solicitation by mail, executive officers and other employees of the
Company may solicit proxies, without additional compensation, personally and by
telephone and other means of communication. The Company will also reimburse
brokers and other persons holding Common Stock in their names or in the names of
their nominees for their reasonable expenses in forwarding proxies and proxy
materials to beneficial owners. The Company has also retained Morrow & Co, Inc.
to assist in the solicitation of proxies for a fee not to exceed $25,000 plus
expenses.
Voting Rights and Outstanding Shares
Stockholders of record as of the close of business on April 27, 2005
(the "Record Date") will be entitled to vote at the Meeting (except as noted in
the specific Proposal descriptions set forth below). Each share of outstanding
Common Stock is entitled to one vote. As of the Record Date, there were
29,219,112 shares of Common Stock outstanding.
The presence at the Meeting, in person or by proxy, of a majority of
the outstanding shares of Common Stock as of the Record Date will constitute a
quorum for transacting business at the Meeting. With respect to voting
generally, votes that are withheld broker non-votes, will be counted to
determine whether a quorum is present, but will not be counted as part of the
total number of votes cast on any proposal and will have no effect on the
outcome. Broker non-votes occur when a broker nominee, holding shares in street
name for the beneficial owner thereof, has not received voting instructions from
the beneficial owner and does not have discretionary authority to vote. In
determining whether a proposal has received the requisite number or favorable
votes, abstentions will be counted as part of the total number of votes cast on
such proposal to determine whether a quorum is present. Thus abstentions will
have the same effect as votes "against" the proposal.
The election of directors requires the plurality vote of the shares of
Common Stock present in person or represented by proxy and voting. The
ratification of BDO Seidman, LLP as our independent registered public accounting
firm for the fiscal year ending June 30, 2005 requires the affirmative vote of a
1
majority of the shares of Common Stock present in person or represented by proxy
at the Meeting. Therefore, abstentions and broker non-votes will not have any
effect on the voting to elect directors. Broker non-votes will not have any
effect on the vote to ratify appointment of the auditors, but abstentions will
have the effect of a vote "against" ratification.
Approval of Proposal 3 requires the affirmative vote of a majority of
the shares of Common Stock present in person or represented by proxy at the
meeting, excluding shares of common stock issued in connection with the
Company's acquisition of Farequest Holdings, Inc. Broker non-votes will not have
any effect on the vote in Proposal 3, but abstentions will have the effect of a
vote "against."
Approval of Proposal 4 requires the affirmative vote of a majority of
the shares of Common Stock present in person or represented by proxy at the
meeting, excluding shares of common stock acquired from the conversion of the
Company's Series A Convertible Preferred Stock or exercise of Warrants and
Additional Investment Rights sold in September 2004 and Warrants sold in October
2003 and February 2005. Broker non-votes will not have any effect on Proposal 4,
and abstentions will have the effect of a vote "against" Proposal 4. However,
approval of Proposal 4 is also contingent upon approval of Proposals 5 and 6.
Therefore, although broker non-votes will not have any effect on Proposal 4,
they do act as a vote against Proposal 6 and consequently will indirectly act as
a vote against Proposal 4.
Approval of Proposal 5 requires the affirmative vote of a majority of
the shares of Common Stock present in person or represented by proxy at the
meeting. Broker non-votes will not have any effect on Proposal 5, and
abstentions will have the effect of a vote "against" Proposal 5. However,
approval of Proposal 5 is also contingent on approval of Proposals 4 and 6.
Therefore, although broker non-votes will not have any effect on voting for
Proposal 5, they do act as a vote against Proposal 6 and consequently will
indirectly act as a vote against Proposal 5.
The approval of Proposal 6, which is an amendment to the Company's
Certificate of Incorporation effecting a 1 for 10 reverse split of the Company's
Common Stock and reducing the Company's authorized common stock, requires the
affirmative vote of a majority of the outstanding shares of Common Stock.
Therefore, abstentions and broker non-votes will have the effect of a vote
"against" this proposal. Also, approval of Proposals 4, 5 and 6 are contingent
upon them all being approved. Consequently, abstentions, broker non-votes or the
failure to return a proxy or vote at the meeting will have the effect of voting
against the proposal and indirectly Proposals 4 and 5.
The approval of Proposal 7 - to approve, to the extent required for
compliance with the American Stock Exchange rules, the issuance of additional
shares of the Company's Common Stock as needed for full conversion of the
Company's aggregate $12,500,000 Secured Promissory Notes issued for the
acquisition of OneTravel, Inc. - requires the affirmative vote of a majority of
the shares of Common stock present in person or represented by proxy at the
meeting. Broker non-votes will not have any effect on Proposal 7, and
abstentions will have the effect of a vote "against" Proposal 7.
Revocability of Proxies
The shares of Common Stock represented by proxy will be voted as
instructed if received in time for the Meeting. If no instructions are
indicated, such shares will be voted in favor of (FOR) (i) each nominee for
election as a director specified herein; (ii) the ratification of the
appointment of BDO Seidman, LLP, as the independent registered public accounting
firm for the Company for the fiscal year ending June 30, 2005; (iii) to approve,
to the extent required for compliance with the American Stock Exchange rules,
the issuance of additional shares of the Company's common stock in connection
with the Company's February 2005 acquisition of Farequest Holdings, Inc., as
needed for full (a) conversion of the Company's Series B 6% Redeemable
Participating Preferred Stock into Common Stock; (b) payment of the Company's
$6,037,872 Promissory Note with 3,018,936 shares of Common Stock for the
principal amount plus payment of interest of 4% per year in shares of Common
Stock as needed, and (c) issuance of
2
shares of Common Stock as needed in full satisfaction of the Contingent Shares
payable to the Farequest Holdings, Inc. former shareholders; (iv) to approve, to
the extent required for compliance with the American Stock Exchange rules,
issuance of additional shares of the Company's Common Stock as needed for the
full conversion of the Company's Series A 6% Convertible Preferred Stock and
exercise of Warrants and Additional Investment Rights sold in a private
placement offering completed by the Company in September 2004 and Warrants sold
in private placement offerings completed by the Company in October 2003 and
February 2005 and adjusted in April 2005; (v) to approve, to the extent required
for compliance with the American Stock Exchange rules, issuance of additional
shares of the Company's Common Stock as needed for full conversion of the
Company's Series C Convertible Preferred Stock and exercise of the Company's
Warrants sold in a private placement in April 2005; (vi) to approve an amendment
to the Company's Certificate of Incorporation effecting a 1 for 10 reverse split
of the Company's Common Stock and reduction of the Company's authorized Common
Stock to 50,000,000 shares; (vii) to approve, to the extent required for
compliance with the American Stock Exchange rules, the issuance of additional
shares of the Company's Common Stock for full conversion of the Company's
aggregate $12,500,000 Secured Promissory Notes issued for the acquisition of
OneTravel, Inc.; and (viii) in the discretion of the proxy holder as to any
other matter that may properly come before the meeting or any adjournment(s) or
postponement(s) thereof.
Most stockholders have a choice of voting over the Internet, by using a
toll-free telephone number or by completing a proxy card and mailing it in the
postage-paid envelope provided. Please check your proxy card or the information
forwarded by your bank, broker or other holder of record to see which options
are available to you. Please be aware that if you vote over the Internet, you
may incur costs such as telecommunication and Internet access charges for which
you will be responsible. The Internet and telephone voting facilities for
stockholders of record will close at 11:59 PM, Eastern Time, the day prior to
date on which the meeting takes place. The internet and telephone voting
procedures have been designed to authenticate stockholders by use of a control
number and allow you to vote your shares and to confirm that your instructions
have been properly recorded. Each executed and returned proxy card will be voted
in accordance with the directions indicated thereon, or if no direction is
indicated, such proxy will be voted in accordance with the recommendations of
the Board of Directors contained in this Proxy Statement. Each stockholder
giving a proxy (by executing the proxy card, over the Internet or by telephone)
has the power to revoke it at any time before the shares it represents are
voted. Revocation of a proxy is effective upon receipt by the Secretary of the
Company (c/o Investor Relations, 6836 Morrison Blvd, Suite 200, Charlotte NC
28211) of either (1) an instrument revoking the proxy or (2) a proxy bearing a
later date (which can be done by mail, over the Internet or by telephone).
Additionally, a stockholder may change or revoke a previous proxy by voting in
person at the Annual Meeting.
3
--------------------------------------------------------------------------------
EFFECTS OF THE STOCKHOLDER VOTES
The Board of Directors of the Company believes that approval of
Proposals 3 through 7 are in the best interests of the Company and its common
stockholders. The Company has a working capital deficit and negative cash flow
from operations. Proposals 3, 4, 5, 6 and 7, if approved, present the Company
with the opportunity to satisfy significant obligations, for which it does not
currently have adequate cash resources, by issuing Common Stock.
Proposal 3
In connection with the acquisition of Farequest Holdings Inc., the
Company issued a Promissory Note for $6,037,872, and Series B 6% Redeemable
Participating Preferred Stock with a stated value of $8.18 per share that bears
an annual cumulative dividend of 6% unless the Series B Preferred Stock converts
to Common Stock no later than October 29, 2005. If this proposal is approved,
the principal amount of the promissory note will be satisfied by paying
3,018,936 shares of Common Stock, plus payment of interest of 4% per year in
shares of Common Stock as needed, the Series B Preferred Stock will convert into
an estimated 15,273,890 shares of Common Stock and no dividend will be payable
and up to an estimated 2,995,683 shares of Common Stock would be issuable as an
anti-dilution measure as and when the Company's Series A 6% Convertible
Preferred Stock is converted into Common Shares, assuming the conversion price
is $0.55 per share. If this proposal is not approved, the promissory note will
be payable in cash on February 1, 2006 and the Series B Stock will remain
outstanding, ranking senior to the Common Stock, and bearing a cumulative
dividend of 6% per annum.
Proposals 4, 5 and 6
In connection with the Company's April 2005 Private Placement, the
proceeds of which were used to finance the acquisition of OneTravel, Inc., to
redeem outstanding Debentures and for working capital, the Company issued Series
C Convertible Preferred Stock with an aggregate liquidation preference of
approximately $31,000,000. The Series C Preferred Stock is redeemable, if not
converted earlier into common stock, one year from its issuance, i.e. April 14,
2006. Approval of all three Proposals 4, 5 and 6 is required for any of the
three Proposals to be approved, i.e. approval of any one of them is contingent
on all three being approved.
If these proposals are approved, the Series C Convertible Stock will
automatically convert into common stock. If these proposals are not approved,
the Series C Preferred Stock will remain outstanding and will be mandatorily
redeemable by the Company for approximately $31,000,000 on April 14, 2006.
Assuming the conversion price of the Series A 6% Convertible Preferred
Stock is $0.55 per share and is not reset as a result of the reverse stock
split, up to an estimated 2,854,546 shares of Common Stock would be issued upon
conversion of the Series A 6% Convertible Preferred Stock. Assuming the
conversion price of the warrants issued September 2004 is $1.00 per share up to
an estimated 1,143,617 shares of Common Stock would be issued upon conversion of
such warrants. Assuming the exercise price of the Additional Investment Rights
issued in September 2004 is $0.55 per share, up to an estimated 3,430,851 shares
of Common Stock would be issued upon exercise of the Additional Investment
Rights. Assuming the exercise price of the warrants issued April 2005, February
2005 and October 2003 is $0.55 per share and the exercise price of the April
2005 warrants is not reset as a result of the reverse stock split, up to an
estimated 35,193,331 shares of Common Stock would be issued upon exercise of
such warrants. Assuming the exercise price of the placement agent warrants
issued April 2005 is $0.605 per share and is not reset as a result of the
reverse stock split, up to an estimated 3,393,835 shares of Common Stock would
be issued upon exercise of such warrants. Assuming the exercise price of the
Series C Convertible Stock is $0.55 per share and the exercise price of the
April 2005 warrants is not reset as a result of the reverse stock split, up to
an estimated 56,563,945 shares of Common Stock would be issued upon conversion
of the Series C Convertible Stock.
Proposal 7
In connection with the Company's acquisition of OneTravel, Inc. in
April 2005, the Company issued an aggregate of $12,500,000 Convertible
Promissory Notes to certain stockholders of OneTravel, Inc. The notes are due
October 12, 2005, but may be extended by the Company for five separate one month
extension periods by payment of an aggregate of $125,000 for each extension.
Although the Convertible Promissory Notes would only be converted at
the holders' option, if Proposal 7 is approved the holders may convert the notes
into Common Stock and the Company could satisfy its obligations for the notes
with Common Stock. If Proposal 7 is not approved, however, the Company will not
have the flexibility to honor a conversion request by the noteholders and
satisfy the promissory notes by issuing Common Stock.
Assuming the conversion price of the Convertible Promissory Notes is
$0.6875 per share and is not reset as a result of the reverse stock split, up to
an estimated 18,181,820 shares of Common Stock would be issued upon conversion
of the Convertible Promissory Notes.
--------------------------------------------------------------------------------
4
PROPOSAL 1
ELECTION OF DIRECTORS
Eight directors, constituting the entire Board, are to be elected at
the Meeting and, if elected, will serve until the next Meeting of Stockholders
and until their successors have been elected and qualified. The Company's
Bylaws, as amended, provide that the Board shall consist of a minimum of three
and a maximum of nine members.
The nominees of the Board are set forth below. All of the current
members of the Board have been nominated to continue to serve as directors of
the Company. In the event any nominee is unable or declines to serve as a
director at the time of the Meeting, the proxies will be voted for any nominee
who shall be designated by the Board to fill the vacancy. If additional persons
are nominated for election as directors, then the proxy holders intend to vote
all proxies received by them for the nominees listed below unless instructed
otherwise. As of the date of this Proxy Statement, the Company is not aware of
any nominee who is unable or who will decline to serve as a director, if
elected.
Nominees for Election as Directors
Set forth below are the names, ages, positions and offices held and a
brief description of the business experience during the past five years of each
person nominated to serve as a director of the Company.
William A. Goldstein (age 41), has served as the Company's Chairman of
the Board since February 2, 2005, and became Chief Executive Officer of the
Company effective April 28, 2005. From June 2003 to present, Mr. Goldstein
served as Chairman of the Board of Farequest Holdings, Inc., and from March 1992
to November 2004 as Chairman and Chief Executive Officer of J&C Nationwide,
Inc., a physician staffing company which he founded in 1992. Mr. Goldstein has
also served as an executive or board member for several companies including
Market Central, Inc., a publicly traded technology company from February 2003
until November 2004, and as Chairman of LA Digital Post, a privately held post
production film equipment rental company from September 2003 to present, and
nPorta, Inc., a travel software and booking engine technology company from April
2000 to present. Mr. Goldstein earned his Bachelor's Degree in Business
Administration from Old Dominion University.
Michael D. Pruitt (age 44) became the Company's Chief Executive Officer
and President on November 8, 2000 and continued in these positions until April
28, 2005. He has served as a director of the Company since October 3, 2000.
Additionally, Mr. Pruitt served as the Company's Chairman from July 2001 to
February 2003. Mr. Pruitt was also the founder of Avenel Ventures, Inc., a
business development company, and has served as President, Chief Executive
Officer and director of Avenel Ventures, Inc. since its formation in June 2000.
From May 1999 to June 2000, Mr. Pruitt was involved in founding Avenel Financial
Group, Inc., a financial services firm specializing in e-commerce and
technology. From October 1997 to May 1999, Mr. Pruitt was the Executive Vice
President of Marketers World International. Mr. Pruitt was an independent
consultant from January 1997 to October 1997. From January 1992 to January 1997,
Mr. Pruitt was the COO of Ty Pruitt Trucking, Inc.
Jeffrey F. Willmott (age 56), has served as a director of the Company
since October 17, 2002. Mr. Willmott served as the Company's Chairman of the
Board from February 2003 until February 2005. From 2001 to 2002, Mr. Willmott
was Chairman and Chief Executive Officer of EKN Asset Management, a registered
investment advisory firm in New York City. From 1999 to 2000, Mr. Willmott
served as the managing director of Trenwith Securities, a middle market
investment bank, were he was responsible for the origination and execution of
5
corporate finance engagements. From 1991 to 1999, Mr. Willmott was a Senior Vice
President at Warburg Dillon Read (now UBS Warburg), where he was responsible for
business development. From 1983 to 1990, he was a regional director of sales and
marketing at Westinghouse Broadcasting.
Dr. James A. Verbrugge (age 64) has served as a director of the Company
since January 11, 1999. Dr. Verbrugge is a Professor of Finance (Emeritus) at
the University of Georgia where he has been employed since 1968. He is also the
Director of the Center for Strategic Risk Management in the Terry College of
Business at the University of Georgia and is actively involved in executive
education programs. Since July 2001, Dr. Verbrugge has also been a director of
Crown Crafts, Inc.
P. Roger Byer (age 59), CPA, has served as a director of the Company
since June 2003. From May 2001 to September 2002, Mr. Byer served as CEO and
President of Stellex Aerostructures, Inc., a manufacturer of commercial and
defense RF electronics and military machined aerostructure components. From July
1997 to September 2000, Mr. Byer was the COO of Mentmore Holdings Corporation, a
New York based private equity firm with aggregate portfolio companies generating
over $1 billion in revenues. Mr. Byer also served as CFO for several of the
portfolio companies. From 1986 to 1997, he served as Vice President and CFO for
KDI Corporation.
J. Michael Carroll (age 56) has served as a Director of the Company
since January 2004. He currently owns and operates a sales and training
consulting firm based in Richmond, Virginia. From 1999 to present he has
assisted management teams and individuals to recognize the realities of
consistent long term growth. Mr. Carroll previously spent 22 years in the
distribution business, 19 of which were in computer products distribution. From
1997 to 1999, he was a division president at Corporate Express, a publicly
traded business-to-business office products and service provider. In 1978, Mr.
Carroll founded MicroMagnetic, Inc., a computer supply distribution company that
he sold to Corporate Express in 1997. Mr. Carroll holds a Bachelor's Degree in
Business Management from The College of William & Mary in Williamsburg,
Virginia, and a Master's Degree in Business Administration from Virginia
Commonwealth University.
Ronald L. Attkisson (age 56) has served as a Director of the Company
since February 1, 2005. Mr. Attkisson has served as Chairman and Chief Executive
Officer of IFS Holdings since its inception in June, 2003. Mr. Attkisson is also
president of Jones, Bird & Attkisson, a position he has held since October,
2003. Previously, Mr. Attkisson provided investment banking services through
Attkisson, Carter & Company, which he founded in 1988 as Attkisson and
Associates. Mr. Attkisson sold most of his interest in the firm in January,
2001, but retained an association with the firm until May, 2003, when he
resigned from the firm before forming IFS Holdings. Prior to founding Attkisson
& Associates, Mr. Attkisson was associated with Interstate Securities and
Johnson, Lane, Space, Smith & Company, which were predecessor firms to Wachovia
Securities. Prior to this, he was a vice president at The Robinson-Humphrey
Company from 1978 to 1981. Mr. Attkisson graduated from the University of North
Carolina at Chapel Hill in 1970.
John J. Sicilian (age 44) has served as a Director of the Company
since February 9, 2005. Mr. Sicilian is currently Chairman and President of 105
Capital LLC, a management advisory firm and has held that position since mid
2003 when he founded the firm. Prior to that he served as Chairman, President
and Liquidating Agent of the Eastern Airlines Estate from 1995 through 2002. He
also served as Executive Vice President and General Counsel of Eastern Airlines
from 1990 to 1994. Mr. Sicilian is a director of privately held AgentWare which
provides automated travel data aggregation technology products to travel
professionals.
There are no family relationships among any of the executive officers
or directors of the Company. No arrangement or understanding exists between any
executive officer and any other person pursuant to which any executive officer
was selected as an executive officer of the Company. Executive officers of the
Company are elected or appointed by the Board and hold office until their
successors are elected or until their death, resignation or removal.
6
Stockholder Communication with the Board
The Board of Directors has established a process to receive
communications from Stockholders. Stockholders may contact any member (or all
members) of the Board of Directors (or the non-management directors as a group)
or any committee of the Board of Directors by mail. To communicate with the
Board of Directors, any individual director or any group or committee of
directors, correspondence should be addressed to the Board of Directors or any
such individual director or group or committee of directors by either name or
title. All such correspondence should be sent "c/o Investor Relations" at 6836
Morrison Boulevard, Suite 200, Charlotte, NC 28211.
All communications received as set forth in the preceding paragraph
will be opened by the office of our Director of Investor Relations for the sole
purpose of determining whether the contents represent a message to our
directors. Any contents that are not in the nature of advertising, promotions of
a product or service, or patently offensive material will be forwarded promptly
to the addressee. In the case of communications to the Board of Directors or any
group or committee of directors, the Investor Relations' office will make
sufficient copies of the contents to send to each director who is a member of
the group or committee to which the correspondence or e-mail is addressed.
Director Attendance at Annual Meetings and Board Meetings
It is our policy that directors are invited and encouraged to attend
our Annual Meetings. All directors attended our last Annual Meeting, and are
expected to attend the Meeting this year.
During the fiscal year ended June 30, 2004, the Board met 14 times, 7
of which was by written consent. All Board and committee members attended 75% or
more of the meetings. The Board is currently comprised of Dr. Verbrugge, Mr.
Willmott, Mr. Byer, Mr. Pruitt, Mr. Carroll, Mr. Goldstein, Mr. Attkisson, and
Mr. Sicilian.
The Audit Committee
The Board has established an audit committee (the "Audit Committee").
The Audit Committee is currently comprised of Dr. Verbrugge, Mr. Byer and Mr.
Carroll, with Dr. Verbrugge serving as its Chairman. During the fiscal year
ended June 30, 2004, the Audit Committee met 7 times. All members of the Audit
Committee attended 75% or more of the meetings. The Audit Committee convenes
when deemed appropriate or necessary by its members.
The Company's Board of Directors has adopted a written charter for the
Audit Committee. A copy of the Audit Committee Charter is posted on the
Company's website.
The primary functions of the Audit Committee are set forth in its
charter and include: (i) selecting, compensating, retaining, and replacing the
accounting firm to act as the Company's independent accountants; (ii)
pre-approving the audit and non-audit services to be provided by the independent
accountants; (iii) consulting with the Company's independent accountants
regarding the results and scope of the annual audit; and (iv) providing an open
avenue of communication among the independent accountants, the Company's
financial and senior management and the Board. The members of the Audit
Committee are "independent" as defined in Section 121(A) of the American Stock
Exchange Listing Standards and Section 10A of the Securities Act of 1934. Mr.
Byer serves as the Audit Committee financial expert.
7
The Audit Committee reports as follows:
(i) The Audit Committee received reports from and met and held
discussions with management and BDO Seidman LLP ("BDO") the
Company's independent registered public accounting firm for
the fiscal year ending June 30, 2004;
(ii) The Audit Committee reviewed and discussed the Company's
audited financial statements for the year ended June 30, 2004
with the Company's management;
(iii) The Audit Committee discussed with BDO the matters required to
be discussed by Statement of Accounting Standards 61;
(iv) The Audit Committee received the written disclosures and the
letter from BDO required by Independent Standards Board
Standard No. 1 Independence Discussions with Audit Committees
and has discussed BDO's independence with representatives of
BDO; and
(v) The Audit Committee recommended to the Board of Directors that
the audited financial statements be included in the Company's
Annual Report on Form 10-K for the fiscal year ended June 30,
2004, for filing with the Securities and Exchange Commission.
This recommendation was based on the Audit committee's
discussion with management, and BDO, as well as the
Committee's reliance on management's representation that the
Company's consolidated financial statements were prepared in
accordance with accounting principles generally accepted in
the United States of America.
Members of the Audit Committee: Dr. James A. Verbrugge, Mr. P. Roger
Byer, and Mr. J. Michael Carroll.
The Compensation Committee
In January 2001, the Board established a compensation committee, which
is currently comprised of Mr. Byer and Dr. Verbrugge. The members of the
Compensation Committee are independent as defined in Section 121(A) of the
American Stock Exchange Listing Standards. During fiscal 2004, the Compensation
Committee met 5 times, 3 of which were by written consent. All members of the
compensation committee attended at least 75% of the meetings. The Compensation
Committee convenes when deemed appropriate or necessary by its members. The
responsibilities of the Compensation Committee include the following:
* Overseeing our compensation and benefit plans, including
incentive compensation and equity-based plans;
* evaluating the compensation provided to our directors;
* conducting the annual evaluation by our Board of Directors of
the Chief Executive Officer;
* evaluating the performance of all other executive officers;
and
8
* setting the compensation level of our Chief Executive Officer
and all of our other executive officers based on an evaluation
of each executive's performance in light of the goals and
objectives of our executive compensation plans.
The Nominating and Corporate Governance Committee
The Board established a Nominating and Corporate Governance Committee, which is
currently comprised of Mr. Carroll as chairman and Mr. Sicilian. The charter of
the Committee is available on the Company's website and is attached hereto as
Appendix A. The members of the Nominating and Corporate Governance Committee are
independent as defined in Section 121(A) of the American Stock Exchange Listing
Standards. The Nominating and Corporate Governance Committee convenes when
deemed appropriate or necessary by its members. The Nominating and Corporate
Governance Committee performs the following functions:
* recommending to the Board of Directors individuals qualified
to serve as directors of the Company;
* recommending to the Board of Directors, directors to serve on
committees of the Board of Directors;
* advising the Board of Directors with respect to matters
relating to the composition, procedures and committees of the
Board of Directors;
* developing and recommending to the Board of Directors a set of
corporate governance principles applicable to the company and
overseeing corporate governance matters generally; and
* overseeing the evaluation of the Board of Directors and the
Company's management.
The Nominating and Corporate Governance Committee will consider
director candidates recommended by Stockholders. In considering candidates
submitted by Stockholders, the Nominating and Corporate Governance Committee
will take into consideration the needs of the Board of Directors and the
qualifications of the candidate. The Nominating and Corporate Governance
Committee may also take into consideration the number of shares held by the
recommending Stockholder and the length of time that such shares have been held.
To have a candidate considered by the Nominating and Corporate Governance
Committee, a Stockholder must submit the recommendation in writing and must
include the following information:
* The name of the Stockholder and evidence of the person's
ownership of our common stock, including the number of shares
owned and the length of time of ownership; and
* The name of the candidate, the candidate's resume or a listing
of his or her qualifications to be a director of the company
and the person's consent to be named as a director if selected
by the Nominating and Corporate Governance Committee and
nominated by the Board of Directors.
The Stockholder recommendation and information described above must be
addressed to our Chairman of the Board at 6836 Morrison Boulevard, Suite 200,
Charlotte, NC 28211, and must be received by our Chairman of the Board not less
than 120 days prior to the anniversary date of our most recent annual meeting of
stockholders. If, however, we did not hold an annual meeting the previous year,
or if the date of the annual meeting to which the recommendation applies has
been changed by more than 30 days from the anniversary date of our most recent
9
annual meeting of stockholders, then the recommendation and information must be
received not later than the close of business on the 10th day following the day
on which notice of the date of the meeting is mailed or public disclosure of the
date of the meeting is made, whichever occurs first.
All director candidates recommended by the Nominating and Corporate
Governance Committee must be consistent with the Board of Directors' criteria
for selecting directors. These criteria include the possession of such
knowledge, experience, skills, expertise and diversity so as to enhance the
Board of Directors' ability to manage and direct the affairs and business of the
Company, including, when applicable, to enhance the ability of committees of the
Board of Directors to fulfill their duties and/or to satisfy any independence
requirements imposed by law, regulation or AMEX listing requirement. In
addition, the Nominating and Corporate Governance Committee examines, among
other things, a candidate's ability to make independent analytical inquiries,
understanding of our business environment, potential conflicts of interest,
independence from management and the Company, integrity and willingness to
devote adequate time and effort to responsibilities associated with serving on
the Board of Directors.
The Nominating and Corporate Governance Committee identifies potential
nominees by asking current directors and executive officers to notify the
Committee if they become aware of persons meeting the criteria described above,
and in particular any such persons who have had a change in circumstances that
might make them available to serve on the Board of Directors -- for example,
retirement as a senior executive of a public company. The Nominating and
Corporate Governance Committee also, from time to time, may engage firms that
specialize in identifying director candidates. No firm was engaged to identify
this year's candidate. As described above, the Committee will also consider
candidates recommended by Stockholders.
Once a person has been identified by the Committee as a potential
candidate, the Committee may collect and review publicly available information
regarding the person to assess whether the person should be considered further.
If the Committee determines that the candidate warrants further consideration,
the Chairman or another member of the Committee contacts the person. Generally,
if the person expresses a willingness to be considered and to serve on the Board
of Directors, the Committee requests information from the candidate, reviews the
person's accomplishments and qualifications, including in light of any other
candidates that the Committee might be considering, and conducts one or more
interviews with the candidate. In certain instances, Committee members may
contact one or more references provided by the candidate or may contact other
members of the business community or other persons that may have greater
first-hand knowledge of the candidate's accomplishments. The Committee's
evaluation process does not vary based on whether or not a candidate is
recommended by a Stockholder, although, as stated above, the Board of Directors
may take into consideration the number of shares held by the recommending
Stockholder and the length of time that such shares have been held.
In addition to the selection process of the Nominating and Corporate
Governance Committee, under the Agreement and Plan of Merger among the Company
and Farequest Holdings, Inc., and the terms of the Company's Series B Preferred
Stock, (i) the holders of the Company's Series B 6% Redeemable Participating
Preferred Stock are entitled to elect three directors, and (ii) at this annual
meeting and the next two annual meetings, RCG's board of directors is required
to nominate, and recommend for election by the Stockholders, William A.
Goldstein, as Chairman of the Board of Directors, and provided Mr. Goldstein
shall continue to own at least ten percent (10%) of the outstanding Common Stock
of the Company, the Company's Board of Directors shall also nominate and
recommend for election by the Stockholders, two (2) additional directors named
by Mr. Goldstein who shall be "independent directors" and reasonably acceptable
to the then existing board of directors. Messrs. Attkisson and Sicilian were
10
named by Mr. Goldstein as proposed directors. Mr. Goldstein also agreed to vote
Mr. Goldstein's shares of Common Stock (i) during such three (3) year period,
for Michael Pruitt as a member of the Company's board of directors, provided Mr.
Pruitt holds 750,000 shares of Common Stock at the time of the applicable vote,
and (ii) for the remaining nominees nominated by the Company's board for a
one-year term beginning with the closing of the Company's acquisition of
Farequest Holdings, Inc. The Company is not soliciting a vote by the Series B
Preferred stockholders at this meeting, based on the assumption that the
conversion of the Series B Preferred Stock will be approved and will be effected
promptly following the Meeting.
Executive Officers
Set forth below are the names, ages, positions and offices held and a
brief description of the business experience during the past five years of each
of the Company's executive officers who are not also directors or director
nominees.
Marc E. Bercoon (age 45), currently serves as the President of the
Company. He was appointed Chief Financial Officer of the Company on February 28,
2005 and relinquished that role when he became President of the Company on April
28, 2005. Mr. Bercoon has also served as Vice Chairman of Farequest Holdings,
Inc. since June 2003. From November 2002 until November 2004, Mr. Bercoon served
as Vice Chairman and Chief Financial Officer for J&C Nationwide, Inc., a
physician staffing company that was formerly controlled by William Goldstein.
From January 2002 until November 2002 he served as Senior Vice President of
Mergers and Acquisitions for J&C Nationwide, Inc. From September 1999 to
December 2001, Mr. Bercoon was Chief Operating Officer for Vision Building
Systems, LLC, a dealer of modular buildings, and from November 1998 to present
he has been a director of Mixson Corp., a privately held manufacturer of
products in the law enforcement and safety industry. Mr. Bercoon earned his B.S.
in Accountancy with High Honors from the University of Illinois (Urbana, IL) and
his J.D. from the UCLA School of Law. Mr. Bercoon has also passed the Illinois
CPA exam.
Philip A. Ferri (age 49) became Chief Financial Officer of the Company
effective April 28, 2005. Prior to that he served as President and Chief
Financial Officer of OneTravel, Inc. since 1999. Prior to joining OneTravel,
Inc., Mr. Ferri held CFO and senior financial positions at Direct Travel,
American Express, Rosenbluth International and the BISYS Group, Inc. Mr. Ferri
is a director of PhoCusWright, Inc., an independent research firm covering the
travel, tourism and hospitality industry.
Stephen J. Pello (age 61) was appointed Executive Vice President,
Strategic Alliances of the Company effective April 28, 2005. Prior to that Mr.
Pello held the same position with OneTravel, Inc. since August 2000. From
January 2000 through August 2000, Mr. Pello was Executive Vice President
Strategic Alliances for Travel Services, a travel firm, and prior to that,
beginning in March 1995, he was V.P. Operations of Direct Travel, a large
corporate travel agency.
Henry Wang (age 44) was appointed Chief Information Officer of the
Company effective April 28, 2005. Prior to that Mr. Wang was Chief Information
Officer of OneTravel, Inc. from February 2003. Mr. Wang acted as an independent
information technology consultant from February 2002 to January 2003. Prior to
that, from December 1996 to February 2002, Mr. Wang was Director of Technology
for Sapient Corporation (NASDAQ: SAPE), a leading business consulting and
technology services firm.
Melinda Morris Zanoni (age 35) has served as Executive Vice President
of the Company since November 8, 2000. Additionally, Ms. Zanoni served as a
director of the Company from January 19, 2001 to April 16, 2003, as well as a
director and Executive Vice President of Avenel Ventures, Inc., since June 2000.
From February 1996 to June 2000, Ms. Zanoni was an attorney with the law firm of
11
Nelson Mullins Riley & Scarborough, LLP in Charlotte, North Carolina where she
concentrated in the areas of mergers and acquisitions and commercial finance.
From May 1994 to February 1996, she was a transactional attorney concentrating
in corporate law in Chicago, Illinois. Ms. Zanoni earned her B.S. with Honors
and J.D. Cum Laude from the University of Illinois (Urbana, IL).
Beneficial Ownership of Management and Certain Beneficial Owners
The following table sets forth certain information with respect to the
beneficial ownership of the Company's Common Stock as of May 12, 2005 by: (i)
each person known by the Company to beneficially own more than 5% of the
outstanding shares of Common Stock; (ii) each of the Company's directors; (iii)
each of the Company's named executive officers included in the Summary
Compensation Table included elsewhere herein; and (iv) all of the Company's
current directors and executive officers as a group. Except as otherwise noted,
the person or entity named has sole voting and investment power over the shares
indicated.
Shares of Percent of Shares
Common Stock Beneficially
Name Beneficially Owned(1) Owned (2)
---- --------------------- ---------
Michael D. Pruitt+++(3) 1,690,191 5.7%
Jeffrey F. Willmott++(4) 126,000 *
Dr. James A. Verbrugge++(5) 243,300 *
P. Roger Byer++(6) 268,928 *
Michael Carroll ++(7) 36,000 *
William A. Goldstein+ ++(8) 2,275,004 7.8%
Ronald Attkisson++(9) 143,677 *
John T. Sicilian++ 0 *
Melinda Morris Zanoni+(10) 497,428 1.7%
Mark E. Bercoon +(11) 119,687 *
All Current Executive Officers and Directors as a
Group (10 Persons)(12) 17.9%
+ Executive Officer of the Company
++ Director of the Company
* Less than 1%
(1) Information as to beneficial ownership of Common Stock has been
furnished to the Company either by or on behalf of the indicated person
or is taken from reports on file with the SEC.
(2) In computing the percentage ownership of a person, shares of Common
Stock that are acquirable by such person within 60 days of May 12,
2005, are deemed outstanding. These shares of Common Stock, however,
are not deemed outstanding for the purpose of computing the percentage
ownership of any other person. As of May 12, 2005, there were
29,219,112 shares of Common Stock outstanding.
(3) Includes 989,565 shares of Common Stock, 125,000 shares of Common Stock
issuable upon exercise of warrants and 246,428 shares of Common Stock
issuable upon exercise of options owned directly by Mr. Pruitt.
Includes 318,142 shares of Common Stock owned by Avenel Financial
Group, Inc., which is 100% owned by Mr. Pruitt, and 2,185 shares owned
by Mr. Pruitt's spouse. Mr. Pruitt does not have voting or investment
12
power with respect to the shares owned by his spouse. Includes 8,871
shares of Common Stock in three separate custodian accounts in the
names of Mr. Pruitt's three children. Mr. Pruitt is the trustee of each
of these custodian accounts.
(4) Includes 85,000 shares of Common Stock issuable upon exercise of
options. Includes 41,000 shares of Common Stock, of which 20,000 shares
are owned by Mr. Willmott's spouse. Mr. Willmott does not have voting
or investment power over the shares owned by his spouse.
(5) Consists of 7,586 shares of Common Stock and 235,714 shares of Common
Stock issuable upon exercise of options.
(6) Includes 268,928 shares of Common Stock. Mr. Byer purchased 89,286
shares of restricted Common Stock in a September 2003 private placement
and subscribed to purchase an additional 44,642 restricted shares of
the Company which was closed in early October, 2003. The purchase price
of the Common Stock was $1.12. Mr. Byer exercised 50,000 options at an
exercise price of $1.07 and exercised options to purchase 85,000 shares
of Common Stock at an exercise price of $.55 on January 13, 2005.
(7) Includes 6,000 shares of Common Stock and 30,000 shares of Common Stock
issuable upon exercise of options.
(8) Includes 1,400,522 shares of Common Stock held directly by Mr.
Goldstein and 874,482 shares of Common Stock held in an escrow account
over which Mr. Goldstein has voting power, as described below. Mr.
Goldstein also has the right to receive an estimated 4,475,945 shares
of common stock issuable upon conversion of the Company's Series B
Preferred Stock, an estimated 995,862 shares of Common Stock, including
estimated interest, issuable upon conversion of a promissory note
issued by the Company, and up to an estimated 965,659 shares of common
stock issuable as an anti-dilution measure as and when the Company's
Series A Preferred Stock is converted. Mr. Goldstein also has voting
power with respect to the following securities issued to former holders
of options and warrants to purchase common stock of Farequest in
connection with the Farequest merger held in an escrow account for
which Mr. Bercoon and Mr. Atkisson serve as co-escrow agents: 874,482
shares of Common Stock (included in Mr. Goldstein's number of shares
beneficially owned), an estimated 621,814 shares of Common Stock,
including estimated interest, issuable upon conversion of a promissory
note issued by the Company, an estimated 2,794,768 shares of Common
Stock issuable upon conversion of the Company's Series B Preferred
Stock, and up to an estimated 602,955 shares of Common Stock issuable
as an anti-dilution measure as and when the Company's Series A
Preferred Stock is converted. Mr. Goldstein disclaims beneficial
ownership of these securities.
(9) Includes 143,677 shares of Common Stock issuable upon exercise of
Farequest warrants formerly exercisable for 84,000 shares of Farequest
held by Jones Bird Attkisson, Mr. Attkisson's firm. Upon exercise of
these warrants, Jones Bird Attkisson also has the right to receive an
estimated 458,216 shares of Common Stock issuable upon conversion of
the Series B Preferred Stock, an estimated 92,681 shares of Common
Stock, including estimated interest, issuable upon conversion of a
promissory note issued by the Company, and up to an estimated 29,947
shares of Common Stock issuable as an anti-dilution measure as and when
the Company's Series A Preferred Stock is converted. Mr. Attkisson
disclaims beneficial ownership of the securities held by Jones Bird
Attkisson. Mr. Attkisson serves as co-escrow agent pursuant to that
certain Escrow Agreement, dated February 1, 2005, in connection with
13
the Farequest merger. William A. Goldstein has voting power over these
securities and Mr. Attkisson disclaims beneficial ownership. This
escrow account holds the following securities issued to former holders
of options and warrants to purchase common stock of Farequest: 874,482
shares of Common Stock (included in Mr. Goldstein's number of shares
beneficially owned), an estimated 621,814 shares of Common Stock,
including estimated interest, issuable upon conversion of a promissory
note issued by the Company, an estimated 2,794,768 shares of Common
Stock issuable upon conversion of the Company's Series B Preferred
Stock, and an estimated 602,955 shares of Common Stock issuable as an
anti-dilution measure as and when the Company's Series A Preferred
stock is converted.
(10) Consists of 286,714 shares of Common Stock and 210,714 shares of Common
Stock issuable upon exercise of options.
(11) Includes 85,495 shares of Common Stock held directly by Mr. Bercoon.
Also includes 34,192 shares of Common Stock issuable upon exercise of
options formerly exercisable for 20,000 shares of Farequest held by Mr.
Bercoon. Upon exercise of these warrants, Mr. Bercoon also has the
right to receive an estimated 109,269 shares of Common Stock issuable
upon conversion of the Company's Series B Preferred Stock, an estimated
22,101 shares of Common Stock, including estimated interest, issuable
upon conversion of a promissory note issued by the Company, and up to
an estimated 21,431 shares of Common Stock issuable as an anti-dilution
measure as and when the Company's Series A Preferred Stock is
converted. Mr. Bercoon also has the right to receive an estimated
273,234 shares of Common Stock issuable upon conversion of the
Company's Series B Preferred Stock, an estimated 60,793 shares of
Common Stock, including estimated interest, issuable upon conversion of
a promissory note issued by the Company, and up to an estimated 58,949
shares of Common Stock issuable as an anti-dilution measure as and when
the Company's Series A Preferred Stock is converted. Mr. Bercoon serves
as co-escrow agent pursuant to that certain Escrow Agreement, dated
February 1, 2005, in connection with the Farequest merger. William A.
Goldstein has voting power over these securities and Mr. Bercoon
disclaims beneficial ownership. This escrow account holds the following
securities issued to former holders of options and warrants to purchase
common stock of Farequest: 874,482 shares of Common Stock (included in
Mr. Goldstein's number of shares beneficially owned), an estimated
621,814 shares of Common Stock, including estimated interest, issuable
upon conversion of a promissory note issued by the Company, an
estimated 2,794,768 shares of Common Stock issuable upon conversion of
the Company's Series B Preferred Stock, and an estimated 602,955 shares
of Common Stock issuable as an anti-dilution measure as and when the
Company's Series A Preferred stock is converted.
(12) Excludes shares of Common Stock issuable upon exercise of options that
are not exercisable on or within 60 days of May 12, 2005.
Employment Contracts
On November 7, 2002, the Company entered an employment agreement ("the
Pruitt Agreement") with Mr. Michael Pruitt to serve as the Company's President
and CEO. The Pruitt Agreement provides for an annual base salary of $180,000 and
an initial term of two (2) years. After the initial term, the Pruitt Agreement
renews automatically for one (1) year unless either party gives 60 days' written
notice. Mr. Pruitt is also entitled to receive an annual bonus in the amount and
manner approved by the Board (or by the Compensation Committee thereof). Upon a
termination following a change of control, resignation with cause, termination
without cause, or termination for disability, Mr. Pruitt will be entitled to
severance equal to 12 months' salary and health benefits. The Pruitt Agreement
was terminated effective May 1, 2005. Mr. Pruitt remains with the Company as
Vice Chairman and the severance began on such date.
14
On April 15, 2003, the Company entered an employment agreement ("the
Willmott Agreement") with Mr. Jeffrey Willmott to serve as the Company's
Chairman of the Board. The Willmott Agreement provides for an annual base salary
of $120,000 and an initial term of one (1) year. After the initial term, the
Willmott Agreement renews automatically for one (1) year unless either party
gives 30 days' written notice. Mr. Willmott is also entitled to receive an
annual bonus in the amount and manner approved by the Board (or by the
Compensation Committee thereof). Upon a termination following a change of
control, resignation with cause, termination without cause, or termination for
disability, Mr. Willmott will be entitled to severance equal to 1 months' salary
and health benefits. The Willmott Agreement was terminated February 1, 2005. Mr.
Willmott remains a director of the Company.
On November 7, 2002, the Company entered an employment agreement ("the
Zanoni Agreement") with Ms. Melinda Morris Zanoni to serve as the Company's
Executive Vice President. The Zanoni Agreement provides for an annual base
salary of $160,000 and an initial term of two (2) years. After the initial term,
the Zanoni Agreement renews automatically for one (1) year unless either party
gives 60 days' written notice. Ms. Zanoni is also entitled to receive an annual
bonus in the amount and manner approved by the Board (or by the Compensation
Committee thereof). Upon a termination following a change of control,
resignation with cause, termination without cause, or termination for
disability, Ms. Zanoni will be entitled to severance equal to 12 months' salary
and health benefits.
William A. Goldstein, the Company's Chairman of the Board and Chief
Executive Officer, has agreed to an Employment Agreement with the Company. The
agreement will have a two year term commencing February 1, 2005 and provide for
severance equal to 12 months salary if Mr. Goldstein is terminated without cause
or due to non-renewal. Mr. Goldstein's base salary under the agreement will be
$280,000 in year one and $350,000 in year two, and he will be entitled to
receive options to purchase 2,000,000 Common Shares, 500,000 of which vest upon
the shareholder's meeting with the remaining 1,500,000 vesting 33% per year
(accelerated in the event of termination without cause or change in control of
the Company).
Marc Bercoon, the Company's President, has agreed to an Employment
Agreement with the Company. The agreement will have a two year term commencing
March 1, 2005 and provide for severance equal to 12 months salary if Mr. Bercoon
is terminated without cause or due to non-renewal. Mr. Bercoon's base salary
under the agreement will be $200,000 in year one and $240,000 in year two, and
he will be entitled to receive options to purchase 1,000,000 shares of Common
Stock, 250,000 of which vest upon the shareholder's meeting with the remaining
750,000 vesting 33% per year (accelerated in the event of termination without
cause or change in control of the Company).
Philip A. Ferri has agreed to an Employment Agreement with the Company.
The agreement will have a one (1) year term and provide for severance equal to
12 months salary if Mr. Ferri is terminated by the Company without cause or due
to non-renewal. Mr. Ferri's base salary under the agreement will be $192,800 and
he will be entitled to receive options to purchase 750,000 Common Shares, which
will vest 33% per year.
Stephen J. Pello has agreed to an Employment Agreement with the
Company. The agreement will have a one (1) year term and provide for severance
equal to twelve (12) months salary if Mr. Pello is terminated by the Company
without cause or due to non-renewal. Mr. Pello's base salary under the agreement
will be $175,000 and he will be entitled to receive options to purchase 500,000
Common Shares, which will vest 33% per year.
Henry Wang has agreed to an Employment Agreement with the Company. The
Agreement will have a term of one (1) year and provide for severance equal to
twelve (12) months salary if Mr. Wang is terminated without cause or due to
non-renewal. Mr. Wang's base salary under the Agreement will be $150,000 and he
will be entitled to receive options to purchase 500,000 Common Shares, which
will vest 33% per year.
Compensation Committee Report on Executive Compensation
Our executive compensation program presently is administered by the
Compensation Committee of the Board of Directors set forth below. None of these
Compensation Committee members are employed by us, and each is an independent
director under the AMEX listing standards.
Executive Compensation Policies
The objectives of our executive compensation policies are to attract,
retain and reward executive officers who contribute to our success, to align the
financial interests of executive officers with our performance, to strengthen
the relationship between executive pay and Stockholder value, to motivate
executive officers to achieve our business objectives and to reward individual
performance. Our executive compensation package consists of three components:
base salary and related benefits; short term incentive program; and long term
incentive program in the form of stock options and awards of restricted stock
units, which units, at our option, are convertible into shares of common stock
on the date of conversion.
15
The first component of our executive compensation package is base
salary and related benefits. Each executive officer receives a base salary and
benefits based on competitive compensation information and his responsibilities
and performance. The second component of our executive compensation package is a
bonus program. Generally, the Compensation Committee, together with our
management, establishes objectives at the beginning of the year. At the end of
each year, the Compensation Committee reviews management's and the company's
achievement against those objectives and recommends a bonus based on the
achievement of those objectives. The third component of our executive
compensation package is long-term incentives in the form of stock options and
awards of restricted stock units, which we believe are important as an incentive
tool designed to more closely align the interests of our executive officers with
the long-term interests of our Stockholders and to encourage our executive
officers to remain with us.
Section 162(m) Policy
Section 162(m) of the Internal Revenue Code of 1986, as amended,
generally provides that publicly held companies may not deduct compensation paid
to certain of its top executive officers to the extent such compensation exceeds
$1 million per officer in any year. However, pursuant to regulations issued by
the Treasury Department, certain limited exceptions to Section 162(m) apply with
respect to "performance-based compensation." Awards granted under our Long Term
Incentive Plan are intended to constitute qualified performance-based
compensation eligible for such exceptions, and we will continue to monitor the
applicability of Section 162(m) to our ongoing compensation arrangements. The
Compensation Committee will, in general, seek to qualify compensation paid to
our executive officers for deductibility under Section 162(m), although the
Compensation Committee believes it is appropriate to retain the flexibility to
authorize payments of compensation that may not qualify for deductibility if, in
the Compensation Committee's judgment, it is in the Company's best interest to
do so.
Chief Executive Officer Compensation
The Compensation Committee determined the compensation level of Mr.
Pruitt, while he served as our Chief Executive Officer and certain other
executives. Such compensation is set by the Compensation Committee with due
regard to industry practice, competitive salary information, executive
performance and current market conditions. In addition, Mr. Pruitt participates
in the same executive compensation programs available to other of our executive
officers. For the fiscal year ended 2004 Mr. Pruitt and a company owned by Mr.
Pruitt received $180,000 in the aggregate.
Members of the Compensation Committee: Dr. James A. Verbrugge, and Mr.
P. Roger Byer as its Chairman.
Compensation Committee Interlocks and Insider Participation
The members of the Compensation Committee during fiscal 2004 were Dr.
Verbrugge and Mr. Byer and for a portion of the year included Robert Brooks and
Wesley Jones who are no longer directors of the Company. None of the members of
the Compensation Committee during fiscal 2004 (i) was an officer or employee of
the Company or any of its subsidiaries, (ii) was formerly an officer of the
Company or any of its subsidiaries or (iii) had any relationship requiring
disclosure by the Company under the SEC's rules requiring disclosure of related
party transactions.
16
Executive Compensation
SUMMARY COMPENSATION TABLE
-----------------------------------------------------------------------------------------------------------------------------------
Annual Compensation Long-Term Compensation
--------------------------------------- -----------------------------------------
Awards Payouts
---------------------------- ------------
Securities
Other Under-
Fiscal Annual Restricted lying All Other
Year Compen- Stock Options/ LTIP Compen-
Name and Principal ending Salary Bonus sation Award(s) SARs Payouts sation
Position June 30 ($) ($) ($) ($)(1) (#) ($) ($)
------------------------- ----------- -------------- ------------ ----------- -------------- ------------- ------------ -----------
Jeffrey F. Willmott (2) 2004 120,000 -- -- --
------------------------- ----------- -------------- ------------ ----------- -------------- ------------- ------------ -----------
2003 40,000 -- 175,000 --
------------------------- ----------- -------------- ------------ ----------- -------------- ------------- ------------ -----------
2002 -- -- --
------------------------- ----------- -------------- ------------ ----------- -------------- ------------- ------------ -----------
Michael D. Pruitt,
Vice-Chairman(3) 2004 180,000 -- -- --
------------------------- ----------- -------------- ------------ ----------- -------------- ------------- ------------ -----------
2003 30,000 -- 175,000 --
------------------------- ----------- -------------- ------------ ----------- -------------- ------------- ------------ -----------
2002 -- -- -- --
------------------------- ----------- -------------- ------------ ----------- -------------- ------------- ------------ -----------
Melinda Morris Zanoni,
Executive Vice
President (4) 2004 160,000 -- -- --
------------------------- ----------- -------------- ------------ ----------- -------------- ------------- ------------ -----------
2003 160,000 -- 125,000 --
------------------------- ----------- -------------- ------------ ----------- -------------- ------------- ------------ -----------
2002 147,167 -- -- --
------------------------- ----------- -------------- ------------ ----------- -------------- ------------- ------------ -----------
(1) The stock options listed above are fully vested and have an
exercise price at or above the fair market value of the Common
Stock on the date of grant of such options, unless otherwise
noted.
(2) Mr. Willmott's employment contract dated April 15, 2003
provides for an annual base salary of $120,000. During fiscal
year 2003, the Company did not pay any cash compensation to
Mr. Willmott, but rather accrued $40,000 for services rendered
from March 2003 through June 2003. During fiscal year 2004,
the Company accrued an additional $20,000 and paid Mr.
Willmott $21,500, leaving a balance owed of $38,500. The
Company anticipates paying this compensation to Mr. Willmott
during fiscal year 2005. Beginning September 1, 2003, Mr.
Willmott has been paid the salary stipulated in his employment
contract. Mr. Willmott's employment was terminated on February
1, 2005 but he remains a director.
(3) Mr. Pruitt's employment contract dated November 7, 2002
provides for an annual base salary of $180,000. Mr. Pruitt
agreed to forego his salary in fiscal year 2002 and elected to
receive only a portion of his 2003 salary, which was paid
directly to Mr. Pruitt and to a Company owned by Mr. Pruitt.
(4) Ms. Zanoni's employment contract, dated November 7, 2002,
provides for an annual base salary of $160,000.
17
OPTIONS/SAR GRANTS IN THE LAST FISCAL YEAR
-----------------------------------------------------------------------------------------------------------------------
Potential Realizable (Alternative
Value at Assumed to Prior
Annual Rate of Stock Column)
Price Appreciation Grant
Individual Grants for Option Term Date Value
-------------------------------------------------------------------------------- ------------------------ -------------
Percent of
Total
Number of Options/SARs
Securities Granted to Exercise
Underlying Employees of Base Grant Date
Option/SARs in Fiscal Price Expiration Present
Name Granted (#) Year ($/Sh) Date 5% ($) 10% ($) Value $
--------------------------- -------------- -------------- ---------- ----------- ----------- ------------ ------------
William W. Hodge, CFO 50,000 28.6% 1.90 1/5/2011 38,675 90,128
--------------------------- -------------- -------------- ---------- ----------- ----------- ------------ ------------
AGGREGATED OPTION/SAR EXERCISES IN LAST FISCAL YEAR AND FY-END
OPTION/SAR VALUES
---------------------------------------------------------------------------------------------------------------------
Number of
Securities Value of
Underlying Unexercised
Unexercised In-The-Money
Options/SARs Options/SARs
At Fiscal Year-End At Fiscal Year-
Shares Value (#) End ($)
Acquired On Realized Exercisable/ Exercisable/
Name Exercise (#) ($)(1) Unexercisable Unexercisable(2)
--------------------------------------- ----------------- ------------------ --------------------- ------------------
Jeffrey F. Willmott 0 0 175,000/-0- -0-/-0-
--------------------------------------- ----------------- ------------------ --------------------- ------------------
Michael D. Pruitt 0 0 246,428/-0- -0-/-0-
--------------------------------------- ----------------- ------------------ --------------------- ------------------
Melinda Morris Zanoni 0 0 210,714/-0- -0-/-0-
--------------------------------------- ----------------- ------------------ --------------------- ------------------
(1) Calculated by determining the difference between the fair market value
of the shares of Company Common Stock underlying this option and the
exercise price of such option on the date of exercise.
(2) The dollar values of the Company's stock options are calculated by
determining the difference between the fair market value of the shares
of the Company's Common Stock underlying the options at June 30, 2004
and the exercise price of such options.
Compensation of Non-Employee Directors
During fiscal 2004 and through May 1, 2005, Directors of the Company
who are not employees of the Company did not receive retainers and were entitled
to be compensated at the rate of $1,000 per regular Board meeting, $750 per
telephonic Board meeting, and $500 per committee meeting not held on the same
day as a regular or telephonic Board meeting. Effective beginning May 1, 2005,
Directors who are not employees of the Company will receive a retainer of $1,500
per month ($18,000 per year), and $1,500 per regular Board meeting, $750 per
telephonic meeting, and $750 per committee meeting not held on the same day as a
Board meeting. The chairman of the Audit Committee will also receive an
additional retainer of $500 per month ($6,000 per year) and each Audit Committee
member will receive an additional retainer of $250 per month ($3,000 per year).
The Board expects to meet at least on a quarterly basis in fiscal 2005.
Directors are also entitled to reimbursement of reasonable out-of-pocket
expenses incurred by them in attending Board meetings. In fiscal 2004, the
Company expensed $16,250 for director fees and expenses. The Directors who are
not employees also have received stock options from time to time. In fiscal 2003
Dr. Verbrugge received options in October, 2002 for 100,000 shares of common
18
stock that vested in one year's time in quarterly installments from the date of
grant, and Mr. Willmott received options in October, 2002 for 85,000 shares that
vested in one year's time in quarterly installments from the date of grant. In
fiscal 2004, Mr. Carroll received an option grant in February 2004 for 30,000
shares which vested in two installments at the end of the 3rd and 4th fiscal
quarters of 2004, with a 3 year option period. In fiscal 2005, each of Dr.
Verbrugge and Mr. Byer were awarded option grants in January, 2005 for 50,000
shares, fully vested with a 10 year option period. All option grants to the
Directors were at exercise prices at or above market value at the time of grant.
The Company has also agreed to grant each Director a one-time issuance of
options to purchase 150,000 Common Shares, which will vest 33% upon the
shareholder's meeting with the balance vesting 50% per year thereafter (subject
to immediate vesting upon a change of control of the Company).
19
Performance Graph
The following graph compares the cumulative total Shareholder returns of the
Company over the last five years to the AMEX Composite Index and the Russell
2000. Each of the three measures presented below assume the reinvestment of all
dividends into shares of common stock and an initial investment of $100 at the
closing prices on June 30, 1999. The stock performance shown on the graph below
is not necessarily indicative of future price performance.
[LINE GRAPH OMITTED]
The Company does not believe it can identify a peer group given the changes in
the Company's business. Therefore the Company has shown the Russell 2000 index,
rather than a peer group, as an index of issuers with similar market
capitalization to the Company.
============================= ============ ========== =============== ============ ============ ============
1999 2000 2001 2002 2003 2004
----------------------------- ------------ ---------- --------------- ------------ ------------ ------------
RCG 100 33 34 6 3 12
----------------------------- ------------ ---------- --------------- ------------ ------------ ------------
Amex Composite Index 100 117 115 112 121 157
----------------------------- ------------ ---------- --------------- ------------ ------------ ------------
Russell 2000 100 96 97 76 110 129
============================= ============ ========== =============== ============ ============ ============
20
Certain Relationships and Related Transactions
G. David Gordon, a Company stockholder, also occasionally acts as legal
counsel to the Company.
On April 19, 2004, Robert H. Brooks, Chairman of Hooters of America,
Inc., Hooters Air and Pace Airlines, Inc. joined the Company's Board of
Directors. In addition, Mr. Brooks made a $1,000,000 cash investment in the
Company, and provided a waiver of the requirement of delivery of a letter of
credit in the amount of $1,000,000 to Pace Airlines, Inc., a charter airline
company that charters planes to the Company's Travel Services division. In
exchange, the Company issued 1,250,000 restricted shares of Common Stock and a
warrant to purchase 1,250,000 restricted shares of Common Stock at an exercise
price of $2.44 per share. The $1,000,000 investment was allocated $800,000 to
the Common Stock and $200,000 to the warrants using the Black-Scholes option
pricing model. On August 2, 2004, Mr. Brooks resigned from the Company's Board
of Directors, sighting time constraints.
On February 8, 2005, K. Wesley M. Jones, Sr. resigned as a member of
the Company's Board of Directors, sighting time constraints. Mr. Jones has an
ownership stake in a private investment group that has secured certain letters
of credit issued by the Company in the amount of $2 million. During the nine
months ended March 31, 2005, the Company paid the private investment group
approximately $180,000. On December 14, 2004, the Company granted the
aforementioned private investment group, for a one time release of collateral
and a term extension to the letters of credit, 215,000 three-year common stock
warrants at an exercise price of $1.25. The common stock warrants were valued at
$125,000 using the Black-Scholes option pricing model and the expenses is
included in selling, general and administrative expenses.
Mr. Jones and Mr. Michael D. Pruitt, RCG's Vice Chairman, as with other
accredited investors, each advanced the Company $250,000 of the total $1.1
million advanced (see Note 3). Messrs. Jones and Pruitt each received three year
options to purchase 125,000 Common Shares at an exercise price of $1.25 in
return for their respective loans of $250,000.
Included in accounts payable and other accrued expenses is $100,000
received from P. Roger Byer, a Director, which was subsequently used to exercise
common stock options.
On February 2, 2005, the Company acquired Farequest Holdings, Inc.,
which is now a subsidiary of the Company. In connection with that transaction,
Mr. Goldstein, who is now the Company's Chairman and Chief Executive Officer, Mr
Atkisson, who is now a Director, and Mr. Bercoon, who is now the Company's
President, received securities from the Company in exchange for their stock in
Farequest. Additionally, the warrants they hold which were formerly exercisable
for stock in Farequest were converted into the right to receive the merger
consideration consisting of securities of the Company upon exercise. Their
holdings are described under "Beneficial Ownership of Management and Certain
Beneficial Owners" above.
Farequest licenses an Internet-based travel booking engine from nPorta
which is a company majority owned by William Goldstein, the Chairman and Chief
Executive Officer of the Company. Farequest is obligated to pay a monthly
license fee for support and maintenance at a rate of $3.00 per reservation
booked on-line. Monthly fees charged by nPorta to Farequest during the period
from the date of the Farequest acquisition to April 30, 2005 totaled $77,739 of
which $44,093 has been paid as of April 30, 2005.
During the calendar year ended December 31, 2004, Farequest purchased
several automobiles, which were financed through notes payable. Certain notes
were personally guaranteed by two stockholders of Farequest. In exchange for the
guarantees, the Company pays fees to the stockholders which, during the period
from the date of the Farequest acquisition to April 30, 2005, totaled $9,000. Of
this amount $4,500 was paid to Marc Bercoon, the Company's President, who
guarantees ten of the vehicle loans. The fees are expected to be paid through
the term of the notes, which mature in 2009. Mr. Bercoon also received $4,000
per month in connection with a consulting agreement with Farequest which totaled
$12,000 for period from the date of the Farequest acquisition to April 30, 2005.
Securities Authorized for Issuance Under Equity Compensation Plans
Equity Compensation Plan Information
Number of securities
Number of securities remaining available for
to be issued upon Weighted-average future issuance under
exercise of exercise price of equity compensation plans
outstanding options, outstanding options, (excluding securities
Plan category warrants and rights warrants and rights reflected in column (a))
---------------------------------------------------------------------------------------------------------------
(a) (b) (c)
Equity compensation plans
approved by security holders 2,261,657 $ 2.20 17,738,343
Equity compensation plans not
approved by security holders 6,421,963 $ 4.91 --
Total 8,683,620 $ 4.20 17,738,343
Section 16(a) Beneficial Ownership Reporting Compliance
Section 16(a) of the Securities and Exchange Act of 1934, as amended,
requires the Company's directors, executive officers, and persons who own
beneficially more than 10% of a registered class of the Company's equity
securities, to file with the SEC initial reports of ownership and reports of
changes in ownership of such securities of the Company. Directors, executive
officers and greater than 10% Stockholders are required by SEC regulations to
furnish the Company with copies of all Section 16(a) reports they file.
To the Company's knowledge, based solely on review of the copies of
such reports furnished to the Company and representations that no other reports
were required, all Section 16(a) filing requirements applicable to its
directors, executive officers and greater than 10% beneficial owners were
complied with during the fiscal year ended June 30, 2004.
Board Recommendation
For the reasons outlined above, the Board recommends a vote FOR each
nominee standing for election to the Board of Directors.
21
PROPOSAL 2
RATIFICATION OF APPOINTMENT OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Audit Committee has selected BDO to serve as the Company's
independent registered public accounting firm for fiscal year 2005.
Representatives of BDO are expected to be present at the Annual Meeting and will
have an opportunity to make a statement and to respond to appropriate questions.
BDO served as the Company's independent registered public accounting firm for
fiscal year 2004 and Crisp Hughes Evans LLP ("CHE") for fiscal 2003.
Audit Fees
The aggregate fees billed for professional services for the audit of
the Company's annual financial statements and the reviews of the financial
statements included in the Company's Quarterly Reports on Form 10-Q were
$289,495 for the fiscal year ended June 30, 2004 (of which $238,312 was billed
by BDO and $51,183 was billed by CHE), and were $255,000 for the fiscal years
ended June 30, 2003 and 2002 (of which $135,000 was billed by BDO and $120,000
was billed by CHE). The foregoing fees were incurred with respect to
professional services that are normally provided by our auditors. In connection
with statutory and regulatory filings or engagements, such services are rendered
for the audit of the Company's consolidated financial statements and review of
the interim consolidated financial statements included in quarterly reports and
services.
Audit-Related Fees
The aggregate fees billed for professional services for assurance and
related services that are reasonably related to the performance of the audit or
review of the Company's financial statements and are not reported under the
caption "Audit Fees" above were $219,980 (which were billed by CHE) for the
fiscal year ended June 30, 2004, and were $0 for the fiscal year ended June 30,
2003. The foregoing fees were incurred with respect to professional services
provided in connection with due diligence and audits of acquisitions.
Tax Fees
The aggregate fees billed for professional services for tax compliance,
which were billed by CHE (see caption "Change in Auditor" below) tax advice, and
tax planning were $68,930 for the fiscal year ended June 30, 2004, and were
$50,450 for the fiscal year ended June 30, 2003. The foregoing fees were
incurred with respect to professional services provided in connection with tax
compliance, advice and planning. These services include assistance regarding
federal, state and international tax compliance, assistance with tax reporting
requirements and audit compliance, and mergers and acquisitions tax compliance.
All Other Fees
The aggregate fees billed for all other accounting services to RCG for
the fiscal year ended June 30, 2004 was $4,475. The foregoing fees were incurred
with respect to professional services provided in connection with products and
services other than the aforementioned services. There were no management
consulting services provided.
Change in Auditor
On February 26, 2004 the Company acted to dismiss Crisp Hughes Evans
LLP as its independent registered accounting firm. This determination followed
the Company's decision to seek proposals from independent registered accounting
firms to audit its financial statements, and was approved by the Company's Board
22
of Director's upon the recommendation of its Audit Committee. The decision to
terminate the Company's relationship with CHE did not involve a dispute with the
Company over accounting policies or practices.
The independent audit report of CHE on the consolidated financial
statements of the Company as of and for the fiscal years ended June 30, 2003 and
2002 did not contain any adverse or disclaimer of opinion and were not qualified
or modified as to uncertainty, audit scope, or accounting principles. During the
two fiscal years ended June 30, 2003, and during the period from that date to
February 26, 2004, there were no disagreements with CHE on any matter of
accounting principles or practices, financial statement disclosure, or auditing
scope or procedure, which disagreements, if not resolved to the satisfaction of
CHE, would have caused CHE to make reference to the subject matter of the
disagreements in connection with its report.
In the Report to the Audit Committee as of June 30, 2003, CHE
recommended the Company hire a Chief Financial Officer. The Company informed CHE
that it was conducting an executive search for a CFO and a CFO was subsequently
hired. No other reportable event described under Item 304(a)(1)(v) of Regulation
S-K occurred within the two fiscal years ended June 30, 2003 and during the
period from that date to February 26, 2004. CHE has reviewed the preceding
statements, and a copy of the response of CHE is attached as Exhibit 99.1 to
that certain Form 8-KA filed with the SEC on March 3, 2004.
Miscellaneous
The Audit Committee reviews, and in its sole discretion pre-approves,
our independent auditors' annual engagement letter including proposed fees and
all audit and non-audit services provided by the independent auditors.
Accordingly, all services described under "Audit-Related Fees," "Tax Fees" and
"All Other Fees" were pre-approved by our Audit Committee. The Audit Committee
may not engage the independent auditors to perform the non-audit services
proscribed by law or regulation. The Audit Committee may delegate pre-approval
authority to a member of the Audit Committee, and authority delegated in such
manner must be reported at the next scheduled meeting of the Audit Committee.
Board Recommendation
The Board recommends that the Stockholders vote FOR the ratification of
the appointment of BDO as the Company's independent registered public accounting
firm for the fiscal year 2005.
23
PROPOSAL 3
TO APPROVE, TO THE EXTENT REQUIRED FOR COMPLIANCE WITH THE AMERICAN
STOCK EXCHANGE RULES, THE ISSUANCE OF ADDITIONAL SHARES OF THE COMPANY'S COMMON
STOCK IN CONNECTION WITH THE COMPANY'S FEBRUARY 2005 ACQUISITION OF FAREQUEST
HOLDINGS, INC., AS NEEDED FOR FULL (I) CONVERSION OF THE COMPANY'S SERIES B 6%
REDEEMABLE PARTICIPATING PREFERRED STOCK INTO COMMON STOCK; (II) PAYMENT OF THE
COMPANY'S $6,037,872 PROMISSORY NOTE WITH 3,018,936 SHARES OF COMMON STOCK FOR
THE PRINCIPAL AMOUNT PLUS PAYMENT OF INTEREST OF 4% PER YEAR IN SHARES OF COMMON
STOCK AS NEEDED, AND (III) ISSUANCE OF SHARES OF COMMON STOCK AS NEEDED IN FULL
SATISFACTION OF THE CONTINGENT SHARES PAYABLE TO THE FAREQUEST HOLDINGS, INC.
FORMER SHAREHOLDERS.
Description of Transaction
On February 1, 2004, the Company closed a transaction through which its
wholly owned subsidiary WTI Acquisition, Inc. ("Sub") merged with and into
Farequest Holdings, Inc. ("Farequest"). Pursuant to the terms of the Agreement
and Plan of Merger dated November 30, 2004, as amended (the "Merger Agreement")
the Farequest stockholders received (i) 4,779,196 shares of the Company's Common
Stock, (ii) 1,527,389 shares of the Company's Series B 6% Senior Participating
Preferred Stock ("Series B Preferred Stock"), and (iii) a promissory note (the
"Promissory Note") payable within one year of the effective time of the merger,
at the Company's option, in either (a) an amount in cash equal to lesser of (x)
$6,037,872 or (y) 19% of the value of the total maximum consideration payable or
(b) 3,018,936 shares of the Company's Common Stock. Solely as an anti-dilution
mechanism, if and when holders of the Company's Series A 6% Convertible
Preferred Stock convert shares of Series A 6% Convertible Preferred Stock into
shares of the Company's Common Stock, the Farequest stockholders are entitled to
receive additional shares of the Company's Series B Preferred Stock (if the
Company's Series B Preferred Stock has not yet been converted), or additional
shares of the Company's Common Stock based on the conversion ratio of the Series
B Preferred Stock (if the Company's Series B Preferred Stock has been
converted), (such additional shares being the "Contingent Shares"), as needed
based upon a formula designed to prevent the dilution of the Farequest
stockholders' equity interest in the Company.
The Company agreed to file a registration statement with the SEC
registering for resale all shares of the Company's Common Stock initially issued
in the merger transaction, underlying the Series B Preferred Stock, and
underlying the Promissory Note.
At the effective time of the merger, the Company's Board of Directors
was expanded to eight (8) members. William A. Goldstein, a director and
executive officer of Farequest, was appointed the Chairman of the Board of
Directors, Ronald Attkisson was appointed as a director of the Company, and John
T. Sicilian was appointed as a director of the Company. For a period of three
years, the Company's Board of Directors will nominate and recommend for election
by the Stockholders, Mr. Goldstein, as Chairman of the Board, and, provided that
Mr. Goldstein shall have continued to own at least 10% of the outstanding Common
Stock of the Company, two additional directors named by Mr. Goldstein. Such
nominees shall be independent directors and shall be reasonably acceptable to
the then existing Board of Directors. Mr. Goldstein has agreed to vote his
shares of the Company's Common Stock (i) during such three year period for
Michael Pruitt as a member of the Company's Board of Directors, provided that
Mr. Pruitt holds at least 750,000 shares of the Company's Common Stock at the
time of the nomination, and (ii) for the remaining nominees nominated by the
Company's board for a one year term beginning with the effective time.
24
The merger transaction was approved by the Company's Board of Directors
on November 29, 2004 and the final terms approved on January 28, 2005. The
Company's Common Stock, Series B Preferred Stock, and Promissory Note, and the
shares of Common Stock underlying such securities were issued pursuant to the
exemption from registration provided by Section 4(2) of the Securities Act, as
amended, and Regulation D promulgated under the Securities Act.
American Stock Exchange Approval Rule
The Company's Common Stock is listed for trading on the American Stock
Exchange and therefore, is subject to the Rules of the American Stock Exchange.
Pursuant to the American Stock Exchange Constitution and Rules, Section 712,
"the corporation is required to obtain shareholder approval as a prerequisite to
approval of applications to list additional shares to be issued as sole or
partial consideration for an acquisition of the stock or assets of another
company . . . where the present or potential issuance of common stock, or
securities convertible into common stock, could result in an increase in
outstanding common shares of 20% or more." As of January 31, 2005, a day prior
to closing of the merger transaction with Farequest Holdings, Inc., the Company
had 24,016,206 shares of Common Stock issued and outstanding. Generally, in
making a determination regarding the shareholder approval on the 20% rule, the
American Stock Exchange will compute the number of shares to be obtained by
utilizing the lowest possible conversion ratio and will rely on the number of
shares outstanding at the time of the offering. The issuance of any additional
shares of Common Stock in connection with the merger transaction, whether upon
conversion of the Series B Preferred Stock, the Promissory Note, or otherwise,
when added to the shares of Common Stock already issued in the merger
transaction, would result in an increase in the Company's outstanding Common
Stock of 20% or more. Therefore, shareholder approval is required regarding any
additional issuances of Common Stock in connection with the merger transaction,
whether as a result of a conversion of the Series B Preferred Stock, the
Promissory Note, or otherwise.
If shareholder approval is received, the Series B Preferred Stock will
automatically convert into 15,273,890 shares of Common Stock, and no dividends
will be paid or accrue on the Series B Preferred Stock, and all of the Company's
obligations under the Promissory Note will be paid in Common Stock, including
the principal amount of $6,037,872 will be paid in full by issuance of 3,018,936
shares of Common Stock plus payment of interest of 4% per year in shares of
Common Stock as needed. In the event that shareholder approval is not obtained,
the Series B Preferred Stock and Promissory Note will not be converted, the
Series B Preferred Stock will remain outstanding and will be senior to the
Common Stock and will bear dividends at 6% per annum, and the Promissory Note
will be payable in cash on February 1, 2006, and no additional shares of Common
Stock may be issued in connection with the merger transaction.
Holders of Common Stock whose shares were issued in connection with the
merger transaction will not be counted in the vote on this Proposal.
Description of Series B Preferred Stock
The following is a summary of the material terms of the Series B
Preferred Stock and is qualified in its entirety by the Certificate of
Designation of Preferences, Rights and Limitations of Series B 6% Redeemable
Participating Preferred Stock (the "Certificate") filed as an exhibit to Form
8-K filed by the Company with the SEC on February 7, 2005.
25
Amount, Stated Value, and Definitions
The number of shares of Series B Preferred Stock designated was
3,000,000. Each share of Series B Preferred Stock has a stated value equal to
$8.18 (the "Stated Value"). Capitalized terms not otherwise defined in this
Description of Series B Preferred Stock section shall have the meaning given
such terms in the Certificate.
Dividends
Holders are entitled to receive and the Company shall pay, cumulative
dividends at the rate per share (as a percentage of the Stated Value per share)
of 6% per annum from the date of issuance, payable annually beginning with
January 31, 2006, and at the Conversion Time pursuant to the terms of the
Certificate ("Dividend Payment Date"); provided, however if the Preferred Stock
is converted into Common Stock before 270 days have lapsed from the Effective
Time under the Merger Agreement then no dividend will be due or payable. The
form of dividend payments to each Holder shall be made at the option of the
Company either in cash or additional Shares of Series B Preferred Stock with a
Stated Value equal to the amount of dividend being paid. Dividends on the Series
B Preferred Stock shall be calculated on the basis of a 360-day year, shall
accrue daily commencing on the date of issuance, and shall be deemed to accrue
from such date whether or not earned or declared and whether or not there are
profits, surplus or other funds of the Company legally available for the payment
of dividends. Except as otherwise provided herein, if at any time the Company
pays dividends partially in cash and partially in shares, then such payment
shall be distributed ratably among the Holders based upon the number of shares
of Series B Preferred Stock held by each Holder. Any dividends, whether paid in
cash or shares, that are not paid within fifteen Trading Days following a
Dividend Payment Date shall continue to accrue and shall be in default.
So long as any Series B Preferred Stock shall remain outstanding,
neither the Company nor any subsidiary thereof shall redeem, purchase or
otherwise acquire directly or indirectly either (i) any Junior Securities or
Parity Securities, or (ii) Senior Securities other than the Company's Series A
6% Convertible Preferred Stock in accordance with the terms thereof as in effect
on November 30, 2004 or other Senior Securities that are issued, if any, after
the Effective Time under the Merger Agreement with the consent of the Holders of
the Series B Preferred Stock or with Preferred Director Approval ("Approved
Senior Securities"). So long as any Series B Preferred Stock shall remain
outstanding, neither the Company nor any subsidiary thereof shall directly or
indirectly pay or declare any dividend or make any distribution (other than a
dividend or distribution described in the Section titled "Conversion" below)
upon, nor shall any distribution be made in respect of, any Junior Securities,
nor shall any monies be set aside for or applied to the purchase or redemption
(through a sinking fund or otherwise) of any (i) Junior Securities or Parity
Securities or (ii) Senior Securities other than Approved Senior Securities.
Voting Rights
Except as otherwise provided in the Certificate and as otherwise
required by law, the Series B Preferred Stock do not have voting rights. Except
as expressly required under Delaware Law, on any matter on which holders of
shares of Series B Preferred Stock are entitled to vote, they are entitled to
one vote per share, voting as a single class, and any consent, approval or
action to be taken by the Series B Preferred Stock shall require the consent or
approval of a majority of the shares of the outstanding Series B Preferred
Stock.
So long as any shares of Series B Preferred Stock are outstanding, the
Company shall not, without the written consent or affirmative vote at a meeting
called for that purpose of the holders of a majority of the shares of Series B
Preferred Stock then outstanding, amend, alter or repeal, whether by merger,
consolidation, combination, reclassification or otherwise, the Certificate of
Incorporation, as may be amended or restated to date, or any Certificate of
26
Designation or Bylaws of the Company or of any provision thereof (including the
adoption of a new provision thereof) which would result in an alteration or
circumvention of the voting powers, designation and preferences and relative
participating, optional and other special rights, and qualifications,
limitations and restrictions of the Series B Preferred Stock.
So long as any shares of Series Preferred Stock are outstanding, the
Company shall not, without the affirmative vote of the Holders of the shares of
the Series B Preferred Stock then outstanding, (i) alter or change adversely the
powers, preferences or rights given to the Series B Preferred Stock or alter or
amend the Certificate, (ii) authorize or create any (A) Senior Securities other
than Senior Securities for the acquisition of any business including the Merger,
on terms approved by a Preferred Director Approval, (B) Parity Securities, or
(C) any Junior Securities other than Common Stock, (iii) amend its certificate
of incorporation except to decrease the authorized Common Stock (but not below
an amount required to be maintained under Section 10(b) of the Certificate),
(iv) increase the authorized number of shares of Series B Preferred Stock or the
number of shares of the Company's Series A 6% Convertible Preferred Stock, (v)
unless authorized by a Preferred Director Approval, create, incur, assume,
maintain or permit to exist, except as may be in existence at the Effective Time
under the Merger Agreement, any long-term debt or any short-term debt for
borrowed money other than under lines of credit existing on November 30, 2004
(which amounts permitted or drawn thereunder shall not be increased), or
relating to purchase money security interests or obligations as a lessee under
leases recorded as capital leases, each as incurred in the ordinary course of
business and in amounts less than $25,000; (vi) assume, guarantee, endorse or
otherwise become liable or responsible (whether directly, contingently or
otherwise) for the obligations of any other Person other than a subsidiary of
the Company; or (vii) make any loans, advances or capital contributions to, or
investments in, any other Person other than a subsidiary of the Company; (viii)
authorize, recommend, propose or announce an intention to authorize, recommend
or propose, or enter into any agreement in principle or an agreement with
respect to, any (A) plan of liquidation or dissolution, (B) unless authorized by
a Preferred Director Approval, acquisition of an amount of assets or securities
in excess of $500,000, (C) unless authorized by a Preferred Director Approval,
disposition of assets or securities in amounts greater than $500,000, or (D)
unless authorized by a Preferred Director Approval, merger or combination to
which the Company or any subsidiary of the Company is a party, (ix) unless
authorized by a Preferred Director Approval, engage in any unusual or novel
method of transacting business or change any accounting procedure or practice or
its financial structure; or (x) enter into any agreement with respect to the
foregoing. Notwithstanding the foregoing, in no event shall the consent of the
Holders or a Preferred Director Approval be required for the issuance of any
Common Stock which is issuable upon exercise or conversion of warrants, options
or convertible securities that are outstanding at the Effective Time under the
Merger Agreement or that are otherwise permitted to be issued in connection with
transactions authorized pursuant to the foregoing provision.
The consent or votes required as described above in this Voting Rights
Section are in addition to any approval of Stockholders of the Company which may
be required by law or pursuant to any provision of the Company's certificate of
incorporation or bylaws.
At the Effective Time under the Merger Agreement, the Directors were
constituted and established pursuant to the Merger Agreement and the holders of
shares of Series B Preferred Stock, voting as a single class, shall be entitled
to elect three directors to serve on the Board of Directors at any annual
meeting of stockholders or special meeting held in place thereof, or at a
special meeting of the holders of the Series B Preferred Stock called as
hereinafter provided. If a vacancy shall exist in the office of a director
elected by the holders of Series B Preferred Stock, a proper officer of the
Company may, and upon the written request of the holders of record of at least
twenty-five percent (25%) of the shares of Series B Preferred Stock then
outstanding to the Secretary of the Company shall, call a special meeting of the
holders of Series B Preferred Stock, for the purpose of electing the director
which such holders are entitled to elect. If such meeting shall not be called by
proper officer of the Company within twenty (20) days after personal service of
27
said written request upon the Secretary of the Company, or within twenty (20)
days after mailing the same within the United States by certified mail,
addressed to the Secretary of the Company at its principal executive offices,
then the holders of at least twenty-five percent (25%) of the outstanding shares
of Series B Preferred Stock may designate in writing one of their number to call
such meeting at the expense of the Company, and such meeting may be called by
the person so designated upon the notice required for the annual meeting of
stockholders of the Company and shall be held at the place for holding the
annual meetings of stockholders. Any holder of Series B Preferred Stock so
designated shall have, and the Company shall provide, access to the lists of
Stockholders to be called pursuant to the provisions thereof.
Liquidation
Upon any liquidation, dissolution or winding-up of the Company, whether
voluntary or involuntary (a "Liquidation"), the holders of the Series B
Preferred Stock are entitled to receive out of the assets of the Company,
whether such assets are capital or surplus, for each share of Series B Preferred
Stock an amount equal to the greater of (i) the Stated Value per share plus any
accrued and unpaid dividends thereon and any other fees owing thereon before any
distribution or payment shall be made to the holders of any Junior Securities,
or (ii) the Participating Value per Share (the greater of the two being
"Liquidation Value"), and if the assets of the Company are insufficient to pay
in full such amounts, then the entire assets to be distributed to the holders of
the Series B Preferred Stock shall be distributed among the holders of the
Series B Preferred Stock ratably in accordance with the respective amounts that
would be payable on such shares if all amounts payable thereon were paid in
full.
Conversion
Automatic Conversion to Common Stock. If a Stockholder Approval Event
shall occur and the Equity Conditions are satisfied, or with the consent of the
holders of the Series B Preferred Stock waived, each outstanding share of Series
B Preferred Stock, and fractions thereof, shall automatically and immediately
convert, into the Conversion Ratio number of shares of Common Stock and (ii)
unless the conversion has occurred within 270 days of the issuance date, any
right to obtain any then accrued but unpaid dividends on each share of Series B
Preferred Stock shall be due and payable. After such conversion, upon surrender
to the Company for cancellation of a certificate previously representing
outstanding shares of Series B Preferred Stock, together with instruments of
transfer in form satisfactory to the Company, the holder of such certificate
shall be entitled to receive in exchange therefore a certificate representing
the number of shares of Common Stock equal to the Conversion Ratio multiplied by
the number of shares of Series B Preferred Stock previously represented by the
surrendered certificate plus payment of any accrued and unpaid dividend (payable
at the option of the Company either in cash or Common Stock valued at the VWAP
as of the Conversion Time). Until so surrendered, each outstanding certificate
that, prior to the time of the conversion of the Series B Preferred Stock into
Common (the "Conversion Time"), represented outstanding shares of Series B
Preferred Stock will be deemed from and after the Conversion Time, for all
corporate purposes, to evidence the ownership of the applicable number of shares
of Common Stock.
Conversion Ratio. The conversion ratio shall equal ten (the "Conversion
Ratio"), subject to the following adjustment. If the Company, at any time while
the Series B Preferred Stock is outstanding: (A) shall pay a stock dividend or
otherwise make a distribution or distributions on shares of its Common Stock or
any other equity or equity equivalent securities payable in shares of Common
Stock, (B) subdivide outstanding shares of Common Stock into a larger number of
shares, (C) combine (including by way of reverse stock split) outstanding shares
of Common Stock into a smaller number of shares, or (D) issue by
reclassification of shares of the Common Stock any shares of capital stock of
28
the Company, then the Conversion Ratio shall be multiplied by a fraction of
which the denominator shall be the number of shares of Common Stock Outstanding
before such event and of which the numerator shall be the number of shares of
Common Stock Outstanding after such event. Any adjustment made pursuant to this
Section shall become effective immediately after the record date for the
determination of Stockholders entitled to receive such dividend or distribution
and shall become effective immediately after the effective date in the case of a
subdivision, combination or reclassification.
Redemption upon Triggering Events
Upon the occurrence of a Triggering Event, each holder of the Series B
Preferred Stock shall have the right to require the Company to redeem all of the
Series B Preferred Stock then held by such holder for a redemption price, in
cash, equal to the Liquidation Value. The Liquidation Value shall be due and
payable within 5 Trading Days of the date on which the notice for the payment
therefore is provided by a holder of the Series B Preferred Stock (the
"Triggering Redemption Payment Date"). If the Company fails to pay the
Liquidation Value in full the Company will pay interest thereon at a rate of 12%
per annum, accruing daily from such date until the Liquidation Value, plus all
such interest thereon, is paid in full.
"Triggering Event" means any one or more of the following events to
which the holders of the Series B Preferred Stock have not given their prior
consent:
* the Company or any Significant Subsidiary (for purposes
hereof Significant Subsidiary shall mean FS SunTours, Inc. and
Farequest Holdings, Inc., or their respective successors) thereof
commences a case or other proceeding under any bankruptcy,
reorganization, arrangement, adjustment of debt, relief of debtors,
dissolution, insolvency or liquidation or similar law of any
jurisdiction relating to the Company or any Significant Subsidiary
thereof;
* there is commenced against the Company or any Significant
Subsidiary thereof any such case or proceeding that is not dismissed
within 60 days after commencement;
* the Company or any Significant Subsidiary thereof is
adjudicated insolvent or bankrupt or any order of relief or other order
approving any such case or proceeding is entered;
* the Company or any Significant Subsidiary thereof suffers
any appointment of any custodian or the like for it or any substantial
part of its property that is not discharged or stayed within 60 days;
* the Company or any Significant Subsidiary thereof makes a
general assignment for the benefit of creditors;
* the Company or any Significant Subsidiary thereof calls a
meeting of its creditors with a view to arranging a composition,
adjustment or restructuring of its debts;
* the Company or any Significant Subsidiary thereof, by any
act or failure to act, expressly indicates its consent to, approval of
or acquiescence in any of the foregoing or takes any corporate or other
action for the purpose of effecting any of the foregoing;
* an acquisition after the date hereof by an individual or
legal entity or "group" (as described in Rule 13d-5(b)(1) promulgated
under the Exchange Act) of effective control (whether through legal or
beneficial ownership of capital stock of the Company, by contract or
otherwise) of in excess of 25% of the voting securities of the Company;
29
* a replacement at one time or within a one year period of
more than one-half of the members of the Company's Board of Directors
which is not approved by a majority of those individuals who are
members of the Board of Directors named by Farequest Holdings, Inc.
immediately following the Effective Time of the Merger (or by those
individuals who are serving as members of the Board of Directors on any
date whose nomination to the Board of Directors was approved by a
majority of the members of the Board of Directors named by Farequest
Holdings, Inc., immediately following the Effective Time of the Merger;
* the execution by the Company of an agreement to which the
Company is a party or by which it is bound, providing for any of the
events set forth above in the prior two paragraphs;
* the Company effects any merger or consolidation of the
Company or a subsidiary with or into another Person, in which the
Company is not the surviving entity, or the Company's then existing
shareholders will own less than 51% of the surviving entity or less
than 51% of its stock which is entitled to ordinarily elect its
directors;
* the Company effects any sale of all or substantially all of
its assets in one or a series of related transactions;
* any tender offer or exchange offer (whether by the Company
or another Person) is completed pursuant to which holders of Common
Stock are permitted to tender or exchange their shares for other
securities, cash or property, the result of which to the Company's
shareholders at such time own less than 51% of the shares of Common
Stock of the Company; or
* the Company effects any reclassification of the Common Stock
or any compulsory share exchange pursuant to which the Common Stock is
effectively converted into or exchanged for other securities, cash or
property.
Subscription rights
If the Company, at any time while the Series B Preferred Stock is
outstanding, issues rights, options or warrants to all holders of Common Stock
entitling them to subscribe for or purchase shares of Common Stock or, subject
to approval by the holders of the Series B Preferred Stock, other securities of
the Company, then the Company shall issue to the Holders the same rights,
options or warrants to which they would have been entitled had the Series B
Preferred Stock been converted into the Conversion Shares immediately before the
date on which a record is taken for the grant, issuance or sale of such rights,
options or warrants or if no such record is taken, the date as of which the
record holders of Common Stock are to be determined for the grant, issue or sale
of such rights, options or warrants.
Fundamental Transactions
If a Fundamental Transaction occurs, then upon any subsequent
conversion of shares of Series B Preferred Stock, the holder of the Series B
Preferred Stock shall have the right to receive, for each Conversion Share that
would have been issuable upon such conversion absent such Fundamental
Transaction, the same kind and amount of securities, cash or property as it
would have been entitled to receive upon the occurrence of such Fundamental
Transaction if it had been, immediately prior to such Fundamental Transaction,
the holder of the Conversion Shares into which such Preferred Stock is
convertible (the "Alternate Consideration"). If holders of Common Stock are
given any choice as to the securities, cash or property to be received in a
Fundamental Transaction, then the holder of the Series B Preferred Stock shall
30
be given the same choice as to the Alternate Consideration it receives upon any
conversion of shares of Series B Preferred Stock following such Fundamental
Transaction. To the extent necessary to effectuate the foregoing provisions, any
successor to the Company or surviving entity in such Fundamental Transaction
shall issue to the holder new Series B Preferred Stock consistent with the
foregoing provisions and evidencing the holder's right to convert such Series B
Preferred Stock into Alternate Consideration. The terms of any agreement
pursuant to which a Fundamental Transaction is effected shall include terms
requiring any such successor or surviving entity to comply with the provisions
of this provision and insuring that the Series B Preferred Stock (or any such
replacement security) will be similarly adjusted upon any subsequent transaction
analogous to a Fundamental Transaction.
"Fundamental Transaction" means the occurrence of any of the following
events:
* the Company effects any merger or consolidation of the
Company or a subsidiary with or into another Person, in which the
Company is not the surviving entity, or the Company's then existing
shareholders will own less than 51% of the surviving entity or less
than 51% of its stock which is entitled to ordinarily elect its
directors;
* the Company effects any sale of all or substantially all of
its assets in one or a series of related transactions;
* any tender offer or exchange offer (whether by the Company
or another Person) is completed pursuant to which holders of Common
Stock are permitted to tender or exchange their shares for other
securities, cash or property, the result of which to the Company's
shareholders at such time own less than 51% of the shares of Common
Stock of the Company; or
* the Company effects any reclassification of the Common Stock
or any compulsory share exchange pursuant to which the Common Stock is
effectively converted into or exchanged for other securities, cash or
property.
Description of Promissory Note
The following is a summary of the material terms of the Promissory Note
and is qualified by its entirety by the form of Promissory Note filed as an
exhibit to Form 8-K filed by the Company with the SEC on February 7, 2005.
Amount, Maturity, Definitions
The Promissory Note is payable in an amount equal to the lesser of (i)
$6,037,872 or (ii) 19% of the value of the total maximum consideration payable
under Section 2.1(a) of the Merger Agreement, with the Company's Common Stock
valued for this purpose at the closing price on January 31, 2005, and the Series
B Preferred Stock valued for this purpose on an as-converted basis with the
Company's Common Stock. At the Company's option (i) all principal payable under
the Promissory Note may be paid through the issuance of 3,018,936 shares of the
Company's Common Stock, and (ii) any interest payable under the Promissory Note
may be paid in the Company's Common Stock, which, for such purposes shall be
valued at the greater of (a) $2.00 per share or (b) Market Value (as defined in
the Merger Agreement) at the Maturity Date of the Promissory Note (subject to
standard adjustment mechanisms).
31
The Promissory Note is due on February 1, 2006.
Capitalized terms used and not otherwise defined in this Description of
Promissory Note Section shall have the meanings set forth in the Promissory
Note.
Interest
Interest shall accrue on the unpaid principal balance of the Promissory
Note at the rate of four percent (4%) per year. The Company may prepay any
amount outstanding under the Promissory Note, provided, however, that if such
payment is to be made in shares of the Company's Common Stock a registration
statement for the resale of such shares must be effective.
Default
The failure by the Company to remedy any of the following events within
ten (10) business days of the Company's receipt of written notice of the
occurrence of the event shall constitute an "Event of Default" under the
Promissory Note: (i) the Company's failure to pay timely any amount due under
the Promissory Note; or (ii) bankruptcy, reorganization, insolvency or
liquidation proceedings or other proceedings for relief under any bankruptcy law
or any law for the relief of debtors shall be instituted by or against the
Company and, if instituted against the Company, the Company shall by any action
or answer approve of, consent to or acquiesce in any such proceedings or admit
the material allegations of, or default in answering a petition filed in any
such proceeding or such proceedings shall not be dismissed within ninety (90)
calendar days thereafter. If any such Event of Default occurs, Payee may, then
or at any time thereafter, at its option, accelerate maturity and cause the
entire unpaid principal balance of the Promissory Note, with interest, fees and
charges accrued hereon, to become immediately due and payable. If Payee waives
Payee's right to accelerate maturity as a result of an Event of Default
hereunder, either one or more time or repeatedly, nevertheless Payee shall not
be deemed to have waived the right to require strict compliance with the terms
of the Promissory Note thereafter.
Interests of Certain Officers and Directors of the Company in Proposal 3
If this Proposal 3 is approved by the Company's Stockholders, certain
officers and directors of the Company will receive shares of the Company's
Common Stock upon conversion of shares of Series B Preferred Stock and the
Promissory Note. The following calculations assume that (i) no indemnification
claims are made by the Company with respect to the merger transaction, (ii) all
Company securities reserved in the indemnification escrow account will be
distributed to the Farequest stockholders as additional merger consideration,
(iii) all Farequest warrants/options are exercised, (iv) interest under the
Promissory Note is not paid in shares of the Company's Common Stock, and (v) no
Series A Preferred Stock holders convert said shares to the Company's Common
Stock after the Effective Time of the merger.
William A. Goldstein is the Company's Chairman of the Board and a
Farequest stockholder at the time of the merger. Pursuant to the terms of the
Merger Agreement, the 819,030 share of Farequest stock held by Mr. Goldstein
entitled him to receive approximately 1,400,522 shares of RCG Common Stock,
447,595 shares of Series B Preferred Stock, and a 32.52% interest in the
Promissory Note. If this Proposal 3 is approved Mr. Goldstein will be entitled
to receive, in addition, up to an estimated 4,475,945 shares of the Company's
Common Stock upon conversion of his Series B Preferred Stock, and 995,862 shares
of the Company's Common Stock, including estimated interest, if the Company
elects to pay the Promissory Note in shares of the Company's Common Stock.
32
Ronald Attkisson is a director of the Company. Pursuant to the terms of
the Merger Agreement, the 84,000 Farequest warrants held by Jones Bird
Attkisson, Mr. Attkisson's firm, entitles Jones Bird Attkisson to receive (upon
exercise thereof) approximately 143,677 shares of Common Stock, 45,821 shares of
Series B Preferred Stock, and a 3.0% interest in the Promissory Note. If this
Proposal 3 is approved, Jones Bird Attkisson will be entitled to receive, in
addition, an estimated 458,216 shares of the Company's Common Stock upon
conversion of the Series B Preferred Stock, and 92,681 shares of the Company's
Common Stock, including estimated interest, if the Company elects to pay the
Promissory Note in shares of the Company's Common Stock.
Marc E. Bercoon is the Company's President and a Farequest stockholder
at the time of the merger. Pursuant to the terms of the Merger Agreement, the
50,000 shares of Farequest stock held by Mr. Bercoon entitled him to receive
approximately 85,495 shares of Common Stock, 27,323 shares of Series B Preferred
Stock, and a 2% interest in the Promissory Note. If this Proposal 3 is approved,
Mr. Bercoon will be entitled to receive, in addition, an estimated 273,234
shares of the Company's Common Stock upon conversion of the Series B Preferred
Stock, and 60,793 shares of the Company's Common Stock, including estimated
interest, if the Company elects to pay the Promissory Note in shares of the
Company's Common Stock.
Board Recommendation
For the reasons outlined above, the Board recommends a vote FOR the
proposal to approve, to the extent required for compliance with the American
Stock Exchange rules, the issuance of additional shares of the Company's common
stock in connection with the Company's February 2005 acquisition of Farequest
Holdings, Inc., as needed for full (i) conversion of the Company's Series B 6%
Redeemable Participating Preferred Stock into Common Stock; (ii) payment of the
Company's $6,037,872 Promissory Note with 3,018,936 shares of Common Stock for
the principal amount plus payment of interest of 4% per annum in shares of
Common Stock as needed, and (iii) issuance of shares of Common Stock as needed
in full satisfaction of the Contingent Shares payable to the Farequest Holdings,
Inc. former shareholders.
33
PROPOSAL 4
TO APPROVE, TO THE EXTENT REQUIRED FOR COMPLIANCE WITH THE AMERICAN
STOCK EXCHANGE RULES, ISSUANCE OF ADDITIONAL SHARES OF THE COMPANY'S COMMON
STOCK AS NEEDED FOR FULL CONVERSION OF THE COMPANY'S SERIES A 6% CONVERTIBLE
PREFERRED STOCK AND EXERCISE OF WARRANTS AND ADDITIONAL INVESTMENT RIGHTS SOLD
IN A PRIVATE PLACEMENT OFFERING COMPLETED BY THE COMPANY IN SEPTEMBER 2004 AND
WARRANTS SOLD IN A PRIVATE PLACEMENT OFFERING COMPLETED BY THE COMPANY IN
FEBRUARY 2005 AND ADJUSTED IN APRIL 2005.
Description of Transactions
October 2003 Private Placement
The Company entered into a Securities Purchase Agreement on October 31,
2003 (the "10/03 Securities Purchase Agreement") with institutional investors
(the "10/03 Investors"). Pursuant to the terms of the 10/03 Securities Purchase
Agreement, the Company initially issued the following securities to the 10/03
Investors in consideration for the 10/03 Investors making payment to the Company
in the aggregate amount of $4,000,000: (i) 2,500,000 shares of the Company's
Common Stock, and (ii) Warrants to purchase approximately 2,500,000 shares of
the Company's Common Stock at an exercise price of $2.44 per share for a period
of 3 years (the "10/03 Warrants").
The 10/03 Securities Purchase Agreement provided the 10/03 Investors
with certain rights to participate in future financings, and contained negative
covenants limiting the Company's rights to engage in certain types of future
financings.
The Company agreed to file a registration statement with the SEC
registering for resale all shares of the Company's Common Stock issued in the
private placement as well as shares of the Company's Common Stock underlying the
10/03 Warrants.
The transaction was approved by the Company's Board of Directors on
October 29, 2003, and closed on October 31, 2003. The Company's Common Stock and
the 10/03 Warrants were issued, and the shares of Common Stock underlying the
10/03 Warrants will be issued, pursuant to the exemption from registration
provided by Regulation D as promulgated under the Securities Act.
September 2004 Private Placement
The Company entered into a Securities Purchase Agreement effective as
of September 13, 2004 (the "9/04 Securities Purchase Agreement") with
institutional and accredited investors (collectively the "9/04 Investors").
Pursuant to the terms of the 9/04 Securities Purchase Agreement, the Company
initially issued the following securities to the 9/04 Investors in consideration
for the 9/04 Investors making payment to the Company in the aggregate amount of
$4,300,000:
* 4,300 shares of Series A 6% Convertible Preferred Stock;
* Warrants to purchase approximately 1,143,617 shares of common
stock of the Company at an exercise price of $1.20 per share,
exercisable commencing 6 months after the closing date until
the date that is 3 years after such date, with anti-dilution
provisions subject to a $1 floor, and that are, subject to
certain conditions, callable by the Company (the "9/04
Warrants"); and
* Additional Investment Rights ("Additional Investment Rights")
to purchase approximately 3,430,851 shares of common stock of
the Company at an exercise price of $1.03 per share,
exercisable commencing 6 months after the closing date until
the earlier of (a) the later of the date that is 6 months
after the effective date of the registration statement
covering the shares and the date that is 1 year after the
closing date, and (b) September 13, 2006, with standard
anti-dilution, and that are, subject to certain conditions,
callable by the Company.
The 9/04 Securities Purchase Agreement provided the 9/04 Investors with
certain rights to participate in future financings of the Company, and negative
covenants limiting the rights of the Company to engage in certain types of
future financings.
The Company has agreed to file a registration statement with the U.S.
Securities and Exchange Commission (the "SEC") registering for resale 130% of
all shares of common stock of the Company underlying the Series A Preferred
Stock, the 9/04 Warrants, and the Additional Investment Rights, and shares
issuable as dividends for 3 years.
The transaction was approved by the Company's Board of Directors on
August 25, 2004, and closed on September 14, 2004. The shares of Series A
Preferred Stock, the 9/04 Warrants, and the Additional Investment Rights, the
shares of common stock underlying such securities, and shares issuable as
dividends were issued pursuant to the exemption from registration provided by
Section 4(2) of the Securities Act of 1933, as amended.
34
February 2005 Private Placement
The Company entered into a Securities Purchase Agreement, as amended,
on February 8, 2005 (the "2/05 Securities Purchase Agreement") with
institutional and accredited investors (the "2/05 Investors"). Pursuant to the
terms of the 2/05 Securities Purchase Agreement, the Company initially issued
the following securities to the 2/05 Investors in consideration for the 2/05
Investors making payment to the Company in the aggregate amount of $6,294,391:
(i) Senior Secured Convertible Debentures in the original amount of $7,968,700
(the "Senior Convertible Debentures"), (ii) Warrants to purchase approximately
5,088,570 shares of the Company's Common Stock at an exercise price of $1.55 per
share, and (iii) Warrants to purchase approximately 5,088,570 shares of the
Company's Common Stock at an exercise price of $1.87 per share (collectively the
"2/05 Warrants").
The 2/05 Securities Purchase Agreement provided the 2/05 Investors with
certain rights to participate in future financings, and contained negative
covenants limiting the Company's rights to engage in certain types of future
financings.
The Company has agreed to file a registration statement with the SEC
registering for resale 130% of all shares of the Company's Common Stock
underlying the Senior Convertible Debentures and 2/05 Warrants.
The transaction was approved by the Company's Board of Directors on
February 7, 2005, and closed on February 8, 2005. The Senior Convertible
Debentures and the 2/05 Warrants were issued, and the shares of Common Stock
underlying the 2/05 Warrants will be issued, pursuant to the exemption from
registration provided by Section 4(2) of the Securities Act.
The proceeds of this financing were used in part for the Company's
escrow deposit in connection with its agreement to acquire OneTravel, Inc., and
for working capital purposes.
April 2005 Adjustment to Terms of Private Placements
On or about April 15, 2005, in connection with the closing of a private
placement to finance the closing of the Company's acquisition of OneTravel,
Inc., with the consent and approval of the 9/04 Investors and the 2/05
Investors, the Company took the following actions:
* Paid in full and retired all of the issued and outstanding
Senior Convertible Debentures for $8,765,570;
* Subject to receipt of stockholder approval as needed under the
American Stock Exchange rules, reduced the conversion price of
the Series A Preferred Stock to $0.55 per share, and provided
that said conversion price will no longer be subject to any
anti-dilution adjustments with the single exception that it
will be reset to the same conversion price of the Company's
Series C Preferred Stock if the Company's Series C Preferred
Stock is reset following the proposed 1 for 10 reverse split
of the Company's Common Stock;
* Subject to receipt of stockholder approval as needed under the
American Stock Exchange rules, reduced the exercise price of
the 10/03 Warrants to $0.55 per share and provided that said
exercise price will no longer be subject to any anti-dilution
adjustments;
* Subject to receipt of stockholder approval as needed under the
American Stock Exchange rules, reduced the exercise price of
the 9/04 Warrants to $1.00 per share and provided that said
exercise price will no longer be subject to any anti-dilution
adjustments; and
* Subject to receipt of stockholder approval as needed under the
American Stock Exchange rules, reduced the exercise price of
the 2/05 Warrants to $0.55 per share and provided that said
exercise price will no longer be subject to any anti-dilution
adjustments.
35
These actions were taken under a waiver letter agreement (the "Waiver")
which amended certain provisions of the agreements governing the September 2004
Private Placement and the February 2005 Private Placement. The Waiver was filed
as an Exhibit to Form 8-K filed with the SEC by the Company on April 15, 2005.
Under the Waiver, in addition to the matters described above, the 9/04 Investors
and the 2/05 Investors agreed (a) to modify their respective unsatisfied
registration rights; (b) to waive any obligation of the Company to conduct a
meeting of its shareholders prior to June 30, 2005; (c) to acknowledge, consent
to and approve the Reverse Stock Split; (d) to waive any violations of the terms
of, or conflicts with, or liquidated damages in connection with, their
respective agreements with the Company which may exist or which may arise solely
as a result of the entering into or consummation of any of the April 2005
Private Placement, the Reverse Stock Split and the redemption of the Senior
Convertible Debentures and the respective transactions undertaken by the Company
in connection therewith; (e) that no default or violation by the Company of any
of their respective agreements with the Company has occurred that has not been
waived or cured; and (f) that they waived any liquidated or other damages and
penalties that otherwise might have accrued to their benefit prior to the
redemption of the Senior Convertible Debentures. The agreements under the Waiver
were required to consummate the April 2005 Private Placement. Under the Waiver,
the Company agreed to submit the matters requiring shareholder approval for the
September 2004 Private Placement and the February 2005 Private Placement as a
single item together with the approvals of the matters relating to the April
2005 Private Placement, including the 1 for 10 Reverse Stock Split. As a
consequence, approval of the matters in this Proposal 4 is contingent on
approval of Proposals 5 and 6.
American Stock Exchange Approval Rule
The Company's common stock is listed for trading on the American Stock
Exchange and therefore, is subject to the Rules of the American Stock Exchange.
Pursuant to the American Stock Exchange Constitution and Rules, Section 713,
"the corporation is required to obtain shareholder approval for an offering in
the event that 20% or more of the presently outstanding common stock, or
securities convertible into common stock are issued at a price lower than market
value." As of October 30, 2003, a day prior to the closing of the 10/03
Securities Purchase Agreement, the Company had 15,553,551 shares of Common Stock
issued and outstanding. As of September 13, 2004, a day prior to closing of the
9/04 Private Placement, the Company had 21,170,290 shares of Common Stock issued
and outstanding. Generally, in making a determination regarding the shareholder
approval on the 20% rule, the American Stock Exchange will compute the number of
shares to be obtained by utilizing the lowest possible conversion ratio and will
rely on the number of shares outstanding at the time of the offering. Pursuant
to the April 2005 Adjustment, (i) the conversion price of the Series A Preferred
Stock has been reduced to below market price of the Company's Common Stock on
the applicable determination date, and (ii) the exercise price of the 10/03
Warrants, the 9/04 Warrants and the 2/05 Warrants have been reduced to below the
market price of the Company's Common Stock on the applicable determination date.
Therefore, shareholder approval is required regarding the issuance, upon
conversion of Series A Preferred Stock, the exercise of the 10/03 Warrants, the
exercise of the 9/04 Warrants, and the exercise of the 2/05 Warrants, of Common
Stock equaling 20% or more of the Company's shares outstanding at the applicable
determination date.
In the event that Stockholder approval is not obtained, we may not
issue upon conversion of the Series A Preferred Stock and exercise of the 10/03
Warrants, the 9/04 Warrants and 2/05 Warrants, in the aggregate, in excess of
4,212,887 shares of Common Stock (19.9% of the number of shares of Common Stock
outstanding on September 13, 2004). In addition, because approval of this
proposal is, together with Proposals 5 and 6, contingent upon all three of the
proposals being approved, if this proposal is not approved, Proposals 5 and 6
will not be approved and consequently the Series C Preferred Stock will not
convert into Common Stock and will remain redeemable by the Company in February
2006 for approximately $31 million.
36
Holders of Common Stock whose shares were issued upon conversion of
Series A Preferred Stock, upon exercise of the 10/03 Warrants, upon exercise of
the 9/04 Warrants, upon exercise of Additional Investment Rights, or upon
exercise of the 2/05 Warrants will not be counted in the vote on this Proposal.
Description of Series A Preferred Stock
The following is a summary of the material terms of the Series A
Preferred Stock as initially issued and is qualified by its entirety by the
Certificate of Designation of Preferences, Rights and Limitations of Series A 6%
Convertible Preferred Stock (the "Certificate") filed as an exhibit to Form 8-K
filed by the Company with the SEC on September 16, 2004. The following
description does not take into account the April 2005 Adjustment (see
"Adjustment to Conversion Price" below).
Amount, Stated Value, and Definitions
The number of shares of Series A Preferred Stock designated was 6,000.
Each share of Series A Preferred Stock has a stated value equal to $1,000 (the
"Stated Value"). Capitalized terms not otherwise defined in this Description of
Series A Preferred Stock section shall have the meaning given such terms in the
Certificate.
Dividends
Holders shall be entitled to receive and the Company shall pay,
cumulative dividends at the rate per share (as a percentage of the Stated Value
per share) of 6% per annum from the date of issuance, payable quarterly on March
1, June 1, September 1 and December 1, beginning with December 1, 2004 and on
any Conversion Date pursuant to the terms of the Certificate ("Dividend Payment
Date"). The form of dividend payments to each Holder shall be made in the
following order: (i) if funds are legally available for the payment of dividends
and the Equity Conditions (which Equity Conditions include the following: (a)
all conversions have been honored or cured; (b) the registration statement
covering the shares is effective; (c) the Common Stock is listed on the
Company's trading market; (d) all liquidated damages and other amounts owing
including dividends in respect of the preferred stock shall have been paid or
will be paid; (e) there is a sufficient number of authorized and unissued shares
to cover all conversions; (f) no Triggering Event has occurred and is
continuing; (g) the issuable conversion shares won't violate the applicable
ownership limitations; and (h) no public announcement of a pending Fundamental
Transaction or Change of Control Transaction has occurred that hasn't been
consummated) have not been met, in cash only, (ii) if funds are legally
available for the payment of dividends and the Equity Conditions have been met,
at the sole election of the Company, in cash or shares of Common Stock which
shall be valued solely for such purpose at 90% of the average of the 5 VWAPs
immediately prior to the Dividend Payment Date; (iii) if funds are not legally
available for the payment of dividends and the Equity Conditions have been met,
in shares of Common Stock which shall be valued at 90% of the average of the 5
VWAPs immediately prior to the Dividend Payment Date; (iv) if funds are not
legally available for the payment of dividends and the Equity Conditions
relating to registration have been waived by such Holder, as to such Holder
only, in unregistered shares of Common Stock which shall be valued at 90% of the
average of the 5 VWAPs immediately prior to the Dividend Payment Date; and (v)
if funds are not legally available for the payment of dividends and the Equity
Conditions have not been met, then, at the election of such Holder, such
dividends shall accrue to the next Dividend Payment Date or shall be accreted to
the outstanding Stated Value. As of the Closing Date, the Company shall pay the
dividends in shares of Common Stock. Dividends on the Series A Preferred Stock
shall be calculated on the basis of a 360-day year, shall accrue daily
commencing on the Original Issue Date, and shall be deemed to accrue from such
date whether or not earned or declared and whether or not there are profits,
surplus or other funds of the Company legally available for the payment of
dividends.
37
So long as any Series A Preferred Stock shall remain outstanding,
neither the Company nor any subsidiary thereof shall redeem, purchase or
otherwise acquire directly or indirectly any Junior Securities. So long as any
Series A Preferred Stock shall remain outstanding, neither the Company nor any
subsidiary thereof shall directly or indirectly pay or declare any dividend or
make any distribution (other than a dividend or distribution described in the
Section titled "Conversion" below or dividends due and paid in the ordinary
course on Series A Preferred Stock of the Company at such times when the Company
is in compliance with its payment and other obligations) upon, nor shall any
distribution be made in respect of, any Junior Securities so long as any
dividends currently due on the Series A Preferred Stock remain unpaid, nor shall
any monies be set aside for or applied to the purchase or redemption (through a
sinking fund or otherwise) of any Junior Securities or shares pari passu with
the Series A Preferred Stock.
Voting Rights
Except as otherwise provided in the Certificate and as otherwise
required by law, the Series A Preferred Stock shall have no voting rights.
However, so long as any shares of Series A Preferred Stock are outstanding, the
Company shall not, without the affirmative vote of the holders of the shares of
the Series A Preferred Stock then outstanding, (a) alter or change adversely the
powers, preferences or rights given to the Series A Preferred Stock or alter or
amend the Certificate, (b) authorize or create any class of stock ranking as to
dividends, redemption or distribution of assets upon a Liquidation senior to the
Series A Preferred Stock, (c) amend its certificate of incorporation or other
charter documents so as to affect adversely any rights of the holders of the
Series A Preferred Stock, (d) increase the authorized number of shares of Series
A Preferred Stock, or (e) enter into any agreement with respect to the
foregoing.
Liquidation
Upon any liquidation, dissolution or winding-up of the Company, whether
voluntary or involuntary (a "Liquidation"), the holders of the Series A
Preferred Stock shall be entitled to receive out of the assets of the Company,
whether such assets are capital or surplus, for each share of Series A Preferred
Stock an amount equal to the Stated Value per share plus any accrued and unpaid
dividends thereon and any other fees or liquidated damages owing thereon before
any distribution or payment shall be made to the holders of any Junior
Securities, and if the assets of the Company shall be insufficient to pay in
full such amounts, then the entire assets to be distributed to the holders of
the Series A Preferred Stock shall be distributed among the holders ratably in
accordance with the respective amounts that would be payable on such shares if
all amounts payable thereon were paid in full.
Conversion
Conversions at Option of Holder. Each share of Series A Preferred Stock
shall be convertible into that number of shares of Common Stock (subject to the
limitations set forth below) determined by dividing the Stated Value of such
share of Series A Preferred Stock by the Set Price.
Beneficial Ownership Limitation. The Company shall not effect any
conversion of the Series A Preferred Stock, and the holder of the Series A
Preferred Stock shall not have the right to convert any portion of the Series A
Preferred Stock to the extent that after giving effect to such conversion, the
Holder (together with the Holder's affiliates), as set forth on the applicable
Conversion Notice, would beneficially own in excess of 4.9% of the number of
shares of the Common Stock outstanding immediately after giving effect to such
conversion.
Limitation on Number of Shares Issuable. Notwithstanding anything
herein to the contrary, the Company shall not issue to any holder of the Series
A Preferred Stock any shares of Common Stock, including pursuant to any rights
under the Certificate, including, without limitation, any conversion rights or
right to issue shares of Common Stock in payment of dividends, to the extent
such shares, when added to the number of shares of Common Stock previously
issued upon conversion of any shares of Series A Preferred Stock would exceed
38
3,875,188, or such greater or lesser number of shares of Common Stock permitted
pursuant to the corporate governance rules of the Principal Market that is at
the time the principal trading exchange or market for the Common Stock (the
"Maximum Aggregate Share Amount"), unless the Company first obtains shareholder
approval permitting such issuances in accordance with the Principal Market rules
("Shareholder Approval").
Forced Conversion. If after the date that the registration statement
which registers for resale all of the Conversion Shares (the "Conversion Shares
Registration Statement") is declared effective (the "Effective Date") the VWAP
for each of any 10 consecutive Trading Days ("Threshold Period"), which 10
consecutive Trading Day period shall have commenced only after the Effective
Date, exceeds 200% of the then effective Set Price (defined below), the Company
may, within 2 Trading Days after any such Threshold Period, deliver a notice to
all Holders (a "Forced Conversion Notice" and the date such notice is received
by the Holders, the "Forced Conversion Notice Date") to cause the Holders to
immediately convert all or part of the then outstanding shares of Series A
Preferred Stock pursuant to Section 5 and the Holders shall surrender (if all
Series A Preferred Stock is converted) their respective shares of Series A
Preferred Stock to the Company for conversion within 5 Trading Days of the
Forced Conversion Notice Date. The Company may only effect a Forced Conversion
Notice if all of the Equity Conditions have been met during the Threshold Period
through the Forced Conversion Notice Date.
The conversion price shall equal $0.94 (the "Set Price"), subject to
the following adjustments.
* if the Company, at any time while the Series A Preferred
Stock is outstanding: (A) shall pay a stock dividend or otherwise make
a distribution or distributions on shares of its Common Stock or any
other equity or equity equivalent securities payable in shares of
Common Stock, (B) subdivide outstanding shares of Common Stock into a
larger number of shares, (C) combine (including by way of reverse stock
split) outstanding shares of Common Stock into a smaller number of
shares, or (D) issue by reclassification of shares of the Common Stock
any shares of capital stock of the Company, then the Set Price shall be
multiplied by a fraction of which the numerator shall be the number of
shares of Common Stock Outstanding before such event and of which the
denominator shall be the number of shares of Common Stock Outstanding
after such event. Any adjustment made pursuant to this Section shall
become effective immediately after the record date for the
determination of Stockholders entitled to receive such dividend or
distribution and shall become effective immediately after the effective
date in the case of a subdivision, combination or reclassification.
* if the Company, at any time while the Series A Preferred
Stock is outstanding, shall issue rights, options or warrants to all
holders of Common Stock (and not to Holders) entitling them to
subscribe for or purchase shares of Common Stock at a price per share
less than the VWAP at the record date mentioned below, then the Set
Price shall be multiplied by a fraction, of which the denominator shall
be the number of shares of the Common Stock Outstanding on the date of
issuance of such rights or warrants plus the number of additional
shares of Common Stock offered for subscription or purchase, and of
which the numerator shall be the number of shares of the Common Stock
Outstanding on the date of issuance of such rights or warrants plus the
number of shares which the aggregate offering price of the total number
of shares so offered (assuming receipt by the Company in full of all
consideration payable upon exercise of such rights, options or
warrants) would purchase at such VWAP. Such adjustment shall be made
whenever such rights or warrants are issued, and shall become effective
immediately after the record date for the determination of Stockholders
entitled to receive such rights, options or warrants.
39
* if the Company or any subsidiary thereof at any time while
any of the Series A Preferred Stock is outstanding, shall sell, grant
any option or warrant to purchase or sell or grant any right to reprice
its securities, or otherwise dispose of or issue any Common Stock or
any equity or equity equivalent securities (including any equity, debt
or other instrument that is at any time over the life thereof
convertible into or exchangeable for Common Stock) (collectively,
"Common Stock Equivalents") entitling any Person to acquire shares of
Common Stock, at an effective price per share less than the Set Price
(a "Dilutive Issuance"), as adjusted (if the holder of the Common Stock
or Common Stock Equivalent so issued shall at any time, whether by
operation of purchase price adjustments, reset provisions, floating
conversion, exercise or exchange prices or otherwise, or due to
warrants, options or rights per share which are issued in connection
with such issuance, be entitled to receive shares of Common Stock at a
price per share which is less than the Set Price, such issuance shall
be deemed to have occurred for less than the Set Price), then the Set
Price shall be reduced to equal the effective conversion, exchange or
purchase price for such Common Stock or Common Stock Equivalents
(including any reset provisions thereof) at issue. Such adjustment
shall be made whenever such Common Stock or Common Stock Equivalents
are issued. The Company shall notify the Holder in writing, no later
than the second Trading Day following the issuance of any Common Stock
or Common Stock Equivalent subject to this section, indicating therein
the applicable issuance price, or of applicable reset price, exchange
price, conversion price and other pricing terms. For purposes of this
subsection, a Dilutive Issuance shall be deemed to have occurred when
binding agreements have been closed by the Company and any purchaser
therein.
* if the Company, at any time while the Series A Preferred
Stock is outstanding, shall distribute to all holders of Common Stock
(and not to Holders) evidences of its indebtedness or assets or rights
or warrants to subscribe for or purchase any security other than the
Common Stock (which shall be subject to Section 5(c)(iii) of the
Certificate), then in each such case the Set Price shall be adjusted by
multiplying the Set Price in effect immediately prior to the record
date fixed for determination of Stockholders entitled to receive such
distribution by a fraction of which the denominator shall be the VWAP
determined as of the record date mentioned above, and of which the
numerator shall be such VWAP on such record date less the then per
share fair market value at such record date of the portion of such
assets or evidence of indebtedness so distributed applicable to one
outstanding share of the Common Stock as determined by the Board of
Directors in good faith. In either case the adjustments shall be
described in a statement provided to the Holders of the portion of
assets or evidences of indebtedness so distributed or such subscription
rights applicable to one share of Common Stock. Such adjustment shall
be made whenever any such distribution is made and shall become
effective immediately after the record date mentioned above.
No adjustment shall be made in connection with an Exempt Issuance.
Redemption upon Triggering Events
Upon the occurrence of a Triggering Event, each Holder shall have the
right to require the Company to redeem all of the Series A Preferred Stock then
held by such Holder for a redemption price, in cash, equal to the Triggering
Redemption Amount. The Triggering Redemption Amount shall be due and payable
within 5 Trading Days of the date on which the notice for the payment therefor
is provided by a Holder (the "Triggering Redemption Payment Date"). If the
Company fails to pay the Triggering Redemption Amount in full the Company will
pay interest thereon at a rate of 18% per annum, accruing daily from such date
until the Triggering Redemption Amount, plus all such interest thereon, is paid
in full.
40
"Triggering Event" means any one or more of the following events:
* the failure of a Conversion Shares Registration Statement to
be declared effective by the Commission on or prior to the 180th day
after the Original Issue Date;
* if, during the Effectiveness Period, the effectiveness of
the Conversion Shares Registration Statement lapses for any reason for
more than an aggregate of 60 calendar days (which need not be
consecutive days) during any 12 month period, or the Holder shall not
be permitted to resell Registrable Securities under the Conversion
Shares Registration Statement other than as a result of any action or
inaction of a Holder for more than an aggregate of 60 calendar days
(which need not be consecutive days) during any 12 month period (the
Effectiveness Period is that period commencing with the Effectiveness
Date and continuing until all securities covered by the Conversion
Shares Registration Statement have been sold or may be sold without
volume restrictions pursuant to Rule 144(k));
* the Company shall fail to deliver certificates representing
Conversion Shares issuable upon a conversion prior to the 10th Trading
Day after such shares are required to be delivered, or the Company
shall provide written notice to any Holder, including by way of public
announcement, at any time, of its intention not to comply with requests
for conversion of any shares of Series A Preferred Stock in accordance
with the terms hereof;
* if either of the following events shall not have been cured
to the satisfaction of the Holders prior to the expiration of 15 days
from the Event Date (as defined in the Registration Rights Agreement)
relating thereto (other than an Event resulting from a failure of a
Conversion Shares Registration Statement to be declared effective by
the Commission on or prior to the 180th day after the Original Issue
Date, which is covered above): (i) a Registration Statement is not
filed on or prior to its Filing Date (as defined in the Registration
Rights Agreement), or (ii) the Company fails to file with the
Commission a request for acceleration in accordance with Rule 461
promulgated under the Securities Act, within five Trading Days of the
date that the Company is notified (orally or in writing, whichever is
earlier) by the Commission that a Registration Statement will not be
"reviewed," or not subject to further review;
* the Company shall fail for any reason to pay in full the
amount of cash due pursuant to a Buy-In within 5 Trading Days after
notice therefor is delivered or shall fail to pay all amounts owed on
account of an Event within five days of the date due (for purposes
hereof an Event includes the following events: (i) a registration
statement is not timely filed, (ii) the Company fails to timely file
with the Commission a request for acceleration after being notified
that a Registration Statement will not be "reviewed," or is not subject
to further review, (iii) prior to its Effectiveness Date, the Company
fails to timely file a pre-effective amendment and otherwise respond in
writing to comments made by the Commission, (iv) a registration
statement filed or required to be filed is not declared effective by
the Commission by its Effectiveness Date, or (v) after the
Effectiveness Date, a registration statement ceases for any reason to
remain continuously effective as to all registrable securities for
which it is required to be effective, or the Holders are not permitted
to utilize the prospectus therein to resell such registrable securities
for 10 consecutive days or an aggregate of 15 days during any 12-month
period);
* the Company shall fail to have available a sufficient number
of authorized and unreserved shares of Common Stock to issue to such
Holder upon a conversion unless the Company has complied with Section
4.10(b) of the Purchase Agreement (which section provides the Company
an opportunity to amend the Company's certificate of incorporation to
increase the number of shares the Company is authorized to issue);
41
* the Company shall fail to observe or perform any other
material covenant, agreement or warranty contained in, or otherwise
commit any breach of the Transaction Documents, and such material
failure or breach shall not, if subject to the possibility of a cure by
the Company, have been remedied within 30 calendar days after the date
on which written notice of such failure or breach shall have been
given;
* the Company shall be a party to any Change of Control
Transaction or the Company shall redeem more than a deminimis number of
Junior Securities;
* there shall have occurred a Bankruptcy Event;
* any breach of the officer's/director's voting agreement
delivered to the initial Holders at the Closing; or
* the Common Stock shall fail to be listed or quoted for
trading on a Trading Market for more than 5 consecutive Trading Days.
Fundamental Transactions
If a Fundamental Transaction occurs, then upon any subsequent
conversion of shares of Series A Preferred Stock, the holder of the Series A
Preferred Stock shall have the right to receive, for each Conversion Share that
would have been issuable upon such conversion absent such Fundamental
Transaction, the same kind and amount of securities, cash or property as it
would have been entitled to receive upon the occurrence of such Fundamental
Transaction if it had been, immediately prior to such Fundamental Transaction,
the holder of one share of Common Stock (the "Alternate Consideration"). For
purposes of any such conversion, the determination of the Set Price shall be
appropriately adjusted to apply to such Alternate Consideration based on the
amount of Alternate Consideration issuable in respect of one share of Common
Stock in such Fundamental Transaction, and the Company shall apportion the Set
Price among the Alternate Consideration in a reasonable manner reflecting the
relative value of any different components of the Alternate Consideration. If
holders of Common Stock are given any choice as to the securities, cash or
property to be received in a Fundamental Transaction, then the holder of the
Series A Preferred Stock shall be given the same choice as to the Alternate
Consideration it receives upon any conversion of shares of Series A Preferred
Stock following such Fundamental Transaction. To the extent necessary to
effectuate the foregoing provisions, any successor to the Company or surviving
entity in such Fundamental Transaction shall issue to the holder of the Series A
Preferred Stock new Series A Preferred Stock consistent with the foregoing
provisions and evidencing the holder's right to convert such Series A Preferred
Stock into Alternate Consideration. The terms of any agreement pursuant to which
a Fundamental Transaction is effected shall include terms requiring any such
successor or surviving entity to comply with the provisions of this provision
and insuring that the Series A Preferred Stock (or any such replacement
security) will be similarly adjusted upon any subsequent transaction analogous
to a Fundamental Transaction.
42
Adjustment to Conversion Price
Notwithstanding any terms to the contrary set forth in the above
description, on April 15, 2005, subject to stockholder approval as required
under the American Stock Exchange rules, the terms of the Series A Preferred
Stock were adjusted such that the conversion price of the Series A Preferred
Stock was reduced to $0.55 per share, which conversion price will no longer be
subject to any anti-dilution adjustments, with the single exception that it will
be reset to the same conversion price of the Company's Series C Preferred Stock
if the Company's Series C Preferred Stock is reset following the proposed 1 for
10 reverse split of the Company's Common Stock.
Description of 10/03 Warrants
The following is a summary of the material terms of the 10/03 Warrants
as initially issued and is qualified by its entirety by the form of 10/03
Warrant filed as an exhibit to Form 8-K filed by the Company with the SEC on
November 17, 2003. The following description does not take into account the
April 2005 Adjustment (see "Adjustment to Exercise Price" below).
Number, Term, and Definitions
The 10/03 Warrants entitle the holders thereof to initially purchase up
to a total of approximately 2,500,000 shares of the Common Stock of the Company.
The 10/03 Warrants are exercisable at any time on or after the 181st
day following the date of issuance (the "Initial Exercise Date") and on or prior
to the close of business on the three year anniversary of the Initial Exercise
Date.
Capitalized terms used and not otherwise defined in this Description of
10/03 Warrants Section shall have the meanings set forth in the 10/03 Warrant
agreement.
Exercise
Exercise of 10/03 Warrant. Exercise of the 10/03 Warrants may be made
at any time or times on or after the Initial Exercise Date and on or before the
Termination Date by delivery to the Company of a duly executed facsimile copy of
the Notice of Exercise Form annexed to the 10/03 Warrant.
Exercise Price. The exercise price of each share of Common Stock under
the 10/03 Warrants shall be $2.48, subject to adjustment (the "Exercise Price").
Cashless Exercise. If at any time after one year from the date of
issuance of the 10/03 Warrants there is no effective Registration Statement
registering the resale of the Warrant Shares by its holder, then the 10/03
Warrants may also be exercised at such time by means of a "cashless exercise."
Holder's Restrictions. Each holder of the 10/03 Warrant shall not have
the right to exercise any portion of their 10/03 Warrant to the extent that
after giving effect to such issuance after exercise, the holder (together with
the holder's affiliates), as set forth on the applicable Notice of Exercise,
would beneficially own in excess of 4.99% of the number of shares of the Common
Stock outstanding immediately after giving effect to such issuance.
Call Provision. Subject to the provisions of Section 3(e) of the 10/03
Warrants, if after the Effective Date the Closing Price for each of 15
consecutive Trading Days (the "Measurement Price", which period shall not have
commenced until after the Effective Date) exceeds $4.80 per share (subject to
adjustment as set forth herein) (the "Threshold Price), then the Company may,
within two Trading Days of such period, call for cancellation of all or any
portion of the 10/03 Warrants for which a Notice of Exercise has not yet been
delivered (such right, a "Call"). To exercise this right, the Company must
deliver to the Holder an irrevocable written notice (a "Call Notice"),
indicating therein the portion of unexercised portion of the 10/03 Warrants to
which such notice applies. If the conditions set forth below for such Call are
satisfied from the period from the date of the Call Notice through and including
the Call Date (as defined below), then any portion of the 10/03 Warrant subject
to such Call Notice for which a Notice of Exercise shall not have been received
from and after the date of the Call Notice will be cancelled at 6:30 p.m. (New
York City time) on the 44th Trading Day after the date the Call Notice is
received by the Holder (such date, the "Call Date"). Any unexercised portion of
the 10/03 Warrant to which the Call Notice does not pertain will be unaffected
by such Call Notice. Notwithstanding anything to the contrary set forth in the
10/03 Warrant, the Company may not deliver a Call Notice or require the
cancellation of the 10/03 Warrant (and any Call Notice will be void), unless,
from the beginning of the 15 consecutive Trading Days used to determine whether
the Common Stock has achieved the Threshold Price through the Call Date, a
Registration Statement with respect to the Warrant Shares shall be effective,
the Common Stock is listed or quoted for trading on the Principal Market, and
such issuance would not violate the prohibition against owning in excess of
4.99% of the number of shares of the Common Stock outstanding immediately after
giving effect to such issuance.
43
Certain Adjustments.
Stock Dividends and Splits. If the Company, at any time while the 10/03
Warrants are outstanding: (A) pays a stock dividend or otherwise make a
distribution or distributions on shares of its Common Stock or any other equity
or equity equivalent securities payable in shares of Common Stock (which, for
avoidance of doubt, shall not include any shares of Common Stock issued by the
Company pursuant to the 10/03 Warrants), (B) subdivides outstanding shares of
Common Stock into a larger number of shares, (C) combines (including by way of
reverse stock split) outstanding shares of Common Stock into a smaller number of
shares, or (D) issues by reclassification of shares of the Common Stock any
shares of capital stock of the Company, then in each case the Exercise Price
shall be multiplied by a fraction of which the numerator shall be the number of
shares of Common Stock (excluding treasury shares, if any) outstanding before
such event and of which the denominator shall be the number of shares of Common
Stock outstanding after such event and the number of Warrant Shares issuable
upon exercise of the 10/03 Warrants shall be proportionately adjusted. Any
adjustment made pursuant to this Section 11(a) shall become effective
immediately after the record date for the determination of Stockholders entitled
to receive such dividend or distribution and shall become effective immediately
after the effective date in the case of a subdivision, combination or
re-classification.
Subsequent Equity Sales. If the Company or any Subsidiary thereof, as
applicable, at any time while the 10/03 Warrants are outstanding, shall sell,
grant any option to purchase, sell or grant any right to reprice its securities,
or otherwise dispose of or issue any Common Stock or Common Stock Equivalents
entitling any Person to acquire shares of Common Stock, at an effective price
per share less than the then Exercise Price (such lower price, the "Base Share
Price" and such issuances collectively, a "Dilutive Issuance"), as adjusted (if
the holder of the Common Stock or Common Stock Equivalents so issued shall at
any time, whether by operation of purchase price adjustments, reset provisions,
floating conversion, exercise or exchange prices or otherwise, or due to
warrants, options or rights per share which is issued in connection with such
issuance, be entitled to receive shares of Common Stock at an effective price
per share which is less than the Exercise Price, such issuance shall be deemed
to have occurred for less than the Exercise Price), then, the Exercise Price
shall be reduced to equal the Base Share Price. Such adjustment shall be made
whenever such Common Stock or Common Stock Equivalents are issued. The Company
shall notify the Holder in writing following the issuance of any Common Stock or
Common Stock Equivalents subject to this section, indicating therein the
applicable issuance price, or of applicable reset price, exchange price,
conversion price and other pricing terms.
Fundamental Transaction. If, at any time while the 10/03 Warrants are
outstanding, the Company effects any the Company shall reorganize its capital,
reclassify its capital stock, consolidate or merge with or into another
corporation (where the Company is not the surviving corporation or where there
is a change in or distribution with respect to the Common Stock of the Company),
or sell, transfer or otherwise dispose of its property, assets or business to
another corporation and, pursuant to the terms of such reorganization,
reclassification, merger, consolidation or disposition of assets, shares of
common stock of the successor or acquiring corporation, or any cash, shares of
44
stock or other securities or property of any nature whatsoever (including
warrants or other subscription or purchase rights) in addition to or in lieu of
common stock of the successor or acquiring corporation ("Other Property"), are
to be received by or distributed to the holders of Common Stock of the Company,
then the Holder shall have the right thereafter to receive, at the option of the
Holder, (a) upon exercise of this Warrant, the number of shares of Common Stock
of the successor or acquiring corporation or of the Company, if it is the
surviving corporation, and Other Property receivable upon or as a result of such
reorganization, reclassification, merger, consolidation or disposition of assets
by a Holder of the number of shares of Common Stock for which this Warrant is
exercisable immediately prior to such event or (b) cash equal to the value of
this Warrant as determined in accordance with the Black Scholes option pricing
formula. In case of any such reorganization, reclassification, merger,
consolidation or disposition of assets, the successor or acquiring corporation
(if other than the Company) shall expressly assume the due and punctual
observance and performance of each and every covenant and condition of this
Warrant to be performed and observed by the Company and all the obligations and
liabilities hereunder, subject to such modifications as may be deemed
appropriate (as determined in good faith by resolution of the Board of Directors
of the Company) in order to provide for adjustments of Warrant Shares for which
this Warrant is exercisable which shall be as nearly equivalent as practicable
to the adjustments provided for in this section. For purposes of this section,
"common stock of the successor or acquiring corporation" shall include stock of
such corporation of any class which is not preferred as to dividends or assets
over any other class of stock of such corporation and which is not subject to
redemption and shall also include any evidences of indebtedness, shares of stock
or other securities which are convertible into or exchangeable for any such
stock, either immediately or upon the arrival of a specified date or the
happening of a specified event and any warrants or other rights to subscribe for
or purchase any such stock. The foregoing provisions shall similarly apply to
successive reorganizations, reclassifications, mergers, consolidations or
disposition of assets.
Adjustment to Exercise Price
Notwithstanding any terms to the contrary set forth in the above
description, on April 15, 2005, subject to stockholder approval as required
under the American Stock Exchange rules, the terms of the 10/03 Warrants were
adjusted by the Company such that the exercise price of the 10/03 Warrants was
reduced to $0.55 per share, which exercise price will no longer be subject to
any anti-dilution adjustments.
Description of 9/04 Warrants
The following is a summary of the material terms of the 9/04 Warrants
as initially issued and is qualified by its entirety by the form of 9/04 Warrant
filed as an exhibit to Form 8-K filed by the Company with the SEC on September
16, 2004. The following description does not take into account the April 2005
Adjustment (see "Adjustment to Exercise Price" below).
Number, Term, and Definitions
The 9/04 Warrants entitle the holders thereof to initially purchase up
to a total of approximately 1,143,617 shares of the Common Stock of the Company.
The 9/04 Warrants are exercisable at any time on or after the 181st day
following the date of issuance (the "Initial Exercise Date") and on or prior to
the close of business on the three year anniversary of the Initial Exercise
Date. The Exercise Period shall be extended for the number of Trading Days
during such period in which (x) trading in the Common Stock is suspended by any
Trading Market, or (y) following the Effective Date, the Registration Statement
is not effective or the prospectus included in the Registration Statement may
not be used by the Purchasers for the resale of the Warrant Shares.
Capitalized terms used and not otherwise defined in this Description of
9/04 Warrants Section shall have the meanings set forth in Section 1 of the 9/04
Warrant agreement.
Exercise
Exercise of 9/04 Warrant. Exercise of the 9/04 Warrants may be made at
any time or times on or after the Initial Exercise Date and on or before the
Termination Date by delivery to the Company of a duly executed facsimile copy of
the Notice of Exercise Form annexed to the 9/04 Warrant.
Exercise Price. The exercise price of each share of Common Stock under
the 9/04 Warrants shall be $1.20, subject to adjustment (the "Exercise Price").
Cashless Exercise. If at any time after one year from the date of
issuance of the 9/04 Warrants there is no effective Registration Statement
registering the resale of the Warrant Shares by its holder, then the 9/04
Warrants may also be exercised at such time by means of a "cashless exercise."
Holder's Restrictions. Each holder of the 9/04 Warrant shall not have
the right to exercise any portion of their 9/04 Warrant to the extent that after
giving effect to such issuance after exercise, the holder (together with the
holder's affiliates), as set forth on the applicable Notice of Exercise, would
beneficially own in excess of 4.99% of the number of shares of the Common Stock
outstanding immediately after giving effect to such issuance.
45
Call Provision. Subject to the provisions of Section 2(f) of the 9/04
Warrants, if after the Effective Date the VWAP for each of 20 consecutive
Trading Days (the "Measurement Price", which period shall not have commenced
until after the Effective Date) exceeds 200% of the then Exercise Price (subject
to adjustment as set forth herein) (the "Threshold Price), then the Company may,
within ten Trading Days of such period, call for cancellation of all or any
portion of the 9/04 Warrants for which a Notice of Exercise has not yet been
delivered (such right, a "Call"). To exercise this right, the Company must
deliver to the Holder an irrevocable written notice (a "Call Notice"),
indicating therein the portion of unexercised portion of the 9/04 Warrants to
which such notice applies. If the conditions set forth below for such Call are
satisfied from the period from the date of the Call Notice through and including
the Call Date (as defined below), then any portion of the 9/04 Warrant subject
to such Call Notice for which a Notice of Exercise shall not have been received
from and after the date of the Call Notice will be cancelled at 6:30 p.m. (New
York City time) on the tenth Trading Day after the date the Call Notice is
received by the Holder (such date, the "Call Date"). Any unexercised portion of
the 9/04 Warrant to which the Call Notice does not pertain will be unaffected by
such Call Notice. Notwithstanding anything to the contrary set forth in the 9/04
Warrant, the Company may not deliver a Call Notice or require the cancellation
of the 9/04 Warrant (and any Call Notice will be void), unless, from the
beginning of the 20 consecutive Trading Days used to determine whether the
Common Stock has achieved the Threshold Price through the Call Date, the Equity
Conditions (as defined in the Certificate of Designation) have been met. The
Company's right to Call the 9/04 Warrant shall be exercised ratably among the
Purchasers based on each Purchaser's initial purchase of Common Stock pursuant
to the Purchase Agreement.
Certain Adjustments.
Stock Dividends and Splits. If the Company, at any time while the 9/04
Warrants are outstanding: (A) pays a stock dividend or otherwise make a
distribution or distributions on shares of its Common Stock or any other equity
or equity equivalent securities payable in shares of Common Stock (which, for
avoidance of doubt, shall not include any shares of Common Stock issued by the
Company pursuant to the 9/04 Warrants), (B) subdivides outstanding shares of
Common Stock into a larger number of shares, (C) combines (including by way of
reverse stock split) outstanding shares of Common Stock into a smaller number of
shares, or (D) issues by reclassification of shares of the Common Stock any
shares of capital stock of the Company, then in each case the Exercise Price
shall be multiplied by a fraction of which the numerator shall be the number of
shares of Common Stock (excluding treasury shares, if any) outstanding before
such event and of which the denominator shall be the number of shares of Common
Stock outstanding after such event and the number of Warrant Shares issuable
upon exercise of the 9/04 Warrants shall be proportionately adjusted. Any
adjustment made pursuant to this Section 3(a) shall become effective immediately
after the record date for the determination of Stockholders entitled to receive
such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.
Subsequent Equity Sales. If the Company or any Subsidiary thereof, as
applicable, at any time while the 9/04 Warrants are outstanding, shall sell,
grant any option to purchase, sell or grant any right to reprice its securities,
or otherwise dispose of or issue any Common Stock or Common Stock Equivalents
entitling any Person to acquire shares of Common Stock, at an effective price
per share less than the then Exercise Price (such lower price, the "Base Share
Price" and such issuances collectively, a "Dilutive Issuance"), as adjusted (if
the holder of the Common Stock or Common Stock Equivalents so issued shall at
any time, whether by operation of purchase price adjustments, reset provisions,
floating conversion, exercise or exchange prices or otherwise, or due to
warrants, options or rights per share which is issued in connection with such
issuance, be entitled to receive shares of Common Stock at an effective price
per share which is less than the Exercise Price, such issuance shall be deemed
to have occurred for less than the Exercise Price), then, the Exercise Price
shall be reduced to equal the Base Share Price; provided, however, in no event
shall the Exercise Price be less than $1.00, subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar
46
transactions of the Common Stock that occur after the date of the Securities
Purchase Agreement. Such adjustment shall be made whenever such Common Stock or
Common Stock Equivalents are issued. The Company shall notify the Holder in
writing, no later than the second Trading Day following the issuance of any
Common Stock or Common Stock Equivalents subject to this section, indicating
therein the applicable issuance price, or of applicable reset price, exchange
price, conversion price and other pricing terms.
Pro Rata Distributions. If the Company, at any time prior to the
Termination Date, shall distribute to all holders of Common Stock (and not to
holders of the 9/04 Warrants) evidences of its indebtedness or assets or rights
or warrants to subscribe for or purchase any security other than the Common
Stock (which shall be subject to Section 3(b) of the 9/04 Warrants), then in
each such case the Exercise Price shall be adjusted by multiplying the Exercise
Price in effect immediately prior to the record date fixed for determination of
Stockholders entitled to receive such distribution by a fraction of which the
denominator shall be the VWAP determined as of the record date mentioned above,
and of which the numerator shall be such VWAP on such record date less the then
per share fair market value at such record date of the portion of such assets or
evidence of indebtedness so distributed applicable to one outstanding share of
the Common Stock as determined by the Board of Directors in good faith. In
either case the adjustments shall be described in a statement provided to the
holders of the 9/04 Warrants of the portion of assets or evidences of
indebtedness so distributed or such subscription rights applicable to one share
of Common Stock. Such adjustment shall be made whenever any such distribution is
made and shall become effective immediately after the record date mentioned
above.
Fundamental Transaction. If, at any time while the 9/04 Warrants are
outstanding, (A) the Company effects any merger or consolidation of the Company
with or into another Person, in which the Company is not the surviving entity,
or the Company's then existing shareholders will own less than 51% of the
surviving entity, (B) the Company effects any sale of all or substantially all
of its assets in one or a series of related transactions, (C) any tender offer
or exchange offer (whether by the Company or another Person) is completed
pursuant to which holders of Common Stock are permitted to tender or exchange
their shares for other securities, cash or property, or (D) the Company effects
any reclassification of the Common Stock or any compulsory share exchange
pursuant to which the Common Stock is effectively converted into or exchanged
for other securities, cash or property (in any such case, a "Fundamental
Transaction"), then, upon any subsequent conversion of the 9/04 Warrant, the
Holder shall have the right to receive, for each Warrant Share that would have
been issuable upon such exercise absent such Fundamental Transaction, at the
option of the Holder, (a) upon exercise of the 9/04 Warrants, the number of
shares of Common Stock of the successor or acquiring corporation or of the
Company, if it is the surviving corporation, and Alternate Consideration
receivable upon or as a result of such reorganization, reclassification, merger,
consolidation or disposition of assets by a Holder of the number of shares of
Common Stock for which the 9/04 Warrants are exercisable immediately prior to
such event or (b) only in the event the Company is acquired in an all cash
acquisition, cash equal to the value of the 9/04 Warrants as determined in
accordance with the Black-Scholes option pricing formula (the "Alternate
Consideration"). For purposes of any such exercise, the determination of the
Exercise Price shall be appropriately adjusted to apply to such Alternate
Consideration based on the amount of Alternate Consideration issuable in respect
of one share of Common Stock in such Fundamental Transaction, and the Company
shall apportion the Exercise Price among the Alternate Consideration in a
reasonable manner reflecting the relative value of any different components of
the Alternate Consideration. If holders of Common Stock are given any choice as
to the securities, cash or property to be received in a Fundamental Transaction,
then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of the 9/04 Warrant following such Fundamental
Transaction. To the extent necessary to effectuate the foregoing provisions, any
47
successor to the Company or surviving entity in such Fundamental Transaction
shall issue to the holder of the 9/04 Warrants a new warrant consistent with the
foregoing provisions and evidencing the holder's right to exercise such warrant
into Alternate Consideration upon the payment thereof. The terms of any
agreement pursuant to which a Fundamental Transaction is effected shall include
terms requiring any such successor or surviving entity to comply with the
provisions of this paragraph and insuring that the 9/04 Warrant (or any such
replacement security) will be similarly adjusted upon any subsequent transaction
analogous to a Fundamental Transaction.
Adjustment to Exercise Price
Notwithstanding any terms to the contrary set forth in the above
description, on April 15, 2005, subject to stockholder approval as required
under the American Stock Exchange rules, the terms of the 9/04 Warrants were
adjusted by the Company such that the exercise price of the 9/04 Warrants was
reduced to $1.00 per share, which exercise price will no longer be subject to
any anti-dilution adjustments.
Description of Additional Investment Rights
The following is a summary of the material terms of the Additional
Investment Rights and is qualified by its entirety by the form of Additional
Investment Rights Agreement filed as an exhibit to Form 8-K filed by the Company
with the SEC on September 16, 2004.
Number, Term, and Definitions
The Additional Investment Rights entitle the holders thereof to
initially purchase up to a total of approximately 3,430,851 shares of the Common
Stock of the Company.
The Additional Investment Rights are exercisable at any time on or
after the 181st day after the date of the Additional Investment Rights agreement
(the "Initial Exercise Date") and on or prior to the close of business on the
earlier of (a) the later of (i) the 181st day after the Effective Date and (ii)
the 181st day after the Initial Exercise Date and (b) the 2nd year anniversary
of the date of the Purchase Agreement (the "Termination Date" and the period
from the Initial Exercise Date until the Termination Date
Capitalized terms used and not otherwise defined in this Description of
Additional Investment Rights Section shall have the meanings set forth in
Section 1 of the Additional Investment Rights agreement.
Exercise
Exercise of Additional Investment Right. Exercise of the purchase
rights represented by the Additional Investment Rights may be made at any time
or times on or after the Initial Exercise Date and on or before the Termination
Date by delivery to the Company of a duly executed facsimile copy of the Notice
of Exercise Form annexed to the Additional Investment Rights agreement.
Exercise Price. The exercise price of each share of Common Stock under
the Additional Investment Rights shall be $1.03, subject to adjustment (the
"Exercise Price").
Holder's Restrictions. The holder of Additional Investment Rights shall
not have the right to exercise any portion of the Additional Investment Rights,
pursuant to Section 2(c) thereof or otherwise, to the extent that after giving
effect to such issuance after exercise, the Holder (together with the Holder's
affiliates), as set forth on the applicable Notice of Exercise, would
beneficially own in excess of 4.99% of the number of shares of the Common Stock
outstanding immediately after giving effect to such issuance.
48
Call Provision. Subject to the provisions of Section 2(f) of the
Additional Investment Rights agreement, if after the Effective Date the VWAP for
each of 20 consecutive Trading Days (the "Measurement Price", which period shall
not have commenced until after such anniversary date) is greater than or equal
to 160% of the then Exercise Price (subject to adjustment as set forth therein)
(the "Threshold Price"), then the Company may, in its sole discretion, within
ten Trading Days of such period, call for cancellation of all or any portion of
the Additional Investment Rights for which a Notice of Exercise has not yet been
delivered (such right, a "Call"). To exercise this right, the Company must
deliver to the Holder an irrevocable written notice (a "Call Notice"),
indicating therein the portion of unexercised portion of the Additional
Investment Rights to which such notice applies. If the conditions set forth
below for such Call are satisfied from the period from the date of the Call
Notice through and including the Call Date (as defined below), then any portion
of the Additional Investment Rights subject to such Call Notice for which a
Notice of Exercise shall not have been received from and after the date of the
Call Notice will be cancelled at 6:30 p.m. (New York City time) on the tenth
Trading Day after the date the Call Notice is received by the Holder (such date,
the "Call Date"). Any unexercised portion of the Additional Investment Rights to
which the Call Notice does not pertain will be unaffected by such Call Notice.
Notwithstanding anything to the contrary set forth in the Additional Investment
Rights, the Company may not deliver a Call Notice or require the cancellation of
the Additional Investment Rights (and any Call Notice will be void), unless,
from the beginning of the 20 consecutive Trading Days used to determine whether
the Common Stock has achieved the Threshold Price through the Call Date, the
Equity Conditions have been met. The Company's right to Call the Additional
Investment Right shall be exercised ratably among the Purchasers based on each
Purchaser's initial purchase of Common Stock pursuant to the Securities Purchase
Agreement.
Certain Adjustments
Stock Dividends and Splits. If the Company, at any time while the
Additional Investment Rights are outstanding: (A) pays a stock dividend or
otherwise make a distribution or distributions on shares of its Common Stock or
any other equity or equity equivalent securities payable in shares of Common
Stock (which, for avoidance of doubt, shall not include any shares of Common
Stock issued by the Company pursuant to the Additional Investment Rights), (B)
subdivides outstanding shares of Common Stock into a larger number of shares,
(C) combines (including by way of reverse stock split) outstanding shares of
Common Stock into a smaller number of shares, or (D) issues by reclassification
of shares of the Common Stock any shares of capital stock of the Company, then
in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury
shares, if any) outstanding before such event and of which the denominator shall
be the number of shares of Common Stock outstanding after such event and the
number of Additional Investment Right Shares issuable upon exercise of the
Additional Investment Rights shall be proportionately adjusted. Any adjustment
made pursuant to this Section 3(a) shall become effective immediately after the
record date for the determination of Stockholders entitled to receive such
dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.
Pro Rata Distributions. If the Company, at any time prior to the
Termination Date, shall distribute to all holders of Common Stock (and not to
Holders of the Additional Investment Rights) evidences of its indebtedness or
assets or rights or Additional Investment Rights to subscribe for or purchase
any security other than the Common Stock (which shall be subject to Section 3(b)
of the Additional Investment Rights agreement), then in each such case the
Exercise Price shall be adjusted by multiplying the Exercise Price in effect
immediately prior to the record date fixed for determination of Stockholders
entitled to receive such distribution by a fraction of which the denominator
shall be the VWAP determined as of the record date mentioned above, and of which
the numerator shall be such VWAP on such record date less the then per share
fair market value at such record date of the portion of such assets or evidence
49
of indebtedness so distributed applicable to one outstanding share of the Common
Stock as determined by the Board of Directors in good faith. In either case the
adjustments shall be described in a statement provided to the Holders of the
portion of assets or evidences of indebtedness so distributed or such
subscription rights applicable to one share of Common Stock. Such adjustment
shall be made whenever any such distribution is made and shall become effective
immediately after the record date mentioned above.
Fundamental Transaction. If, at any time while the Additional
Investment Rights are outstanding, (A) the Company effects any merger or
consolidation of the Company with or into another Person, in which the Company
is not the surviving entity, or the Company's then existing shareholders will
own less than 51% of the surviving entity, (B) the Company effects any sale of
all or substantially all of its assets in one or a series of related
transactions, (C) any tender offer or exchange offer (whether by the Company or
another Person) is completed pursuant to which holders of Common Stock are
permitted to tender or exchange their shares for other securities, cash or
property, or (D) the Company effects any reclassification of the Common Stock or
any compulsory share exchange pursuant to which the Common Stock is effectively
converted into or exchanged for other securities, cash or property (in any such
case, a "Fundamental Transaction"), then, upon any subsequent conversion of the
Additional Investment Rights, the holder of Additional Investment Rights shall
have the right to receive, for each Additional Investment Right Share that would
have been issuable upon such exercise absent such Fundamental Transaction, at
the option of the Holder, (a) upon exercise of the Additional Investment Rights,
the number of shares of Common Stock of the successor or acquiring corporation
or of the Company, if it is the surviving corporation, and Alternate
Consideration receivable upon or as a result of such reorganization,
reclassification, merger, consolidation or disposition of assets by a Holder of
the number of shares of Common Stock for which the Additional Investment Rights
are exercisable immediately prior to such event or (b) only in the event the
Company is acquired in an all cash acquisition, cash equal to the value of the
Additional Investment Rights as determined in accordance with the Black-Scholes
option pricing formula (the "Alternate Consideration"). For purposes of any such
exercise, the determination of the Exercise Price shall be appropriately
adjusted to apply to such Alternate Consideration based on the amount of
Alternate Consideration issuable in respect of one share of Common Stock in such
Fundamental Transaction, and the Company shall apportion the Exercise Price
among the Alternate Consideration in a reasonable manner reflecting the relative
value of any different components of the Alternate Consideration. If holders of
Common Stock are given any choice as to the securities, cash or property to be
received in a Fundamental Transaction, then the Holder shall be given the same
choice as to the Alternate Consideration it receives upon any exercise of the
Additional Investment Rights following such Fundamental Transaction. To the
extent necessary to effectuate the foregoing provisions, any successor to the
Company or surviving entity in such Fundamental Transaction shall issue to the
Holder a new Additional Investment Right consistent with the foregoing
provisions and evidencing the Holder's right to exercise such Additional
Investment Right into Alternate Consideration upon the payment thereof. The
terms of any agreement pursuant to which a Fundamental Transaction is effected
shall include terms requiring any such successor or surviving entity to comply
with the provisions of paragraph and insuring that the Additional Investment
Rights (or any such replacement security) will be similarly adjusted upon any
subsequent transaction analogous to a Fundamental Transaction.
Description of 2/05 Warrants
The following is a summary of the material terms of the 2/05 Warrants
and is qualified by its entirety by the form of 2/05 Warrant filed as an exhibit
to Form 8-K filed by the Company with the SEC on February 14, 2005. The
following, description does not take into account the April 2005 Adjustment (see
"Adjustment to Exercise Price" below).
50
Number, Term, and Definitions
The 2/05 Warrants entitle the holders thereof to initially purchase up
to a total of approximately 10,177,139 shares of the Common Stock of the
Company.
The 2/05 Warrants are exercisable at any time on or after the Initial
Exercise Date and on or prior to the close of business on the three-year
anniversary of the Initial Exercise Date. The Exercise Period shall be extended
for the number of Trading Days during such period in which (x) trading in the
Common Stock is suspended by any Trading Market, or (y) following the Effective
Date, the Registration Statement is not effective or the prospectus included in
the Registration Statement may not be used by the Purchasers for the resale of
the Warrant Shares.
Capitalized terms used and not otherwise defined in this Description of
Warrants Section shall have the meanings set forth in Section 1 of the 2/05
Warrant.
Exercise
Exercise of 2/05 Warrant. Exercise of the 2/05 Warrants may be made at
any time or times on or after the Initial Exercise Date and on or before the
Termination Date by delivery to the Company of a duly executed facsimile copy of
the Notice of Exercise Form annexed to the 2/05 Warrant.
Exercise Price. The exercise price of 50% of the 2/05 Warrants shall be
$1.55 per share, and the exercise price of the other 50% of the 2/05 Warrants
shall be 1.87 per share, in each case subject to adjustment (the "Warrant
Exercise Price").
Cashless Exercise. If at any time after one year from the date of
issuance of the 2/05 Warrants there is no effective Registration Statement
registering the resale of the Warrant Shares by the Holder, then the 2/05
Warrants may also be exercised at such time by means of a "cashless exercise."
Holder's Restrictions. Each Holder shall not have the right to exercise
any portion of their 2/05 Warrant, pursuant to Section 2(c) of the 2/05 Warrants
or otherwise, to the extent that after giving effect to such issuance after
exercise, the Holder (together with the Holder's affiliates), as set forth on
the applicable Notice of Exercise, would beneficially own in excess of 4.99% of
the number of shares of the Common Stock outstanding immediately after giving
effect to such issuance.
Certain Adjustments
Stock Dividends and Splits. If the Company, at any time while the 2/05
Warrants are outstanding: (A) pays a stock dividend or otherwise make a
distribution or distributions on shares of its Common Stock or any other equity
or equity equivalent securities payable in shares of Common Stock (which, for
avoidance of doubt, shall not include any shares of Common Stock issued by the
Company pursuant to the 2/05 Warrants), (B) subdivides outstanding shares of
Common Stock into a larger number of shares, (C) combines (including by way of
reverse stock split) outstanding shares of Common Stock into a smaller number of
shares, or (D) issues by reclassification of shares of the Common Stock any
shares of capital stock of the Company, then in each case the Warrant Exercise
Price shall be multiplied by a fraction of which the numerator shall be the
number of shares of Common Stock (excluding treasury shares, if any) outstanding
before such event and of which the denominator shall be the number of shares of
Common Stock outstanding after such event and the number of Warrant Shares
issuable upon exercise of the 2/05 Warrants shall be proportionately adjusted.
Any adjustment made pursuant to Section 3(a) of the 2/05 Warrants shall become
effective immediately after the record date for the determination of
Stockholders entitled to receive such dividend or distribution and shall become
effective immediately after the effective date in the case of a subdivision,
combination or re-classification.
51
Subsequent Equity Sales. If the Company or any Subsidiary thereof, as
applicable, at any time while the 2/05 Warrants are outstanding, shall sell,
grant any option to purchase, sell or grant any right to reprice its securities,
or otherwise dispose of or issue any Common Stock or Common Stock Equivalents
entitling any Person to acquire shares of Common Stock, at an effective price
per share less than the then Warrant Exercise Price (such lower price, the "Base
Share Price" and such issuances collectively, a "Dilutive Issuance"), as
adjusted (if the holder of the Common Stock or Common Stock Equivalents so
issued shall at any time, whether by operation of purchase price adjustments,
reset provisions, floating conversion, exercise or exchange prices or otherwise,
or due to warrants, options or rights per share which is issued in connection
with such issuance, be entitled to receive shares of Common Stock at an
effective price per share which is less than the Warrant Exercise Price, such
issuance shall be deemed to have occurred for less than the Warrant Exercise
Price), then, the Warrant Exercise Price shall be reduced to equal the Base
Share Price; subject to adjustment for reverse and forward stock splits, stock
dividends, stock combinations and other similar transactions of the Common Stock
that occur after the date of the Securities Purchase Agreement.
Pro Rata Distributions. If the Company, at any time prior to the
Termination Date, shall distribute to all holders of Common Stock (and not to
Holders of the 2/05 Warrants) evidences of its indebtedness or assets or rights
or warrants to subscribe for or purchase any security other than the Common
Stock (which shall be subject to Section 3(b) of the 2/05 Warrants), then in
each such case the Warrant Exercise Price shall be adjusted by multiplying the
Warrant Exercise Price in effect immediately prior to the record date fixed for
determination of Stockholders entitled to receive such distribution by a
fraction of which the denominator shall be the VWAP determined as of the record
date mentioned above, and of which the numerator shall be such VWAP on such
record date less the then per share fair market value at such record date of the
portion of such assets or evidence of indebtedness so distributed applicable to
one outstanding share of the Common Stock as determined by the Board of
Directors in good faith.
Fundamental Transaction. If, at any time while the 2/05 Warrants are
outstanding, (A) the Company effects any merger or consolidation of the Company
with or into another Person, in which the Company is not the surviving entity,
or the Company's then existing shareholders will own less than 51% of the
surviving entity, (B) the Company effects any sale of all or substantially all
of its assets in one or a series of related transactions, (C) any tender offer
or exchange offer (whether by the Company or another Person) is completed
pursuant to which holders of Common Stock are permitted to tender or exchange
their shares for other securities, cash or property, or (D) the Company effects
any reclassification of the Common Stock or any compulsory share exchange
pursuant to which the common Stock is effectively converted into or exchanged
for other securities, cash or property (a "Fundamental Transaction"), then, upon
any subsequent conversion of the 2/05 Warrant, the holder of the 2/05 Warrants
shall have the right to receive, for each Warrant Share that would have been
issuable upon such exercise absent such Fundamental Transaction, at the option
of the holder, (a) upon exercise of the 2/05 Warrants, the number of shares of
Common Stock of the successor or acquiring corporation or of the Company, if it
is the surviving corporation, and Alternate Consideration receivable upon or as
a result of such reorganization, reclassification, merger, consolidation or
disposition of assets by a Holder of the number of shares of Common Stock for
which the 2/05 Warrants are exercisable immediately prior to such event or (b)
only in the event the Company is acquired in an all cash acquisition, cash equal
52
to the value of the 2/05 Warrants as determined in accordance with the
Black-Scholes option pricing formula. For purposes of any such exercise, the
determination of the Warrant Exercise Price shall be appropriately adjusted to
apply to such Alternate Consideration based on the amount of Alternate
Consideration issuable in respect of one share of Common Stock in such
Fundamental Transaction, and the Company shall apportion the Warrant Exercise
Price among the Alternate Consideration in a reasonable manner reflecting the
relative value of any different components of the Alternate Consideration. If
holders of Common Stock are given any choice as to the securities, cash or
property to be received in a Fundamental Transaction, then the Holder shall be
given the same choice as to the Alternate Consideration it receives upon any
exercise of the 2/05 Warrant following such Fundamental Transaction. To the
extent necessary to effectuate the foregoing provisions, any successor to the
Company or surviving entity in such Fundamental Transaction shall issue to the
Holder a new warrant consistent with the foregoing provisions and evidencing the
Holder's right to exercise such warrant into Alternate Consideration upon the
payment thereof. The terms of any agreement pursuant to which a Fundamental
Transaction is effected shall include terms requiring any such successor or
surviving entity to comply with the provisions of this paragraph and insuring
that the 2/05 Warrant (or any such replacement security) will be similarly
adjusted upon any subsequent transaction analogous to a Fundamental Transaction.
Adjustment to Exercise Price
Notwithstanding any terms to the contrary set forth in the above
description, on April 15, 2005, subject to stockholder approval as required
under the American Stock Exchange rules, the terms of the 2/05 Warrants were
adjusted by the Company such that the exercise price of the 2/05 Warrants was
reduced to $0.55 per share, which exercise price will no longer be subject to
any anti-dilution adjustments.
Board Recommendation
For the reasons outlined above, the Board recommends a vote FOR the
proposal to approve, to the extent required for compliance with the American
Stock Exchange rules, issuance of additional shares of the Company's Common
Stock as needed for the full conversion of the Company's Series A 6% Convertible
Preferred Stock and exercise of Warrants and Additional Investment Rights sold
in a private placement offering completed by the Company in September 2004 and
Warrants sold in private placement offerings completed by the Company in October
2003, February 2005 and adjusted in April 2005.
53
PROPOSAL 5
TO APPROVE, TO THE EXTENT REQUIRED FOR COMPLIANCE WITH THE AMERICAN
STOCK EXCHANGE RULES, ISSUANCE OF ADDITIONAL SHARES OF THE COMPANY'S
COMMON STOCK AS NEEDED FOR FULL CONVERSION OF THE COMPANY'S SERIES C
CONVERTIBLE PREFERRED STOCK AND EXERCISE OF THE COMPANY'S WARRANTS SOLD
IN A PRIVATE PLACEMENT IN APRIL 2005.
Description of Transaction
April 2005 Private Placement
The Company entered into a Securities Purchase Agreement effective as
of April 14, 2005 (the "4/05 Securities Purchase Agreement") with twelve
institutional investors (collectively the "4/05 Investors"). Pursuant to the
terms of the 4/05 Securities Purchase Agreement, the Company issued the
following securities to the 4/05 Investors in consideration for the 4/05
Investors making payment to the Company in the aggregate amount of $31,110,165:
* 311.10165 shares of Series C Convertible Preferred Stock (the
"Series C Preferred Stock"); and
* Warrants to purchase approximately 22,625,566 shares of common
stock of the Company at an exercise price of $0.55 per share,
and warrants to purchase approximately 3,393,835 shares of
common stock of the Company at an exercise price of $.605 per
share, each exercisable until the date that is 5 years after
the date of issuance (collectively, the "4/05 Warrants").
The Company has agreed to file a registration statement with the
registering for resale all shares of common stock of the Company underlying the
Series C Preferred Stock and the 4/05 Warrants.
The transaction was approved by the Company's Board of Directors on
April 6, 2005, and closed on April 14, 2005. The shares of Series C Preferred
Stock, the 4/05 Warrants, and the shares of Common Stock underlying such
securities have been and will be issued pursuant to the exemption from
registration provided by Section 4(2) of the Securities Act of 1933, as amended.
American Stock Exchange Approval Rule
The Company's Common Stock is listed for trading on the American Stock
Exchange and therefore, is subject to the Rules of the American Stock Exchange.
Pursuant to the American Stock Exchange Constitution and Rules, Section 713,
"the corporation is required to obtain shareholder approval for an offering in
the event that 20% or more of the presently outstanding common stock, or
securities convertible into common stock are issued at a price lower than market
value." As of April 13, 2005, a day prior to closing of the 4/05 Private
Placement, the Company had 29,219,112 shares of Common Stock issued and
outstanding. Generally, in making a determination regarding the shareholder
approval on the 20% rule, the American Stock Exchange will compute the number of
shares to be obtained by utilizing the lowest possible conversion ratio and will
rely on the number of shares outstanding at the time of the offering. The
conversion price of the Series C Preferred Stock and the exercise price of the
4/05 Warrants are below the market price of the Company's Common Stock on the
applicable determination date. Therefore, shareholder approval is required
regarding the issuance, upon conversion of Series C Preferred Stock and the
exercise of the 4/05 Warrants, of Common Stock equaling 20% or more of the
Company's shares outstanding at the applicable determination date.
54
In the event that stockholder approval is not obtained, the Series C
Preferred Stock will not convert into Common Stock, will remain outstanding and
senior in rights of liquidation to the Common Stock, and must be redeemed by the
Company in April 2006 for $31,110,165, and the exercise of the 4/05 Warrants
will not be permitted.
Description of Series C Preferred Stock
The following is a summary of the material terms of the Series C
Preferred Stock as initially issued and is qualified by its entirety by the
Certificate of Designation of Preferences, Rights and Limitations of Series C
Convertible Preferred Stock (the "Certificate") filed as an exhibit to Form 8-K
filed by the Company with the SEC on April 15, 2005.
Amount, Stated Value, and Definitions
The number of shares of Series C Preferred Stock designated was 450.
Each share of Series C Preferred Stock has a stated value equal to $100,000 (the
"Stated Value"). Capitalized terms not otherwise defined in this Description of
Series C Preferred Stock section have the meaning given such terms in the
Certificate.
Dividends
Each Holder shall be entitled to receive, out of funds legally
available therefore, and the Company shall pay, cumulative dividends on the
Preferred Stock on an as converted basis with the Common Stock when, and as if,
declared by the Board of Directors, in arrears within three days of each March
31, June 30, September 30 and December 31, commencing June 30, 2005 except if
such date is not a Trading Day, in which case such dividend shall be payable on
the next succeeding Trading Day (each, a "Dividend Payment Date ").
Certain Protective Rights
For so long as any of the shares of Series C Preferred Stock are
outstanding, neither the Company nor any Subsidiary shall, without the
affirmative vote of the Holders of at least a majority of the shares of Series C
Preferred Stock then outstanding:
* alter or change the powers, preferences or rights given to
the Series C Preferred Stock or alter or amend this Certificate of
Designation;
* authorize or create (by reclassification or otherwise) any
class of equity security or Common Stock Equivalent ranking as to
dividends or distribution of assets upon a Liquidation senior to the
Series C Preferred Stock;
* directly or indirectly pay or declare any dividend or make
any distribution (other than dividends due and paid in the ordinary
course on preferred stock of the Company at such times when the Company
is in compliance with its payment obligations to the Series C Preferred
Stock) upon, nor shall any distribution be made in respect of, any
Junior Securities, nor shall any monies be set aside for or applied to
the purchase or redemption (through a sinking fund or otherwise) of any
Junior Securities or securities pari passu with the Series C Preferred
Stock;
* alter, amend or waive any provision of the Voting Agreement
or the Farequest Voting Agreement;
55
* amend or waive any provision in its Certificate of
Incorporation in a manner adverse to the Series C Preferred Stock; or
* enter into any agreement with respect to the foregoing
clauses.
Liquidation
Upon any liquidation, dissolution or winding-up of the Company, whether
voluntary or involuntary (a "Liquidation"), the Holders shall be entitled to
receive out of the assets of the Company, whether such assets are capital or
surplus, for each share of Series C Preferred Stock an amount equal to the
Stated Value per share before any distribution or payment shall be made to the
holders of any Junior Securities, and if the assets of the Company shall be
insufficient to pay in full such amounts, then the entire assets to be
distributed to the Holders shall be distributed among the Holders ratably in
accordance with the respective amounts that would be payable on such shares if
all amounts payable thereon were paid in full. The Series C Preferred Stock
ranks in order of priority on liquidation, parri passu with the Company's Series
A Preferred Stock and senior to all other stock, including the Series B
Preferred Stock and the Common Stock.
Automatic Conversion
Within one (1) Trading Day following the date on which the Company
obtains the approval of its stockholders for the conversion of the Series C
Preferred Stock and exercise of the 4/05 Warrants and the 1 for 10 Reverse Stock
Split ("Stockholder Approval"), the Company shall deliver to each Holder a
notice ("Automatic Notice") as to all of the then outstanding Series C Preferred
Stock, notifying the Holders that all of the then outstanding Series C Preferred
Stock shall be converted on the date which is the later of (i) the 25th Trading
Day following delivery of the Automatic Notice and (ii) the 21st Trading Day
following the filing of a Current Report on Form 8-K disclosing the
effectiveness of the Reverse Stock Split on the American Stock Exchange (such
later date, the "Automatic Conversion Date ").
Redemption upon Triggering Events
All shares of Series C Preferred Stock which remain outstanding on
April 14, 2006 shall be redeemed by the Company for a redemption price equal to
the $100,000 per share stated value plus accrued but unpaid dividends and any
other amounts then owing on the account thereof to the holder (the "Redemption
Price"). If the Company does not pay the Redemption Price in full on April 14,
2006, the Redemption Price payable to the holder shall bear interest at the rate
of 1% per month (prorated for partial months) or such lesser maximum amount as
then permitted by applicable law, until paid in full.
Adjustment to Conversion Price
The Conversion Price in effect on the Automatic Conversion Date shall
be subject to the following adjustments:
* Stock Dividends and Splits. If the Company, at any time
while shares of Series C Preferred Stock are outstanding: (1) pays a stock
dividend on its Common Stock or otherwise makes a distribution on any class of
capital stock that is payable in shares of Common Stock, (2) subdivides
outstanding shares of Common Stock into a larger number of shares, or (3)
combines outstanding shares of Common Stock into a smaller number of shares,
then in each such case the Conversion Price shall be multiplied by a fraction of
which the numerator shall be the number of shares of Common Stock outstanding
immediately before such event and of which the denominator shall be the number
of shares of Common Stock outstanding immediately after such event. Any
56
adjustment made pursuant to clause (1) of this paragraph shall become effective
immediately after the record date for the determination of stockholders entitled
to receive such dividend or distribution, and any adjustment pursuant to clause
(2) or (3) of this paragraph shall become effective immediately after the
effective date of such subdivision or combination.
* Adjustment Upon Reverse Stock Split. If the average of the
VWAP for the 20 Trading Days immediately following the filing of a Current
Report on Form 8-K disclosing the effectiveness of the Reverse Stock Split on
the American Stock Exchange (such average VWAP, the "Reset Amount" and such
period, the "Reset Period ") is less than the Conversion Price then in effect,
the Conversion Price shall automatically adjust to the Reset Amount. In other
words, based upon the initial Conversion Price of $.55, if the Reset Amount is
less than $5.50, the conversion price is reset to the lower Reset Amount. The
Company shall notify the Holders in writing within one (1) Trading Day should
such adjustment occur. Each Holder covenants that neither it nor any Person
acting on its behalf or pursuant to any understanding with it will engage in or
close out any transactions in the securities of the Company (including Short
Sales) prior to the Trading Day following the Reset Period.
* Fundamental Transactions. If, at any time while shares of
Series Preferred Stock are outstanding (a) the Company effects any merger or
consolidation of the Company with or into another Person in which the Company is
not the survivor, (b) the Company effects any sale of all or substantially all
of its assets in one or a series of related transactions, (c) any tender offer
or exchange offer (whether by the Company or another Person) is completed
pursuant to which holders of Common Stock are permitted to tender or exchange
their shares for other securities, cash or property, or (d) the Company effects
any reclassification of the Common Stock or any compulsory share exchange
pursuant to which the Common Stock is effectively converted into or exchanged
for other securities, cash or property (a "Fundamental Transaction"), then each
Holder shall have the right thereafter to receive, upon conversion of shares of
such Holder's Series C Preferred Stock, the same amount and kind of securities,
cash or property as it would have been entitled to receive upon the occurrence
of such Fundamental Transaction if it had been, immediately prior to such
Fundamental Transaction, the holder of the number of Underlying Shares then
issuable upon conversion of all of such Holder's shares of Series C Preferred
Stock (the "Alternate Consideration"). For purposes of any such conversion, the
determination of the Conversion Price shall be appropriately adjusted to apply
to such Alternate Consideration based on the amount of Alternate Consideration
issuable in respect of one share of Common Stock in such Fundamental
Transaction, and the Company shall apportion the Conversion Price among the
Alternate Consideration in a reasonable manner reflecting the relative value of
any different components of the Alternate Consideration. If holders of Common
Stock are given any choice as to the securities, cash or property to be received
in a Fundamental Transaction, then each Holder shall be given the same choice as
to the Alternate Consideration it receives upon any conversion of such Holder's
Series C Preferred Stock following such Fundamental Transaction.
* Reclassifications; Share Exchanges. In case of any
reclassification of the Common Stock, or any compulsory share exchange pursuant
to which the Common Stock is converted into other securities, cash or property
(other than compulsory share exchanges which constitute Change of Control
Transactions), each Holder of the Series C Preferred Stock then outstanding
shall have the right thereafter to convert such shares only into the shares of
stock and other securities, cash and property receivable upon or deemed to be
held by holders of Common Stock following such reclassification or share
exchange, and such Holders shall be entitled upon such event to receive such
amount of securities, cash or property as a holder of the number of shares of
Common Stock of the Company into which such shares of Series C Preferred Stock
could have been converted immediately prior to such reclassification or share
exchange would have been entitled. This provision shall similarly apply to
successive reclassifications or share exchanges.
57
Description of 4/05 Warrants
The following is a summary of the material terms of the 4/05 Warrants
as initially issued and is qualified by its entirety by the form of 4/05 Warrant
filed as an exhibit to Form 8-K filed by the Company with the SEC on April 15,
2005.
Number, Term, and Definitions
The 4/05 Warrants entitle the holders thereof to initially purchase up
to a total of approximately 26,019,401 shares of the Common Stock of the
Company.
The 4/05 Warrants are exercisable from the Automatic Conversion Date
until the date that is 5 years after the date of issuance. The Automatic
Conversion Date is the latter of the following two dates (i) the 25th trading
day following the Company's delivery of notice to the holders of Series C
Preferred Stock of an automatic conversion of the Series C Preferred Stock
(which notice must be delivered by the Company within 1 trading day of the date
the Company receives shareholder approval under the AMEX rules for the issuance
of 20% or more of the Company's outstanding shares of common stock upon exercise
of the Series C Preferred Stock and the 4/05 Warrants), and (ii) the 21st
trading day following the filing of a Current Report on Form 8-K disclosing the
effectiveness of the reverse stock split of the Company's common stock.
Capitalized terms used and not otherwise defined in this Description of
4/05 Warrants Section shall have the meanings set forth in Section 1 of the 4/05
Warrant agreement.
Exercise
Exercise of 4/05 Warrant. Exercise of the 4/05 Warrants may be made at
any time or times on or after the Automatic Conversion Date and on or before the
date that is 5 years after the date of issuance by delivery to the Company of a
duly executed facsimile copy of the Notice of Exercise Form annexed to the 4/05
Warrant.
Exercise Price. The exercise price of 22,625,566 shares of common stock
of the Company under the 4/05 Warrants shall be $0.55 per share, subject to
adjustment, and the exercise price of 3,393,835 shares of common stock of the
Company under the 4/05 Warrants shall be $.605 per share, subject to adjustment
(the "Exercise Price").
Cashless Exercise. If at any time during the Effectiveness Period there
is no effective Registration Statement registering the resale of the Warrant
Shares by the Holder, then the 4/05 Warrants may also be exercised at such time
by means of a "cashless exercise."
Holder's Restrictions. Each Holder of a 4/05 Warrant shall not have the
right to exercise any portion of their 4/05 Warrant to the extent that after
giving effect to such issuance after exercise, the holder (together with the
holder's affiliates), as set forth on the applicable Notice of Exercise, would
beneficially own in excess of 9.999% of the number of shares of the Common Stock
outstanding immediately after giving effect to such issuance.
Call Provision. If at any time following the Automatic Conversion Date,
(i) the closing price of the Common Stock for each of the 20 consecutive Trading
Days (each occurring after the Automatic Conversion Date) immediately prior to
delivery of a Call Notice (as defined below) is greater than $1.65 (subject to
equitable adjustment as a result of intervening stock splits and reverse stock
splits), (ii) the average daily trading volume of the Common Stock during the
entire 20 Trading Day period referenced in (i) above through the expiration of
the Call Date (as defined below) as reported by Bloomberg L.P. (the "Call
Condition Period") shall be at least 100,000 shares (subject to equitable
adjustment as a result of intervening stock splits and reverse stock splits),
58
(iii) the Warrant Shares are either registered for resale pursuant to an
effective registration statement naming the Holder as a selling stockholder
thereunder (and the prospectus thereunder is available for use by the Holder as
to all Warrant Shares) or freely transferable without volume restrictions
pursuant to Rule 144(k) promulgated under the Securities Act, as determined by
counsel to the Company pursuant to a written opinion letter addressed and in
form and substance reasonably acceptable to the Holder and the transfer agent
for the Common Stock, during the entire Call Condition Period, and (iv) the
Company shall have complied in all material respects with its obligations under
this Warrant and the Transaction Documents and the Common Stock shall at all
times be listed or quoted on a Trading Market during the Call Condition Period,
then the Company may in its sole discretion, elect to require the exercise of
all (but not less than all) of the then unexercised portion of this Warrant, on
the date that is the fifth (5th) calendar day after written notice thereof (a
"Call Notice ") is received by the Holder (the "Call Date").
Certain Adjustments
Stock Dividends and Splits. If the Company, at any time while the 4/05
Warrants are outstanding: (A) pays a stock dividend or otherwise make a
distribution or distributions on shares of its Common Stock or any other equity
or equity equivalent securities payable in shares of Common Stock (which, for
avoidance of doubt, shall not include any shares of Common Stock issued by the
Company pursuant to the 4/05 Warrants), (B) subdivides outstanding shares of
Common Stock into a larger number of shares, or (C) combines (including by way
of reverse stock split) outstanding shares of Common Stock into a smaller number
of shares, then in each case the Exercise Price shall be multiplied by a
fraction of which the numerator shall be the number of shares of Common Stock
outstanding before such event and of which the denominator shall be the number
of shares of Common Stock outstanding after such event, and the number of
Warrant Shares shall be adjusted accordingly. Any adjustment made pursuant to
this Section 3(a) shall become effective immediately after the record date for
the determination of Stockholders entitled to receive such dividend or
distribution and shall become effective immediately after the effective date in
the case of a subdivision, combination or reclassification.
Fundamental Transaction. If, at any time while the 4/05 Warrant is
outstanding there is a Fundamental Transaction, then the Holder shall have the
right thereafter to receive, upon exercise of this Warrant, the same amount and
kind of securities, cash or property as it would have been entitled to receive
upon the occurrence of such Fundamental Transaction if it had been, immediately
prior to such Fundamental Transaction, the holder of the number of Warrant
Shares then issuable upon exercise in full of this Warrant (the "Alternate
Consideration"). For purposes of any such exercise, the determination of the
Exercise Price shall be appropriately adjusted to apply to such Alternate
Consideration based on the amount of Alternate Consideration issuable in respect
of one share of Common Stock in such Fundamental Transaction, and the Company
shall apportion the Exercise Price among the Alternate Consideration in a
reasonable manner reflecting the relative value of any different components of
the Alternate Consideration. If holders of Common Stock are given any choice as
to the securities, cash or property to be received in a Fundamental Transaction,
then the holder of the 4/05 Warrant shall be given the same choice as to the
Alternate Consideration it receives upon any exercise of this Warrant following
such Fundamental Transaction. At the holder's option and request, any successor
to the Company or surviving entity in such Fundamental Transaction shall issue
to the Holder a new warrant substantially in the form of this Warrant and
consistent with the foregoing provisions and evidencing the Holder's right to
purchase the Alternate Consideration for the aggregate Exercise Price upon
exercise thereof. The terms of any agreement pursuant to which a Fundamental
59
Transaction is effected shall include terms requiring any such successor or
surviving entity to comply with the provisions of this paragraph (b) and
insuring that the Warrant (or any such replacement security) will be similarly
adjusted upon any subsequent transaction analogous to a Fundamental Transaction.
Within five Trading Days after entering into a definitive agreement with respect
to a cash-out merger (the "Cash-Out Merger "), the Company shall deliver a
notice to the Holder informing the Holder of such transaction (such notice, a
"Cash-Out Notice"). At 5:30 p.m. (New York City time) by the twentieth Trading
Day after such Holder receives the Cash-Out Notice ("Cash-Out Date"), the Holder
shall notify the Company of its decision to either (1) exercise the portion of
this Warrant not exercised prior thereto or (2) to receive from the Company an
amount in cash equal to the product of (A) the difference between $1.65 and the
Exercise Price, multiplied by (B) the number of Warrant Shares as to which this
Warrant has not been exercised prior thereto. The failure of the Holder to
notify the Company of its election hereunder by the Cash-Out Date shall be
treated as an election under clause (2) in the immediately preceding sentence,
and this warrant shall then only represent the right to receive such funds and
shall no longer be exercisable for Common Stock. The cash payable to the Holder
pursuant to clause (2) above shall be paid to the Holder, against delivery of
such Holder's Warrant to the Company, as and when the consideration for the
cash-out merger is distributed to all holders of Common Stock. The foregoing
shall be contingent upon the closing of the Cash-Out Merger.
Voting Agreements and Pledge Agreement
The 4/05 Investors received Voting Agreements from Company common
stockholders representing 31.4% of the issued and outstanding common stock of
the Company. The parties to the Voting Agreements agreed to vote in favor of the
Reverse Stock Split, and the issuance of common stock upon the conversion of the
Series C Preferred Stock and the exercise of the 4/05 Warrants. Messrs. William
Goldstein, and Michael Pruitt, and P. Roger Byer, who are executive officers
and/or directors of the Company, are parties to such Voting Agreements.
William Goldstein, the Company's Chairman and CEO, also pledged his
holdings in the Company's stock to the 4/05 Investors as security for the
affirmative vote on these matters by the Company's stockholders. The 4/05
Investors also received Lock-Up Agreements from Common Stockholders of the
Company that held 14% of the Common Stock restricting them from selling their
shares of Common Stock until the date following the record date for the annual
meeting, or the date following the annual meeting.
Board Recommendation
For the reasons outlined above, the Board recommends a vote FOR the
proposal to approve, to the extent required for compliance with the American
Stock Exchange rules, issuance of additional shares of the Company's Common
Stock as needed for full conversion of the Company's Series C Convertible
Preferred Stock and exercise of the Company's Warrants sold in a private
placement in April 2005.
60
PROPOSAL 6
TO APPROVE AN AMENDMENT TO THE COMPANY'S CERTIFICATE OF INCORPORATION
TO EFFECT A 1 FOR 10 REVERSE STOCK SPLIT OF THE COMPANY'S COMMON STOCK
AND REDUCE THE NUMBER OF SHARES OF AUTHORIZED COMMON STOCK
The Company's Board of Directors has adopted a resolution approving the
amendment of the Company's Certificate of Incorporation to effectuate a 1 for 10
reverse stock split of the Company's Common Stock (the "Reverse Stock Split").
The form of proposed amendment is attached to this proxy statement as Exhibit B.
The reverse stock split amendment will effect the reverse stock split by
reducing the number of outstanding shares of common stock by the ratio of
1-for-10, but will not increase the par value of our common stock. It will also
reduce the number of authorized shares of our common stock from 200,000,000 to
50,000,000. If the Stockholders approve the Reverse Stock Split, the Reverse
Stock Split would become effective on the date of filing of an amendment to the
Certificate of Incorporation with the Delaware Secretary of State.
Reasons for the Reverse Stock Split
Under the 4/05 Securities Purchase Agreement, the Company is required
to use its best efforts to obtain the approval of its stockholders to effect the
Reverse Stock Split. Accomplishing the Reverse Stock Split is required for the
Company's Series C Preferred Stock to convert into Common Stock and for the
Company to avoid having to redeem the Series C Preferred Stock in April 2006.
Also, the Reverse Stock Split is likely required to maintain the Company's
common stock listing on the American Stock Exchange. The Company's common stock
is currently listed on the American Stock Exchange. The continued listing
criteria of the American Stock Exchange requires, among other things, that the
Company's common stock maintain a closing bid price in excess of $1.00 per
share. The Company believes the trading price of its common stock, if not
addressed, could result in delisting proceedings by the Amex.
The Company's Board of Directors has determined that the continued
listing of our common stock on the American Stock Exchange is in the best
interests of our stockholders. If our common stock were delisted from the
American Stock Exchange, the Company believes that the liquidity in the trading
market for its common stock would be significantly decreased, which would likely
reduce the trading price and increase the transaction costs of trading shares of
our common stock. Delisting of the Company's common stock from the American
Stock Exchange could also have adverse results to the Company under the 9/04
Securities Purchase Agreement and related agreements, such as triggering the
rights of the Series A Preferred to require redemption of their shares and
payment of liquidated damages.
The Board also believes that the decrease in the number of shares of
the Company's Common Stock outstanding as a consequence of the Reverse Stock
Split, and the anticipated increase in the per share price of the Company's
Common Stock, could encourage interest in the Company's Common Stock and
possibly promote greater liquidity for the Company's Stockholders, although such
liquidity could be adversely affected by the reduced number of shares
outstanding after the Reverse Stock Split.
There can be no assurances, however, that the foregoing events will
occur, or that the market price of the Company's Common Stock immediately after
the Reverse Stock Split will be maintained for any period of time. Although the
Reverse Stock Split will not, by itself, impact our assets or prospects, the
reverse split could result in a decrease in the aggregate market value of our
common stock. Moreover, there can be no assurance that the market price of the
Company's Common Stock after the Reverse Stock Split will adjust to reflect the
exchange ratio or that the market price following the Reverse Stock Split will
either exceed or remain in excess of the current market price.
61
Principal Effects of a Reverse Stock Split
The Board of Directors has proposed a 1 for 10 reverse split of the
Company's Common Stock. If approved, upon the filing of an amendment to the
Company's Certificate of Incorporation effectuating the Reverse Stock Split,
each share of the Company's Common Stock outstanding as of the record date
chosen by the Board will, immediately and automatically, be changed into one
tenth (1/10) of a share of the Company's Common Stock. In addition, the number
of shares of the Company's Common Stock subject to outstanding options, warrants
and other convertible securities issued by the Company will be reduced by a
factor of ten, and the exercise or conversion price thereof will be
proportionately increased by a factor of ten. No fractional shares of the
Company's Common Stock will be issued in connection with the Reverse Stock
Split. Holders of the Company's Common Stock who would otherwise receive a
fractional share of the Company's Common Stock pursuant to the Reverse Stock
Split will receive cash in lieu of the fractional share as explained more fully
below. The par value of the Company's Common Stock would remain unchanged at
$.04 per share. The number of authorized common shares will also be reduced from
200,000,000 to 50,000,000. In addition, if the Reverse Split is effected and the
volume weighted average price for the 20 trading days following the
effectiveness of the Reverse Stock Split is less than $5.50, then the effective
conversion price of the Company's Series C Preferred Stock and Series A
Preferred Stock will be reset to such lower average price, and the conversion
price of the Company's $12.5 million Convertible Promissory Notes issued to
OneTravel, Inc. stockholders will be reset to 125% of such average price. (See
Proposal 5 above for a description of the Series C Preferred Stock and Proposal
7 below for a description of the $12.5 million Convertible Promissory Notes).
If this proposal is approved by the Stockholders the Board of Directors
will fix a record date for determination of shares subject to the Reverse Stock
Split.
Because the Reverse Stock Split would apply to all issued and
outstanding shares of the Company's Common Stock and outstanding rights to
purchase the Company's Common Stock or to convert other securities into the
Company's Common Stock, the Reverse Stock Split would not alter the relative
rights and preferences of existing Stockholders. Because the number of
authorized shares of the Company's Common Stock would be proportionately
reduced, the amendment would not increase the proportionate number of shares of
the Company's Common Stock available for future issuances by the Board of
Directors.
Upon the effectuation of the Reverse Stock Split some Stockholders may
own less than one hundred shares of the Company's Common Stock. A purchase or
sale of less than one hundred shares (an "odd lot" transaction) may result in
incrementally higher trading costs through certain brokers, particularly "full
service" brokers. Therefore, those Stockholders who own less than one hundred
shares following the Reverse Stock Split may be required to pay moderately
higher transaction costs should they then determine to sell their shares of the
Company's Common Stock.
Stockholders have no right under Delaware law or the Company's
Certificate of Incorporation or By-Laws to dissent from the Reverse Stock Split
or to dissent from the payment of cash in lieu of issuing fractional shares.
Cash Payment in Lieu of Fractional Shares
If the Reverse Stock Split is approved by the Stockholders, upon the
effectuation thereof no fractional shares would be issued. In lieu of any
fractional shares to which a holder of the Company's Common Stock would
62
otherwise be entitled as a result of the Reverse Stock Split, the Company would
pay cash equal to such fractional share multiplied by the average of the high
and low trading prices of the Common Stock (as adjusted to reflect the Reverse
Stock Split) during regular trading hours for the five (5) trading days
immediately preceding the effective time of the Reverse Stock Split, which
amount is hereby determined to equal the fair market value of the Common Stock
at the effective time of the Reverse Stock Split.
Effectiveness of the Reverse Stock Split
The reverse stock split, if approved by our Stockholders, will become
effective upon our filing with the Delaware Secretary of State of a certificate
of amendment to our certificate of incorporation, in substantially the form
attached to this proxy statement as Exhibit B. We expect that this filing will
take place on or shortly after the date of the Meeting, assuming that our
Stockholders approve the Reverse Stock Split.
Beginning on the effective date of the Reverse Stock Split, each
certificate representing shares of our common stock will be deemed for all
corporate purposes to evidence ownership of the reduced number of shares of
common stock resulting from the Reverse Stock Split. Following the effective
date, stockholders will be notified by a press release of the effectiveness of
the Reverse Stock Split and will be sent instructions as to how and when to
surrender their certificates representing shares of our common stock in exchange
for certificates or other evidence representing the reduced number of shares of
our common stock resulting from the Reverse Stock Split. We intend to use Olde
Monmouth Stock Transfer Co., Inc. as our exchange agent to effect the exchange
of certificates following the reverse stock split. No service charges will be
payable by the Stockholders in connection with the exchange of certificates. All
of these expenses will be borne by the Company. Stockholders should not destroy
any stock certificates and should not submit any certificates to the Company
until requested to do so.
Certain Federal Income Tax Consequences
The following is a summary of certain material United States federal
income tax consequences of the reverse stock split. It does not purport to be a
complete discussion of all of the possible United States federal income tax
consequences of the reverse stock split and is included for general information
only. Further, it does not address any state, local or foreign income or other
tax consequences. This discussion does not address the tax consequences to
holders that are subject to special tax rules, such as banks, insurance
companies, regulated investment companies, personal holding companies, foreign
entities, nonresident alien individuals, broker-dealers and tax-exempt entities.
It also assumes that the shares of our common stock held by our stockholders
before the reverse stock split were, and the shares of our common stock held
after the reverse stock split will be, held as "capital assets," as defined in
the Internal Revenue Code of 1986 (that is, generally, property held for
investment). The tax treatment to a stockholder may vary depending upon the
particular facts and circumstances of that stockholder. Furthermore, this
discussion is based on the provisions of the United States federal income tax
law in effect on the date of this proxy statement, which are subject to change
retroactively as well as prospectively, and is not binding on the Internal
Revenue Service or the courts.
In general, the federal income tax consequences of the Reverse Stock
Split will vary among Stockholders depending upon whether they receive cash for
fractional shares or solely a reduced number of shares of the Company's Common
Stock in exchange for their old shares of the Company's Common Stock. The
Company believes that because the Reverse Stock Split is not part of a plan to
increase periodically a Stockholder's proportionate interest in the Company's
assets or earnings and profits, the Reverse Stock Split will likely have the
following federal income tax effects:
63
* A Stockholder who receives solely a reduced number of shares
of the Company's Common Stock will not recognize gain or loss.
In the aggregate, such a Stockholder's basis in the reduced
number of shares of the Company's Common Stock will equal the
Stockholder's basis in its old shares of the Company's Common
Stock.
* A Stockholder who receives cash in lieu of a fractional share
as a result of the Reverse Stock Split will generally be
treated as having received the payment as a distribution in
redemption of the fractional share, as provided in Section
302(a) of the Code, which distribution will be taxed as either
a distribution under Section 301 of the Code or an exchange to
such Stockholder, depending on that Stockholder's particular
facts and circumstances. Generally, a Stockholder receiving
such a payment would recognize gain or loss equal to the
difference, if any, between the amount of cash received and
the Stockholder's basis in the fractional share. In the
aggregate, such a Stockholder's basis in the reduced number of
shares of the Company's Common Stock will equal the
Stockholder's basis in its old shares of the Company's Common
Stock decreased by the basis allocated to the fractional share
for which such Stockholder is entitled to receive cash.
* The Company will not recognize any gain or loss as a result of
the Reverse Stock Split.
We have included the federal income tax discussion set forth above for
your general information only, and it may not be applicable depending upon your
particular situation. You should consult your own tax advisor with respect to
the tax consequences to you of the reverse stock split, including the tax
consequences under state, local, foreign, and other tax laws and possible
effects of changes in federal or other tax laws.
Board Recommendation
For the reasons outlined above, the Board recommends a vote FOR the
approval of an amendment to the Company's Certificate of Incorporation to
effectuate a 1 for 10 reverse split of the Company's authorized and outstanding
Common Stock and to reduce the authorized common stock to 50,000,000 shares.
64
PROPOSAL 7
TO APPROVE, TO THE EXTENT REQUIRED FOR COMPLIANCE WITH THE AMERICAN STOCK
EXCHANGE RULES, THE ISSUANCE OF ADDITIONAL SHARES OF THE COMPANY'S COMMON
STOCK AS NEEDED FOR FULL CONVERSION OF THE COMPANY'S AGGREGATE $12,500,000
SECURED PROMISSORY NOTES ISSUED FOR THE ACQUISITION OF ONETRAVEL, INC.
Description of Transaction
On April 15, 2005, the Company closed a transaction through which its
wholly owned subsidiary, OT Acquisition Corporation, ("Sub") merged with and
into OneTravel, Inc. ("OneTravel"). Pursuant to the terms of the Agreement and
Plan of Merger dated February 10, 2005 for the acquisition (the "Merger
Agreement") the OneTravel stockholders received (i) $13 million, plus or minus a
working capital adjustment, and (ii) a six month, interest free, convertible
promissory note in the principal amount of $12.5 million (the "Promissory
Note"). The Promissory Note is convertible into the Company's Common Stock at
the option of the note-holder at a conversion price per share of Common Stock
equal to the lesser of (a) $.6875 or (b) if the Conversion Price of the Series C
stock is reset as a consequence of the Reverse Stock Split, then 125% of such
Reset Conversion Price for the Series C Preferred Stock. The Company has the
right to extend the maturity of the Promissory Note by up to five months upon
payment of an extension fee to the note-holders of $125,000 per each one month
extension.
The Company has agreed to file registration statement with the SEC
registering for resale all shares of the Company's Common Stock underlying the
Promissory Note.
The merger transaction was approved by the Company's Board of Directors
on February 7, 2005. The Company's Promissory Note was issued, and the shares of
Common Stock underlying the Promissory Note, will be issued, pursuant to the
exemption from registration provided by Section 4(2) of the Securities Act, as
amended, and Regulation D promulgated under the Securities Act.
American Stock Exchange Approval Rule
The Company's Common Stock is listed for trading on the American Stock
Exchange and therefore, is subject to the Rules of the American Stock Exchange.
Pursuant to the American Stock Exchange Constitution and Rules, Section 712,
"the corporation is required to obtain shareholder approval as a prerequisite to
approval of applications to list additional shares to be issued as sole or
partial consideration for an acquisition of the stock or assets of another
company . . . where the present or potential issuance of common stock, or
securities convertible into common stock, could result in an increase in
outstanding common shares of 20% or more." As of April 14, 2005, a day prior to
closing of the merger transaction, the Company had 29,219,112 shares of Common
Stock issued and outstanding. Generally, in making a determination regarding the
shareholder approval on the 20% rule, the American Stock Exchange will compute
the number of shares to be obtained by utilizing the lowest possible conversion
ratio and will rely on the number of shares outstanding at the time of the
offering. The issuance of shares of Common Stock in connection with the merger
transaction upon conversion of the Promissory Note could result in an increase
in the Company's outstanding Common Stock of 20% or more. Therefore, shareholder
approval is required regarding issuances of Common Stock greater than or equal
to 20% of the Company's outstanding Common Stock as of April 14, 2005, in
connection with the merger transaction upon conversion of the Promissory Note.
65
In the event that shareholder approval is not obtained the Promissory
Note issued in the merger transaction may not be converted, and the Company
would not be able to satisfy the Promissory Note by issuing common stock.
Board Recommendation
For the reasons outlined above, the Board recommends a vote FOR the
proposal to approve, to the extent required for compliance with the American
Stock Exchange rules, the issuance of additional shares of the Company's Common
Stock for full conversion of the Company's aggregate $12,500,000 Secured
Promissory Notes issued for the acquisition of OneTravel, Inc.
66
OTHER MATTERS
Other Business - The Board does not know of any other matters that may
come before the Meeting. If any other matters are properly presented to the
Meeting, it is the intention of the persons named in the accompanying proxy to
vote, or otherwise to act, in accordance with their best judgment on such
matters.
Stockholders Proposals - Under SEC Rule 14a-8, stockholder proposals
for the annual meeting of stockholders to be held in 2006 will not be included
in the Proxy Statement for that meeting unless the proposal is proper for
inclusion in the Proxy Statement and for consideration at the next annual
meeting of stockholders, and is received by the Secretary of the Company at the
Company's executive offices, which are located at 6836 Morrison Boulevard, Suite
200, Charlotte, NC 28211, no later than February 1, 2006, which is 120 days
before the anniversary date of the release of this proxy statement to
stockholders. Stockholders must also follow the other procedures prescribed in
SEC Rule 14a-8 under the Exchange Act.
Annual Report to Stockholders - The Company's Annual Report to
Stockholders for the year ended June 30, 2004, containing financial and other
information pertaining the Company, is being furnished to the stockholders
simultaneously with this Proxy Statement.
Annual Report on Form 10-K - The Company will furnish without charge to
any stockholder as of the record date a copy of the Company's Annual Report on
Form 10-KA for the year ended June 30, 2004, as filed with the SEC. Requests for
such materials should be made in writing and directed to RCG Companies, 6836
Morrison Boulevard, Suite 200, Charlotte, NC 28211, Attention: Controller.
Whether or not you plan to attend, you are urged to complete, sign and
return the enclosed proxy in the accompanying envelope or vote over the internet
or by telephone in accordance with the instructions on the proxy card. A prompt
response will greatly facilitate arrangements for the Meeting, and your
cooperation will be appreciated. Stockholders who attend the Meeting may vote
their shares personally even though they have sent in their proxies.
67
Appendix A
CHARTER OF THE NOMINATING
AND
CORPORATE GOVERNANCE COMMITTEE
OF
THE BOARD OF DIRECTORS
OF RCG COMPANIES INCORPORATED
I. PURPOSE OF THE COMMITTEE
The purposes of the Nominating and Corporate Governance Committee (the
"Committee") of the Board of Directors (the "Board") of RCG Companies
Incorporated (the "Company") shall be to recommend to the Board individuals
qualified to serve as directors of the Company and on committees of the Board;
to advise the Board with respect to the Board composition, procedures and
committees; to develop and recommend to the Board a set of corporate governance
principles applicable to the Company; and to oversee the evaluation of the Board
and the Company's management.
II. COMPOSITION OF THE COMMITTEE
The Committee shall initially be comprised of two directors who qualify as
independent directors ("Independent Directors") under the listing standards of
The American Stock Exchange (the "AMEX"). The Board shall designate one member
of the Committee as its Chairperson.
The number and identities of directors comprising the members of the Committee
shall be determined from time to time by resolution of the Board. Vacancies on
the Committee shall be filled by majority vote of the Board at the next meeting
of the Board following the occurrence of the vacancy.
III. MEETINGS AND PROCEDURES OF THE COMMITTEE
The Committee shall meet as often as it deems necessary in order to perform its
responsibilities. The Chairperson of the Committee or a majority of the members
of the Committee may call a special meeting of the Committee. A majority of the
members of the Committee present in person or by telephone shall constitute a
quorum.
The Committee may form subcommittees for any purpose that the Committee deems
appropriate and may delegate to such subcommittees such power and authority as
the Committee deems appropriate; provided, however, that no subcommittee shall
consist of fewer than two members; and provided further that the Committee shall
not delegate to a subcommittee any power or authority required by any law,
regulation or listing standard to be exercised by the Committee as a whole.
The Committee may request that any directors, officers or employees of the
Company, or other persons whose advice and counsel are sought by the Committee,
attend any meeting of the Committee to provide such pertinent information as the
Committee requests.
Following each of its meetings, the Committee shall deliver to the Board a
meeting report, which includes a description of all actions taken by the
Committee at the meeting. The Committee shall keep written minutes of its
meetings, which minutes shall be maintained with the books and records of the
Company.
IV. DUTIES OF THE COMMITTEE
A. Board Candidates and Nominees
With respect to Board candidates and nominees, the Committee shall have the
following goals and responsibilities:
1
(a) To establish procedures for evaluating the suitability of potential
director nominees proposed by management or shareholders, including conducting
all necessary and appropriate inquiries into the background and qualifications
of potential candidates.
(b) To consider questions of independence and conflicts of interest
pertaining to members of the Board.
(c) Except where the Company is legally required by contract or
otherwise to provide third parties with the ability to nominate directors, the
Committee shall recommend to the Board for approval by the stockholders at the
annual meeting, or by the Board to fill vacancies, the director nominees, which
recommendations shall be consistent with the Board's criteria for selecting new
directors. Such criteria include the possession of such knowledge, experience,
skills, expertise and diversity so as to enhance the Board's ability to manage
and direct the affairs and business of the Company, including, when applicable,
to enhance the ability of committees of the Board to fulfill their duties and/or
to satisfy any independence requirements imposed by law, regulation or AMEX
listing requirement.
(d) To review each director's suitability for continued service when
his or her term expires and when he or she has a significant change in status,
including but not limited to, an employment change, and to recommend whether or
not the director should be re-nominated.
(e) To review and determine directors' compensation.
B. Board Composition and Procedures
The Committee shall have the following goals and responsibilities with respect
to the composition and procedures of the Board as a whole:
(a) To review annually with the Board the composition of the Board as a
whole and recommend, if necessary, measures to be taken so that the Board
reflects the appropriate balance of knowledge, experience, skills, expertise and
diversity required for the Board as a whole and contains at least the minimum
number of Independent Directors required by the AMEX.
(b) To review periodically the size of the Board and recommend to the
Board any appropriate changes.
(c) To make recommendations on the frequency and structure of Board
meetings.
(d) To make recommendations concerning any other aspect of the
procedures of the Board that the Committee considers warranted, including but
not limited to, procedures with respect to the waiver by the Board of any
Company rule, guideline, procedure or corporate governance principle.
C. Board Committees
The following shall be the goals and responsibilities of the Committee with
respect to the committee structure of the Board:
(a) To make recommendations to the Board regarding the size and
composition of each standing committee of the Board of Directors, including the
identification of individuals qualified to serve as members of a committee,
including the Committee, and to recommend individual directors to fill any
vacancy that might occur on a committee, including the Committee.
(b) To monitor the functioning of the committees of the Board and to
make recommendations for any changes, including the creation and elimination of
committees.
(c) To review annually committee assignments and the policy with
respect to the rotation of committee memberships and/or chairpersonships, and to
report any recommendations to the Board.
2
(d) To recommend that the Board establish such special committees as
may be desirable or necessary from time to time in order to address ethical,
legal or other matters that may arise. The Committee's power to make such a
recommendation under this Charter shall be without prejudice to the right of any
other committee of the Board, or any individual director, to make such a
recommendation at any time.
D. Chief Executive Officer
The Committee shall make recommendations to the Board regarding the selection
and replacement, if necessary, of the CEO and periodically evaluate the
performance of the CEO. The Committee shall review and evaluate succession
planning for the CEO and other executive officer positions.
E. Corporate Governance
With respect to corporate governance, the following shall be the goals and
responsibilities of the Committee:
(a) To develop and review periodically, and at least annually, the
corporate governance principles adopted by the Board to assure that they are
appropriate for the Company and comply with the requirements of the AMEX, and to
recommend any desirable changes to the Board.
(b) To consider the adequacy of the Articles of Incorporation and
Bylaws of the Company and recommend amendments to such organizational documents,
if necessary.
(c) To ensure that at each annual meeting, and at other regular Board
meetings if necessary, the Independent Directors meet in executive session prior
to the conclusion of such meetings.
(d) To consider any other corporate governance and ethical issues that
arise from time to time, and to develop appropriate recommendations for the
Board.
V. EVALUATION OF THE BOARD
The Committee shall be responsible for overseeing the evaluation of individual
directors and the Board as a whole. The Committee shall establish procedures to
allow it to exercise this oversight function.
VI. EVALUATION OF THE COMMITTEE
The Committee shall, on an annual basis, evaluate its performance under this
Charter. In conducting this review, the Committee shall evaluate whether this
Charter appropriately addresses the matters that are or should be within its
scope. The Committee shall address all matters that the Committee considers
relevant to its performance, including at least the following: the adequacy,
appropriateness and quality of the information and recommendations presented by
the Committee to the Board; the manner in which they were discussed or debated;
and whether the number and length of meetings of the Committee were adequate for
the Committee to complete its work in a thorough and thoughtful manner.
The Committee shall deliver to the Board a report setting forth the results of
its evaluation, including any recommended amendments to this Charter and any
recommended changes to the Company's or the Board's policies or procedures.
VII. INVESTIGATIONS AND STUDIES; OUTSIDE ADVISERS
The Committee may conduct or authorize investigations into or studies of matters
within the Committee's scope of responsibilities, and may retain, at the
Company's expense, such independent counsel or other advisers as it deems
necessary. The Committee shall have the sole authority to retain or terminate
any search firm to be used to identify director candidates, including the sole
authority to approve the search firm's fees and other retention terms, such fees
to be borne by the Company.
3
[PROXY]
RCG COMPANIES INCORPORATED
6836 MORRISON BLVD., SUITE 200, CHARLOTTE, NORTH CAROLINA 28211
VOTE BY INTERNET - www.proxyvote.com
Use the Internet to transmit your voting instructions and for electronic
delivery of information up until 11:59 P.M. Eastern Time the day before the
cut-off date or meeting date. Have your proxy card in hand when you access the
web site and follow the instructions to obtain your records and to create an
electronic voting instruction form.
ELECTRONIC DELIVERY OF FUTURE SHAREHOLDER COMMUNICATIONS
If you would like to reduce the costs incurred by RCG COMPANIES INCORPORATED in
mailing proxy materials, you can consent to receiving all future proxy
statements, proxy cards and annual reports electronically via e-mail or the
Internet. To sign up for electronic delivery, please follow the instructions
above to vote using the Internet and, when prompted, indicate that you agree to
receive or access shareholder communications electronically in future years.
VOTE BY PHONE - 1-800-690-6903
Use any touch-tone telephone to transmit your voting instructions up until 11:59
P.M. Eastern Time the day before the cut-off date or meeting date. Have your
proxy card in hand when you call and then follow the instructions.
VOTE BY MAIL
Mark, sign, and date your proxy card and return it in the postage-paid envelope
we have provided or return it to RCG COMPANIES INCORPORATED, c/o ADP, 51
Mercedes Way, Edgewood, NY 11717.
PROXY FOR THE ANNUAL MEETING OF
STOCKHOLDERS TO BE HELD ON JUNE 24, 2005
THIS PROXY IS SOLICITED ON BEHALF OF THE
BOARD OF DIRECTORS OF RCG COMPANIES INCORPORATED
The undersigned holder of shares of Common Stock of RCG COMPANIES
INCORPORATED, a Delaware corporation (the "Company"), hereby appoints William A.
Goldstein and Marc Bercoon, and each of them, with full power of substitution,
the proxies and attorneys of the undersigned, to vote as specified hereon at the
Annual Meeting of Stockholders (the "Meeting") of the Company to be held at the
Westin, located at 3391 Peachtree Road NE, Atlanta, Georgia, on June 24, 2005 at
9:30 a.m., local time, and at any adjournments or postponements thereof, with
all powers (other than the power to revoke the proxy or vote the proxy in a
manner not authorized by the executed form of proxy on the reverse side hereof)
that the undersigned would have if personally present at the Meeting, to act in
the undersigned's discretion upon any other matter or matters that may properly
be brought before the Meeting and to appear and vote all the shares of Common
Stock of the Company that the undersigned may be entitled to vote. The
undersigned hereby acknowledges receipt of the accompanying Proxy Statement,
Annual Report on Form 10-K/A for the fiscal year ended June 30, 2004 and
Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2005, and
hereby revokes any proxy or proxies heretofore given by the undersigned relating
to the Meeting.
This proxy may be revoked at any time prior to the voting thereof.
THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR EACH PROPOSAL
The Board of Directors recommends a vote FOR the following proposals:
1. To elect the eight nominees listed below to the Board of Directors of
the Company.
|_| FOR all nominees |_| WITHHOLD AUTHORITY to
(except as marked below) vote for all nominees
NOMINEES: Jeffrey F. Willmott, Michael D. Pruitt, Dr. James A.
Verbrugge, P. Roger Byer, J. Michael Carroll, William A. Goldstein,
Ronald Attkisson, and John J. Sicilian.
INSTRUCTIONS: To withhold authority to vote for any nominee, enter the
name of such nominee in the space provided below:
--------------------------------------------------------------------------------
(Continued and to be signed on the other side)
1
2. To ratify the Company's selection of BDO Seidman LLP as independent
registered public accounting firm for the fiscal year ending June 30,
2005.
|_| FOR |_| AGAINST |_| ABSTAIN
3. To approve, to the extent required for compliance with the American
Stock Exchange rules, the issuance of additional shares of the
Company's common stock in connection with the Company's February 2005
acquisition of Farequest Holdings, Inc., as needed for full (i)
conversion of the Company's Series B 6% Redeemable Participating
Preferred Stock into Common Stock; (ii) payment of the Company's
$6,037,872 Promissory Note with 3,018,936 shares of Common Stock for
the principal amount plus payment of interest of 4% per year in shares
of Common Stock as needed, and (iii) issuance of shares of Common Stock
as needed in full satisfaction of the Contingent Shares payable to the
Farequest Holdings, Inc. former shareholders.
|_| FOR |_| AGAINST |_| ABSTAIN
4. To approve, to the extent required for compliance with the American
Stock Exchange rules, issuance of additional shares of the Company's
Common Stock as needed for the full conversion of the Company's Series
A 6% Convertible Preferred Stock and exercise of Warrants and
Additional Investment Rights sold in a private placement offering
completed by the Company in September 2004 and Warrants sold in private
placement offerings completed by the Company in October 2003 and
February 2005 and adjusted in April 2005.
|_| FOR |_| AGAINST |_| ABSTAIN
5. To approve, to the extent required for compliance with the American
Stock Exchange rules, issuance of additional shares of the Company's
Common Stock as needed for full conversion of the Company's Series C
Convertible Preferred Stock and exercise of the Company's Warrants sold
in a private placement in April 2005.
|_| FOR |_| AGAINST |_| ABSTAIN
6. To approve an amendment to the Company's Certificate of Incorporation
effecting a 1 for 10 reverse split of the Company's Common Stock and
reduction of the authorized Common Stock.
|_| FOR |_| AGAINST |_| ABSTAIN
7. To approve, to the extent required for compliance with the American
Stock Exchange rules, the issuance of additional shares of the
Company's Common Stock as needed for full conversion of the Company's
aggregate $12,500,000 Secured Promissory Notes issued for the
acquisition of OneTravel, Inc.
|_| FOR |_| AGAINST |_| ABSTAIN
8. To transact such other business as may properly come before the Meeting.
|_| FOR |_| AGAINST |_| ABSTAIN
2
UNLESS OTHERWISE MARKED, THIS PROXY WILL BE VOTED AS IF MARKED FOR THE PROPOSALS
ABOVE.
Dated: _______________, 2005
-------------------------------------------
Signature
-------------------------------------------
Signature if jointly held
Please date and sign as name appears
hereon. When signing as Executor,
Administrator, Trustee, Guardian or
Attorney, please give full title as such.
If a corporation, please sign in full
corporate name by president or other
authorized corporate officer. If a
partnership, please sign in partnership
name by authorized person. Joint owners
should each sign.
3